10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2018

Commission File Number: 33-47040

CINEMARK USA, INC.

(Exact name of registrant as specified in its charter)

Texas	75-2206284
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3900 Dallas Parkway
Suite 500
Plano, Texas	75093
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code:  (972) 665-1000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒  (Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐  No ☒

As of July 31, 2018, 1,500 shares of Class A common stock and 182,648 shares of Class B common stock were outstanding.  

CINEMARK USA, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

			Page
PART I.     FINANCIAL INFORMATION
	Item 1.	Financial Statements	4
		Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited)	4
		Condensed Consolidated Statements of Income for the three and six months ended June 30, 2018 and 2017 (unaudited)	5
		Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2018 and 2017 (unaudited)	6
		Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)	7
		Notes to Condensed Consolidated Financial Statements (unaudited)	8
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	38
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	50
	Item 4.	Controls and Procedures	50
PART II.     OTHER INFORMATION
	Item 1.	Legal Proceedings	51
	Item 1A.	Risk Factors	51
	Item 5	Other Information	51
	Item 6.	Exhibits	56
SIGNATURES			57

2

Cautionary Statement Regarding Forward-Looking Statements

Certain matters within this Quarterly Report on Form 10Q include “forward–looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The “forward-looking statements” may include our current expectations, assumptions, estimates and projections about our business and our industry. They may include statements relating to future revenues, expenses and profitability, the future development and expected growth of our business, projected capital expenditures, attendance at movies generally or in any of the markets in which we operate, the number or diversity of popular movies released and our ability to successfully license and exhibit popular films, national and international growth in our industry, competition from other exhibitors and alternative forms of entertainment and determinations in lawsuits in which we are defendants.  Forward-looking statements can be identified by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.  For a description of the risk factors, please review the “Risk Factors” section or other sections in the Company’s Annual Report on Form 10-K filed March 2, 2018 and quarterly reports on Form 10-Q, filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such risk factors. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

3

PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data, unaudited)

	June 30,			December 31,
	2018			2017
Assets
Current assets
Cash and cash equivalents	$	504,695		$	522,415
Inventories		17,685			17,507
Accounts receivable		80,305			89,248
Current income tax receivable		4,815			11,730
Prepaid expenses and other		20,657			16,536
Accounts receivable from parent		18,963			14,581
Total current assets		647,120			672,017
Theatre properties and equipment		3,362,779			3,328,589
Less: accumulated depreciation and amortization		1,545,042			1,500,535
Theatre properties and equipment, net		1,817,737			1,828,054
Other assets
Goodwill		1,281,170			1,284,079
Intangible assets - net		332,506			336,761
Investment in NCM		199,019			200,550
Investments in and advances to affiliates		145,081			120,045
Long-term deferred tax asset		4,050			4,067
Deferred charges and other assets - net		47,488			39,767
Total other assets		2,009,314			1,985,269
Total assets	$	4,474,171		$	4,485,340
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7,984		$	7,099
Current portion of capital lease obligations		26,671			25,511
Current income tax payable		6,850			5,509
Current liability for uncertain tax positions		3,650			11,873
Accounts payable and accrued expenses		394,279			418,294
Total current liabilities		439,434			468,286
Long-term liabilities
Long-term debt, less current portion		1,774,782			1,780,381
Capital lease obligations, less current portion		239,005			251,151
Long-term deferred tax liability		141,307			121,787
Long-term liability for uncertain tax positions		13,405			8,358
Deferred lease expenses		39,750			40,929
Deferred revenue - NCM		295,264			351,706
Other long-term liabilities		47,462			41,247
Total long-term liabilities		2,550,975			2,595,559
Commitments and contingencies (see Note 16)
Equity
Cinemark USA, Inc.'s stockholder's equity:
Class A common stock, $0.01 par value: 10,000,000 shares authorized, 1,500 shares issued and outstanding		—			—
Class B common stock, no par value: 1,000,000 shares authorized, 239,893 shares issued and 182,648 shares outstanding		49,543			49,543
Treasury stock, 57,245 Class B shares at cost		(24,233	)		(24,233	)
Additional paid-in-capital		1,270,927			1,264,505
Retained earnings		484,453			373,069
Accumulated other comprehensive loss		(309,306	)		(253,282	)
Total Cinemark USA, Inc.'s stockholder's equity		1,471,384			1,409,602
Noncontrolling interests		12,378			11,893
Total equity		1,483,762			1,421,495
Total liabilities and equity	$	4,474,171		$	4,485,340

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data, unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2018			2017			2018			2017
Revenues
Admissions	$	508,870		$	449,880		$	961,494		$	926,349
Concession		305,306			262,322			567,078			530,546
Other		74,877			38,993			140,452			73,910
Total revenues		889,053			751,195			1,669,024			1,530,805
Cost of operations
Film rentals and advertising		287,206			246,556			528,121			499,374
Concession supplies		51,033			41,839			91,857			83,939
Salaries and wages		100,344			89,812			193,502			174,013
Facility lease expense		81,190			82,388			163,281			166,650
Utilities and other		115,602			91,053			225,034			179,410
General and administrative expenses		42,293			37,051			84,024			74,667
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Total cost of operations		761,647			652,191			1,438,723			1,300,008
Operating income		127,406			99,004			230,301			230,797
Other income (expense)
Interest expense		(28,466	)		(26,522	)		(55,581	)		(52,891	)
Loss on debt amendments		—			(246	)		(1,484	)		(246	)
Interest income		2,858			1,380			5,093			2,713
Foreign currency exchange gain (loss)		(5,199	)		(155	)		(3,821	)		1,434
Distributions from NCM		3,424			2,772			9,782			9,560
Interest expense - NCM		(4,913	)		—			(9,892	)		—
Equity in income of affiliates		6,414			5,805			15,050			15,865
Total other expense		(25,882	)		(16,966	)		(40,853	)		(23,565	)
Income before income taxes		101,524			82,038			189,448			207,232
Income taxes		18,502			29,742			43,755			74,370
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Less:  Net income attributable to noncontrolling interests		329			571			485			1,037
Net income attributable to Cinemark USA, Inc.	$	82,693		$	51,725		$	145,208		$	131,825

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands, unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method    investments		(116	)		(95	)		20			103
Foreign currency translation adjustments		(56,248	)		(18,401	)		(56,044	)		(3,508	)
Total other comprehensive loss, net of tax		(56,364	)		(18,496	)		(56,024	)		(3,405	)
Total comprehensive income, net of tax		26,658			33,800			89,669			129,457
Comprehensive income attributable to noncontrolling interests		(329	)		(571	)		(485	)		(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	26,329		$	33,229		$	89,184		$	128,420

The accompanying notes are an integral part of the condensed consolidated financial statements.

6

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

	Six Months Ended June 30,
	2018			2017
Operating activities
Net income	$	145,693		$	132,862
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		126,981			115,755
Amortization of intangible and other assets and favorable/unfavorable leases		1,704			738
Amortization of long-term prepaid rents		1,236			989
Amortization of debt issue costs		2,913			3,063
Loss on debt amendments		1,484			246
Amortization of deferred revenues, deferred lease incentives and other		(10,762	)		(7,923	)
Impairment of long-lived assets		3,379			4,574
Share based awards compensation expense		6,422			6,051
Loss on disposal of assets and other		20,840			888
Deferred lease expenses		(932	)		(722	)
Equity in income of affiliates		(15,050	)		(15,865	)
Deferred income tax expenses		7,669			14,515
Distributions from equity investees		16,255			14,919
Changes in assets and liabilities and other		(28,187	)		(34,724	)
Net cash provided by operating activities		279,645			235,366
Investing activities
Additions to theatre properties and equipment		(162,589	)		(182,800	)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(11,508	)		(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,135			14,521
Investment in joint ventures and other, net		(19,467	)		(466	)
Net cash used for investing activities		(191,429	)		(209,574	)
Financing activities
Dividends paid to parent		(74,350	)		(67,250	)
Payroll taxes paid as a result of stock withholdings		(2,905	)		(2,921	)
Repayments of long-term debt		(3,298	)		(1,427	)
Payment of debt issue costs		(5,103	)		(521	)
Fees paid related to debt amendments		(704	)		(246	)
Payments on capital leases		(12,377	)		(10,143	)
Other		—			(311	)
Net cash used for financing activities		(98,737	)		(82,819	)
Effect of exchange rate changes on cash and cash equivalents		(7,199	)		(75	)
Decrease in cash and cash equivalents		(17,720	)		(57,102	)
Cash and cash equivalents:
Beginning of period		522,415			561,138
End of period	$	504,695		$	504,036
Supplemental information (see Note 13)

The accompanying notes are an integral part of the condensed consolidated financial statements.

7

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

1. The Company and Basis of Presentation

Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

The accompanying condensed consolidated balance sheet as of December 31, 2017, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.  

These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Annual Report on Form 10-K filed March 2, 2018 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be achieved for the full year.

2. New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC Topic 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers.  ASC Topic 606 replaces most existing revenue recognition guidance in U.S. generally accepted accounting principles.  In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from the contracts with customers.  The Company adopted ASC Topic 606 effective January 1, 2018.  See Note 3 for further discussion.  

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), (“ASU 2016-02”). The purpose of ASU 2016-02 is to provide financial statement users a better understanding of the amount, timing, and uncertainty of cash flows arising from leases. The adoption of ASU 2016-02 will result in the recognition of a right-of-use asset and a lease liability for most operating leases.  New disclosure requirements include qualitative and quantitative information about the amounts recorded in the financial statements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. ASU 2016-02 requires a modified retrospective transition by means of a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year in which the guidance is effective with the option to elect certain practical expedients. Early adoption is permitted. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, (“ASU 2018-10”). The amendments in ASU 2018-10 provide clarification of narrow aspects of the guidance issued in ASU 2016-02.  In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842), Targeted Improvements, (“ASU 2018-11”). The amendments in ASU 2018-11 provide an additional transition method to adopt the amendments in ASU 2016-02.  Under this new transition method, an entity initially applies the amendments in ASU 2016-02 at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.  Under this transition method, an entity is not required to use the modified transition method described in ASU 2016-02.  The Company plans to adopt the additional transition method provided in ASU 2018-11.  The Company is currently evaluating the impact of ASU 2016-02, ASU 2018-10 and ASU 2018-11 on its condensed consolidated financial statements.  The most significant impact of these amendments will be the recognition of new right-of-use assets and lease liabilities for assets related to leased theatres and certain leased equipment that are currently classified as operating leases.   The Company will adopt the amendments in ASU 2016-02, ASU 2018-10 and ASU 2018-11 in the first quarter of 2019.  

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230):  Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force, (“ASU 2016-15”). The purpose of ASU 2016-15 is to

8

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

reduce the diversity in practice regarding how certain cash receipts and cash payments are presented and classified in the statement of cash flows.  ASU 2016-15 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year.  A retrospective transition method should be used in the application of the amendments within ASU 2016-15.  The Company adopted ASU 2016-15 effective January 1, 2018.  As a result of the adoption of ASU 2016-15, cash paid of $246 related to the June 2017 amendment of the Company’s senior secured credit facility was reclassified from operating activities to financing activities for the six months ended June 30, 2017.  

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, (“ASU 2016-16”).  The purpose of ASU 2016-16 is to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory.  ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year.  A modified retrospective transition method should be used in the application of the amendments within ASU 2016-16 with a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption.  ASU 2016-16 did not have a material impact on the Company’s condensed consolidated financial statements.  

9

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

3. Revenue Recognition

Revenue Recognition Policy

The Company recognizes admissions and concession revenues when sales are made at the box office and concession stand, respectively.  Other revenues include screen advertising, transactional fees and other ancillary revenues such as vendor marketing promotions and meeting rentals located in the Company’s theatres.  The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. Additionally, the Company recognizes unredeemed gift cards and other advanced sale-type certificates, as a proportion of actual redemptions, as other revenues, which is an estimate primarily based on the Company’s historical experience with such cards and certificates.

Screen advertising revenues are generally recognized over the period that the related advertising is delivered on-screen or in-theatre. Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts.

See additional revenue recognition policy considerations, updated for the adoption of ASC Topic 606, below.  

Adoption of ASC Topic 606

The Company adopted ASC 606, Revenue from Contracts with Customers, effective January 1, 2018 under the modified retrospective method (cumulative-effect) and therefore, revenue amounts as presented on the condensed consolidated statements of income have not been adjusted for prior periods presented.

Changes to the way in which the Company recognizes revenue resulted in the following impacts to the condensed consolidated statements of income:

a)   Recording of incremental other revenue and interest expense related to the significant financing component of the Company’s Exhibitor Services Agreement (“ESA”) with NCM, LLC (“NCM”).  See further discussion below, including the estimated interest rates assumed in determining the amount of interest expense.

b) Deferral of a portion of admissions and concession revenues for transactions that include the issuance of loyalty points to customers. To determine the amount of revenues to defer upon issuance of points to customers under its points-based loyalty programs, the Company estimated the values of the rewards expected to be redeemed by its customers for those points.  The estimates are based on the rewards that have historically been offered under the loyalty programs, which the Company believes is representative of the rewards to be offered in the future.

c) Increase in other revenues and an increase in utilities and other expenses due to presentation of transactional fees on a gross versus net basis.

d) Increase in other revenues due to the change in amortization methodology for deferred revenue – NCM that is now amortized on a straight-line basis and effective for the entire term of the ESA.  As a result of the change in amortization method, the Company recorded a cumulative effect of accounting change adjustment of $40,526, net of taxes, in retained earnings on January 1, 2018 (see also Note 5).

10

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The above noted changes increased (decreased) admissions, concession and other revenue for the three and six months ended June 30, 2018 as follows:

	Three Months Ended			Six Months Ended
	June 30, 2018			June 30, 2018
Admissions revenues	$	(1,898	)	$	(3,200	)
Concession revenues	$	(662	)	$	(1,207	)
Other revenues	$	32,710		$	60,169

The Company applied the practical expedient to exclude sales and other similar taxes collected from customers from its transaction price for purposes of recording revenues, as such revenues are presented net of such taxes.

Disaggregation of Revenue

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on major type of good or service and by reportable operating segment.

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Admissions revenues	$	408,863	$	100,007	$	508,870	$	758,215	$	203,279	$	961,494
Concession revenues		249,618		55,688		305,306		453,368		113,710		567,078
Screen advertising and promotional revenues		21,051		15,446		36,497		39,230		29,715		68,945
Other revenues		29,542		8,838		38,380		54,604		16,903		71,507
Total revenues	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on timing of revenue recognition (see Revenue Recognition Policy above).

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	686,463	$	161,350	$	847,813	$	1,262,289	$	327,499	$	1,589,788
Goods and services transferred over time		22,611		18,629		41,240		43,128		36,108		79,236
Total	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

11

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

Deferred Revenues

The following table presents changes in the Company’s deferred revenues for the six months ended June 30, 2018.  

Deferred Revenues	Deferred Revenue - NCM			Other Deferred Revenues (1)			Total
Balance at January 1, 2018	$	351,706		$	86,498		$	438,204
Impact of adoption of ASC Topic 606		(53,605	)		—			(53,605	)
Amounts recognized as accounts receivable		—			11,349			11,349
Cash received from customers in advance		—			53,398			53,398
Common units received from NCM (see Note 7)		5,012			—			5,012
Revenue recognized during period		(7,849	)		(64,996	)		(72,845	)
Foreign currency translation adjustments		—			(1,689	)		(1,689	)
Balance at June 30, 2018	$	295,264		$	84,560		$	379,824

(1) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of June 30, 2018 and when the Company expects to recognize this revenue.

	Twelve Months Ended June 30,
Remaining Performance Obligations	2019		2020		2021		2022		2023		Thereafter		Total
Deferred revenue - NCM	$	15,831	$	15,831	$	15,831	$	15,831	$	15,831	$	216,109	$	295,264
Deferred revenue - other		72,053		12,039		282		186		—		—		84,560
Total	$	87,884	$	27,870	$	16,113	$	16,017	$	15,831	$	216,109	$	379,824

Accounts receivable as of June 30, 2018 included approximately $48,631 of receivables related to contracts with customers.  The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the six months ended June 30, 2018.

Significant Financing Component

As discussed further in Note 6, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM.  The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2037.  In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA.  See Note 6 for additional information regarding the common unit adjustment and related accounting.   Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606.  

As a result of the significant financing component on deferred revenue - NCM, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $4,913 and $9,892 during the three and six months ended June 30, 2018, respectively. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 5.5% to 8.0%.

4. Long Term Debt Activity

Senior Secured Credit Facility

On March 29, 2018, the Company amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The Company incurred debt issue costs of

12

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

approximately $4,962 in connection with the amendment, which are reflected as a reduction of long term debt on the condensed consolidated balance sheet as of June 30, 2018.  As a result of the amendment, the Company wrote-off $780 of unamortized debt issue costs and incurred approximately $704 in legal and other fees, both of which are reflected as loss on debt amendments on the condensed consolidated statements of income for the six months ended June 30, 2018.  

Fair Value of Long-Term Debt

The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”). The carrying value of the Company’s long-term debt was $1,813,997 and $1,817,295 as of June 30, 2018 and December 31, 2017, respectively, excluding unamortized debt discounts and debt issue costs. The fair value of the Company’s long-term debt was $1,800,830 and $1,840,918 as of June 30, 2018 and December 31, 2017, respectively.

5. Equity

Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the six months ended June 30, 2018 and 2017:

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling		Total
	Equity			Interests		Equity
Balance at January 1, 2018	$	1,409,602		$	11,893	$	1,421,495
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)		40,526			—		40,526
Share based awards compensation expense		6,422			—		6,422
Dividends paid to parent		(74,350	)		—		(74,350	)
Net income		145,208			485		145,693
Other comprehensive income in equity method investees		20			—		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)
Balance at June 30, 2018	$	1,471,384		$	12,378	$	1,483,762

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling			Total
	Equity			Interests			Equity
Balance at January 1, 2017	$	1,272,938		$	11,142		$	1,284,080
Share based awards compensation expense		6,051		―				6,051
Dividends paid to parent		(67,250	)	―				(67,250	)
Dividends paid to noncontrolling interests	―				(294	)		(294	)
Net income		131,825			1,037			132,862
Other comprehensive income in equity method investees		103		―				103
Foreign currency translation adjustments		(5,059	)	―				(5,059	)
Balance at June 30, 2017	$	1,338,608		$	11,885		$	1,350,493

6. Investment in National CineMedia

The Company has an investment in National Cinemedia, LLC (“NCM”).  NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. Upon joining NCM, the Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM provides advertising and promotions to our theatres.As described further in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. Following the NCM, Inc. IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a

13

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

component of earnings as Distributions from NCM.  The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

	Investment in NCM			Deferred Revenue			Distributions from NCM			Equity in Earnings			Other Revenue			Interest Expense - NCM (3)		Cash Received
Balance as of January 1, 2018	$	200,550		$	(351,706	)
Impact of adoption of ASC Topic 606 (1)		—			53,605		$	—		$	—		$	—		$	—	$	—
Receipt of common units due to annual common    unit adjustment ("CUA")		5,012			(5,012	)		—			—			—			—		—
Revenues earned under ESA (2) (3)		—			—			—			—			(16,074	)		9,892		6,182
Receipt of excess cash distributions		(8,760	)		—			(7,735	)		—			—			—		16,495
Receipt under tax receivable agreement		(2,294	)		—			(2,047	)		—			—			—		4,341
Equity in earnings		4,511			—			—			(4,511	)		—			—		—
Amortization of deferred revenue		—			7,849			—			—			(7,849	)		—		—
Balance as of and for the six months ended June 30, 2018	$	199,019		$	(295,264	)	$	(9,782	)	$	(4,511	)	$	(23,923	)	$	9,892	$	27,018

(1) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and Common Unit Adjustment agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption.  The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings (see also Note 5).  See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.  

(2) Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $6,227.

(3)   Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements.  See Note 3.  

During the three months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $495 and $176, respectively.  During the six months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $4,511 and $3,065, respectively.

The Company made payments to NCM of $60 and $50 during the six months ended June 30, 2018 and 2017, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre properties and equipment on the condensed consolidated balance sheets.  

Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC Entertainment, Inc. (“AMC”) and Regal Entertainment Group (“Regal”) (collectively, “Founding Members”), annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As further discussed in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis.

During March 2018, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2018, the Company received an additional 908,042 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $5,012. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.  The deferred revenue will be recognized on a straight-line basis over the remaining term of the ESA, which is approximately 19 years.

As of June 30, 2018, the Company owned a total of 28,779,904 common units of NCM, representing an ownership interest of approximately 18%. The estimated fair value of the Company’s investment in NCM was approximately $241,751 based on the price of NCMI common stock as of June 30, 2018 of $8.40 per share (Level 1 input as defined in FASB ASC Topic 820).  See Note 17 for discussion of subsequent event related to the acquisition of additional NCM common units from AMC.  

14

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is summary financial information for NCM for the periods indicated:

	ThreeMonths Ended				Six Months Ended
	June 28, 2018		June 29, 2017		June 28, 2018		June 29, 2017
Gross revenues	$	113,700	$	97,100	$	193,900	$	169,000
Operating income	$	40,100	$	28,300	$	51,100	$	33,400
Net income	$	25,000	$	15,400	$	22,000	$	7,500

	As of			As of
	June 28, 2018			December 28, 2017
Current assets	$	142,800		$	174,400
Noncurrent assets	$	758,800		$	758,300
Current liabilities	$	84,800		$	123,300
Noncurrent liabilities	$	943,500		$	925,400
Members deficit	$	(126,700	)	$	(116,000	)

7. Other Investments

Below is a summary of activity for each of the Company’s other investments for the six months ended June 30, 2018:

	DCIP			ACJV, LLC		DCDC			FE Concepts			Other		Total
Balance at January 1, 2018	$	106,215		$	5,916	$	3,598		$	104		$	4,212	$	120,045
Cash contributions made		739			—		—			20,000					20,739
Cash distributions received		(5,201	)		—		—			—			—		(5,201	)
Equity in income (loss)		9,727			408		481			(77	)		—		10,539
Equity in other comprehensive income		20			—		—			—			—		20
Other		—			—		(1,168	)		(104	)		211		(1,061	)
Balance at June 30, 2018	$	111,500		$	6,324	$	2,911		$	19,923		$	4,423	$	145,081

Digital Cinema Implementation Partners LLC (“DCIP”)

On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of June 30, 2018, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting.

Below is summary financial information for DCIP for the periods indicated:

	Three Months Ended				Six Months Ended
	June 30, 2018		June 30, 2017		June 30, 2018		June 30, 2017
Gross revenues	$	42,521	$	47,095	$	83,554	$	92,574
Operating income	$	25,049	$	29,393	$	48,494	$	57,872
Net income	$	22,169	$	25,616	$	43,703	$	49,757

	As of
	June 30, 2018		December 31, 2017
Current assets	$	51,546	$	56,296
Noncurrent assets	$	725,399	$	772,438
Current liabilities	$	63,982	$	59,153
Noncurrent liabilities	$	213,795	$	296,889
Members' equity	$	499,168	$	472,692

15

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

As of June 30, 2018, the Company had 3,818 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and six months ended June 30, 2018 and 2017:

	ThreeMonths Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Equipment lease payments	$	1,243		$	1,511		$	2,460		$	2,881
Warranty reimbursements from DCIP	$	(2,617	)	$	(2,023	)	$	(5,118	)	$	(3,907	)
Management service fees	$	184		$	206		$	378		$	412

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM.  The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $5,588 and $6,763 for the six months ended June 30, 2018 and 2017, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income.  Additionally, the remaining outstanding balance of a note payable from the Company to NCM, related to the formation of AC, was $2,778 as of June 30, 2018.

Digital Cinema Distribution Coalition

Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal.  DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $461 and $446 to DCDC during the six months ended June 30, 2018 and 2017, respectively, related to content delivery services provided by DCDC.  These fees are included in film rentals and advertising costs on the condensed consolidated statements of income.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities.  The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts.  The Company accounts for its investment in FE Concepts under the equity method of accounting.

8. Share Based Awards

Restricted Stock – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted 321,406 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $35.81 to $39.26 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. The restricted stock awards vest over periods ranging from one to four years.  The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

16

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a summary of restricted stock activity for the six months ended June 30, 2018:

	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2018		650,581		$	35.81
Granted		321,406		$	38.79
Vested		(242,945	)	$	31.16
Forfeited		(18,643	)	$	38.33
Outstanding at June 30, 2018		710,399		$	38.68
Unvested restricted stock at June 30, 2018		710,399		$	38.68

	Six Months Ended June 30,
	2018		2017
Compensation expense recognized by the Company during the period	$	4,342	$	3,901
Additional compensation expense recognized by Cinemark Holdings, Inc. during the period	$	456	$	393
Fair value of restricted shares held by Company employees that vested during the period	$	7,013	$	7,174
Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period	$	802	$	917
Income tax benefit recognized upon vesting of restricted stock awards held by Company employees	$	1,550	$	2,247
Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors	$	201	$	386

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $19,408, of which $18,528 will be recognized by the Company and $880 will be recognized by Cinemark Holdings, Inc.  The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Restricted Stock Units – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted restricted stock units representing 228,194 hypothetical shares of its common stock to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2019 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee of Cinemark Holdings, Inc.’s board of directors prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 7%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 9.5%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 13%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR.  All restricted stock units granted during 2018 will vest subject to an additional two-year service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest.  

17

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the six months ended June 30, 2018at each of the three target levels of financial performance (excluding forfeiture assumptions):

	Number of
	Shares		Value at
	Vesting		Grant
at IRR of at least 7%		76,065	$	2,967
at IRR of at least 9.5%		152,129	$	5,934
at IRR of at least 13%		228,194	$	8,901

Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2018 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $37.55 to $39.03 per share. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period.

	Six Months Ended June 30,
	2018		2017
Number of restricted stock unit awards that vested during    the period		127,084		97,115
Fair value of restricted stock unit awards that vested during    the period	$	4,846	$	4,155
Accumulated dividends paid upon vesting of restricted stock    unit awards	$	501	$	313
Compensation expense recognized during the period	$	2,080	$	2,150
Income tax benefit recognized upon vesting of restricted stock    unit awards	$	740	$	1,745

During the six months ended June 30, 2018, the Company determined that the IRR reached for the restricted stock units granted in February 2016 was 7.2%, compared to a target IRR of 8.0%.  The Company recorded a reduction in compensation expense of $69 during the six months ended June 30, 2018 to reflect the revised number of shares expected to vest in February 2020 for the 2016 restricted stock unit grant.  

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $9,854. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of June 30, 2018, the Company had restricted stock units outstanding that represented a total of 594,266 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 18,667 units, assuming an IRR of 7.2% was achieved for the 2016 grants and the maximum IRR level is achieved for all other grants outstanding.

9. Goodwill and Other Intangible Assets

The Company’s goodwill was as follows:

	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2018 (1)	$	1,174,041	$	110,038		$	1,284,079
Acquisition of theatres in Brazil (2)		—		11,508			11,508
Foreign currency translation adjustments		—		(14,417	)		(14,417	)
Balance at June 30, 2018 (1)	$	1,174,041	$	107,129		$	1,281,170

18

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

(1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

(2) Amount represents preliminary purchase price allocation for theatres acquired in Brazil.

The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable.  The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations).  For the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment on all reporting units, in accordance with ASC Topic 350-20-35.  No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of goodwill might exceed its estimated fair value.

Intangible assets consisted of the following:

	Balance at											Balance at
	January 1,											June 30,
	2018			Additions (1)		Amortization			Other (2)			2018
Intangible assets with finite lives:
Gross carrying amount	$	105,895		$	—	$	—		$	(1,645	)	$	104,250
Accumulated amortization		(68,869	)	―			(2,932	)	―				(71,801	)
Total net intangible assets with finite lives	$	37,026		$	—	$	(2,932	)	$	(1,645	)	$	32,449
Intangible assets with indefinite lives:
Tradename and other		299,735			608	―				(286	)		300,057
Total intangible assets — net	$	336,761		$	608	$	(2,932	)	$	(1,931	)	$	332,506

(1) Amount represents the acquisition of tradeable liquor licenses.

(2) Amount represents foreign currency translation adjustments.

For the year ended December 31, 2017, the Company performed a quantitative assessment for all definite and indefinite-lived tradename assets.  No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of its tradename assets might exceed their estimated fair values.

Estimated aggregate future amortization expense for intangible assets is as follows:

For the six months ended December 31, 2018	$	2,661
For the twelve months ended December 31, 2019		5,152
For the twelve months ended December 31, 2020		5,310
For the twelve months ended December 31, 2021		3,574
For the twelve months ended December 31, 2022		3,207
Thereafter		12,545
Total	$	32,449

10. Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K.  As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the six months ended June 30, 2018 and 2017. As of June 30, 2018, the estimated aggregate fair value of the long-lived assets impaired during the six months ended June 30, 2018 was $871.

19

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre.

Below is a summary of impairment charges for the periods presented:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
U.S. theatre properties	$	1,187	$	84	$	1,778	$	357
International theatre properties		1,601		4,217		1,601		4,217
Impairment of long-lived assets	$	2,788	$	4,301	$	3,379	$	4,574

11. Fair Value Measurements

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

The Company did not have any assets or liabilities measured at fair value on a recurring basis under ASC Topic 820 as of December 31, 2017 or June 30, 2018.  

The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 9 and Note 10). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed March 2, 2018.  There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the six months ended June 30, 2018.  

12. Foreign Currency Translation

The accumulated other comprehensive loss account in stockholder’s equity of $309,306 and $253,282 as of June 30, 2018 and December 31, 2017, respectively, primarily includes cumulative foreign currency adjustments of $309,609 and $253,565, respectively, from translating the financial statements of the Company’s international subsidiaries.

As of June 30, 2018, all foreign countries where the Company has operations are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss.  

A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity.  There has been a steady devaluation of the Argentine peso relative to the U.S. dollar in recent years.  As of June 30, 2018, the Company did not designate Argentina as highly inflationary for accounting purposes.  However, the Company has determined that Argentina will be deemed highly inflationary beginning July 1, 2018.  The financial information of the Company’s Argentina subsidiaries will be remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective July 1, 2018.    

20

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a summary of the impact of translating the June 30, 2018 financial statements of the Company’s international subsidiaries:

					Other
					Comprehensive
					Income (Loss) for the
	Exchange Rate as of				Six Months Ended
Country	June 30, 2018		December 31, 2017		June 30, 2018
Brazil		3.88		3.31	$	(34,511	)
Argentina		28.94		18.65		(16,896	)
Peru		3.28		3.24		(580	)
Chile		654.28		615.97		(4,372	)
All other						315
					$	(56,044	)

13. Supplemental Cash Flow Information

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

	Six Months Ended
	June 30,
	2018			2017
Cash paid for interest	$	51,562		$	49,603
Cash paid for income taxes, net of refunds received	$	28,477		$	55,371
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the    acquisition of theatre properties and equipment (1)	$	2,898		$	(4,959	)
Theatre properties acquired under capital lease	$	4,035		$	7,089
Interest expense - NCM (see Note 3)	$	(9,892	)	$	—
Investment in NCM – receipt of common units (see    Note 6)	$	5,012		$	18,363

(1) Additions to theatre properties and equipment included in accounts payable as of June 30, 2018 and December 31, 2017 were $34,174 and $31,276, respectively.

14. Segments

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments.

21

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a breakdown of selected financial information by reportable operating segment:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Revenues
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
International		179,979			199,926			363,607			401,994
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total revenues	$	889,053		$	751,195		$	1,669,024		$	1,530,805
Adjusted EBITDA
U.S.	$	188,920		$	129,976		$	345,190		$	295,038
International		33,192			41,285			70,778			88,511
Total Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549
Capital expenditures
U.S.	$	59,675		$	77,175		$	129,646		$	155,992
International		22,751			14,438			32,943			26,808
Total capital expenditures	$	82,426		$	91,613		$	162,589		$	182,800

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Add (deduct):		-			-
Income taxes		18,502			29,742			43,755			74,370
Interest expense (1)		28,466			26,522			55,581			52,891
Other (income) expense (2)		840			(7,030	)		(6,430	)		(20,012	)
Loss on debt amendments		—			246			1,484			246
Other cash distributions from equity investees (3)		3,932			2,870			16,255			14,919
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Deferred lease expenses		(449	)		(375	)		(932	)		(722	)
Amortization of long-term prepaid rents		597			496			1,236			989
Share based awards compensation expense		3,223			3,002			6,422			6,051
Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549

(1) Includes amortization of debt issue costs.

(2) Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.

(3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7).  These distributions are reported entirely within the U.S. operating segment.

(4) The adoption of ASC Topic 606 impacted how the Company records certain revenues.  See Note 3 for discussion of the impact of ASC Topic 606.  

22

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Financial Information About Geographic Areas

Below is a breakdown of selected financial information by geographic area:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
Revenues	2018			2017			2018			2017
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
Brazil		72,977			87,841			153,113			182,540
Other international countries		107,002			112,085			210,494			219,454
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total	$	889,053		$	751,195		$	1,669,024		$	1,530,805

	As of		As of
Theatre Properties and Equipment-net	June 30, 2018		December 31, 2017
U.S.	$	1,465,915	$	1,439,168
Brazil		146,467		179,669
Other international countries		205,355		209,217
Total	$	1,817,737	$	1,828,054

15. Related Party Transactions

The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $327 and $305 of management fee revenues during the six months ended June 30, 2018 and 2017, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip.  For the six months ended June 30, 2018 and 2017, the aggregate amounts paid to Copper Beech for the use of the aircraft was $51 and $63, respectively.

The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the six months ended June 30, 2018 and 2017, the Company paid total rent of approximately $12,980 and $13,420, respectively, to Syufy.

The Company has paid certain fees on behalf of its parent, Cinemark Holdings, Inc., and Cinemark Holdings, Inc. has paid income taxes and other items on behalf of the Company.  The net receivable from Cinemark Holdings, Inc. as of June 30, 2018 and December 31, 2017 was $18,963 and $14,581, respectively.  The Company paid Cinemark Holdings, Inc. cash dividends of $74,350 and $67,250 during the six months ended June 30, 2018 and 2017, respectively.  

The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities.  See Note 7 for further discussion.  

23

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

16. Commitments and Contingencies

Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for penalties and attorney's fees arising from alleged violations of the California wage statement law.  The claim is also asserted as a representative action under the California Private Attorney General Act (PAGA) for penalties. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims.  The company denies any violation of law and plans to vigorously defend against all claims.  The parties are awaiting the Court's ruling on Plaintiff's motion for class certification. The Company is unable to predict the outcome of this litigation or the range of potential loss.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles.  Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships.  Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest.  Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016.  The Company denied the allegations.  In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims.  The trial court granted that motion and dismissed Plaintiff’s claims.  Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.”  Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets.  Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim.  Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims.  That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice.  Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court.  The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction.  The case returned to the trial court on October 6, 2016.  On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards.  Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees.  During the three and six months ended June 30, 2018, the Company recorded a litigation reserve based on an estimate of the jury award, which is reflected in loss on disposal of assets and other on the condensed consolidated income statement.  The Company has filed a motion for a judgment notwithstanding the verdict and a motion for a new trial. Depending on the ruling on these motions, the Company intends to appeal any final judgment.  Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals.

The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures.  The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

From time to time, the Company is involved in various other legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

17. Subsequent Event – Acquisition of common units of NCM

On July 5, 2018 the Company acquired 10,738,740 common units of NCM from AMC for $78,400 in cash, or approximately $7.30 per common unit.  As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%.  The amount paid for the additional common units will be recorded as an increase in the Company’s investment in NCM.  See Note 6 for further discussion of the accounting for the Company’s investment in NCM.

24

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

18. Condensed Consolidating Financial Information of Subsidiary Guarantors

As of June 30, 2018, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023,  or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.:

Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC.

The following supplemental condensed consolidating financial information presents:

a. Condensed consolidating balance sheet information as of December 31, 2017 and June 30, 2018, condensed consolidating statements of income information for the three and six months ended June 30, 2017 and 2018, condensed consolidating statements of comprehensive income (loss) information for the three and six months ended June 30, 2017 and 2018 and condensed consolidating statements of cash flows information for the six months ended June 30, 2017 and 2018.

b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column.

c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries

25

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

DECEMBER 31, 2017

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	130,590	$	180,623	$	211,202	$	—		$	522,415
Other current assets		59,661		17,841		76,789		(19,270	)		135,021
Accounts receivable from parent or subsidiaries		117,972		119,616		—		(223,007	)		14,581
Total current assets		308,223		318,080		287,991		(242,277	)		672,017
Theatre properties and equipment - net		650,783		765,500		411,771		—			1,828,054
Investment in subsidiaries		1,691,626		121,795		—		(1,813,421	)		—
Other assets		1,427,328		134,845		536,816		(113,720	)		1,985,269
Total assets	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	5,710	$	—	$	1,389	$	—		$	7,099
Current portion of capital lease obligations		9,532		11,124		4,855		—			25,511
Accounts payable and accrued expenses		215,580		116,409		110,089		(6,402	)		435,676
Accounts payable to parent or subsidiaries		—		—		223,007		(223,007	)		—
Total current liabilities		230,822		127,533		339,340		(229,409	)		468,286
Long-term liabilities
Long-term debt, less current portion		1,878,992		—		11,211		(109,822	)		1,780,381
Capital lease obligations, less current    portion		132,189		75,767		43,195		—			251,151
Other long-term liabilities and deferrals		426,355		60,567		93,871		(16,766	)		564,027
Total long-term liabilities		2,437,536		136,334		148,277		(126,588	)		2,595,559
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,360,059		618,985		726,830		(1,345,815	)		1,360,059
Total Cinemark USA, Inc. stockholder's    equity		1,409,602		1,076,353		737,068		(1,813,421	)		1,409,602
Noncontrolling interests		—		—		11,893		—			11,893
Total equity		1,409,602		1,076,353		748,961		(1,813,421	)		1,421,495
Total liabilities and equity	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340

26

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

JUNE 30, 2018

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	301,796	$	8,711	$	194,188	$	—		$	504,695
Other current assets		70,203		21,043		67,168		(34,952	)		123,462
Accounts receivable from parent or subsidiaries		—		324,697		—		(305,734	)		18,963
Total current assets		371,999		354,451		261,356		(340,686	)		647,120
Theatre properties and equipment - net		670,573		769,293		377,871		—			1,817,737
Investment in subsidiaries		1,763,463		89,214		—		(1,852,677	)		—
Other assets		1,427,050		154,648		540,294		(112,678	)		2,009,314
Total assets	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	—	$	1,389	$	—		$	7,984
Current portion of capital lease obligations		12,192		9,579		4,900		—			26,671
Accounts payable and accrued expenses		237,615		101,384		96,104		(30,324	)		404,779
Accounts payable to parent or subsidiaries		101,094		—		204,640		(305,734	)		—
Total current liabilities		357,496		110,963		307,033		(336,058	)		439,434
Long-term liabilities
Long-term debt, less current portion		1,873,393		—		9,343		(107,954	)		1,774,782
Capital lease obligations, less current portion		129,201		67,623		42,181		—			239,005
Other long-term liabilities and deferrals		401,611		59,509		85,420		(9,352	)		537,188
Total long-term liabilities		2,404,205		127,132		136,944		(117,306	)		2,550,975
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,421,841		672,143		712,928		(1,385,071	)		1,421,841
Total Cinemark USA, Inc. stockholder's equity		1,471,384		1,129,511		723,166		(1,852,677	)		1,471,384
Noncontrolling interests		—		—		12,378		—			12,378
Total equity		1,471,384		1,129,511		735,544		(1,852,677	)		1,483,762
Total liabilities and equity	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171

27

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	247,821		$	305,019		$	209,998		$	(11,643	)	$	751,195
Cost of operations
Theatre operating expenses		197,345			210,406			155,540			(11,643	)		551,648
General and administrative expenses		2,365			20,872			13,814			—			37,051
Depreciation and amortization		20,193			21,767			17,177			—			59,137
Impairment of long-lived assets		41			43			4,217			—			4,301
(Gain) loss on disposal of assets and other		5,072			(4,866	)		(152	)		—			54
Total cost of operations		225,016			248,222			190,596			(11,643	)		652,191
Operating income		22,805			56,797			19,402			—			99,004
Other income (expense)
Interest expense		(23,473	)		(1,836	)		(1,571	)		358			(26,522	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			2,772			—			2,772
Equity in income of affiliates		52,156			12,299			5,851			(64,501	)		5,805
Other income		224			162			1,197			(358	)		1,225
Total other income (expense)		28,661			10,625			8,249			(64,501	)		(16,966	)
Income before income taxes		51,466			67,422			27,651			(64,501	)		82,038
Income taxes		(259	)		25,412			4,589			—			29,742
Net income		51,725			42,010			23,062			(64,501	)		52,296
Less: Net income attributable to    noncontrolling interests		—			—			571			—			571
Net income attributable to Cinemark USA,    Inc.	$	51,725		$	42,010		$	22,491		$	(64,501	)	$	51,725

28

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	332,976		$	385,703		$	191,616		$	(21,242	)	$	889,053
Cost of operations
Theatre operating expenses		255,711			255,943			144,963			(21,242	)		635,375
General and administrative expenses		3,651			25,097			13,545			—			42,293
Depreciation and amortization		22,216			24,049			18,025			—			64,290
Impairment of long-lived assets		1,187			—			1,601			—			2,788
Loss on disposal of assets and other		2,462			13,978			461			—			16,901
Total cost of operations		285,227			319,067			178,595			(21,242	)		761,647
Operating income		47,749			66,636			13,021			—			127,406
Other income (expense)
Interest expense		(24,156	)		(1,703	)		(2,949	)		342			(28,466	)
Distributions from NCM		—			—			3,424			—			3,424
Interest expense - NCM		(4,913	)		—			—			—			(4,913	)
Equity in income of affiliates		68,807			2,677			6,339			(71,409	)		6,414
Other income (expense)		1,392			(62	)		(3,329	)		(342	)		(2,341	)
Total other income (expense)		41,130			912			3,485			(71,409	)		(25,882	)
Income before income taxes		88,879			67,548			16,506			(71,409	)		101,524
Income taxes		6,186			15,586			(3,270	)		—			18,502
Net income		82,693			51,962			19,776			(71,409	)		83,022
Less: Net income attributable to    noncontrolling interests		—			—			329			—			329
Net income attributable to Cinemark USA,    Inc.	$	82,693		$	51,962		$	19,447		$	(71,409	)	$	82,693

29

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	517,702		$	615,975		$	421,993		$	(24,865	)	$	1,530,805
Cost of operations
Theatre operating expenses		402,576			417,589			308,086			(24,865	)		1,103,386
General and administrative expenses		6,625			41,209			26,833			—			74,667
Depreciation and amortization		39,851			42,161			34,481			—			116,493
Impairment of long-lived assets		286			71			4,217			—			4,574
(Gain) loss on disposal of assets and other		5,505			(4,682	)		65			—			888
Total cost of operations		454,843			496,348			373,682			(24,865	)		1,300,008
Operating income		62,859			119,627			48,311			—			230,797
Other income (expense)
Interest expense		(46,783	)		(3,733	)		(3,090	)		715			(52,891	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			9,560			—			9,560
Equity in income of affiliates		120,245			29,754			15,327			(149,461	)		15,865
Other income		1,887			162			2,813			(715	)		4,147
Total other income (expense)		75,103			26,183			24,610			(149,461	)		(23,565	)
Income before income taxes		137,962			145,810			72,921			(149,461	)		207,232
Income taxes		6,137			43,899			24,334			—			74,370
Net income		131,825			101,911			48,587			(149,461	)		132,862
Less: Net income attributable to    noncontrolling interests		—			—			1,037			—			1,037
Net income attributable to Cinemark USA,    Inc.	$	131,825		$	101,911		$	47,550		$	(149,461	)	$	131,825

30

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	615,305		$	704,124		$	384,221		$	(34,626	)	$	1,669,024
Cost of operations
Theatre operating expenses		474,489			474,473			287,459			(34,626	)		1,201,795
General and administrative expenses		6,760			49,950			27,314			—			84,024
Depreciation and amortization		43,655			48,330			36,700			—			128,685
Impairment of long-lived assets		1,201			—			2,178			—			3,379
Loss on disposal of assets and other		4,768			15,409			663			—			20,840
Total cost of operations		530,873			588,162			354,314			(34,626	)		1,438,723
Operating income		84,432			115,962			29,907			—			230,301
Other income (expense)
Interest expense		(48,384	)		(3,361	)		(4,529	)		693			(55,581	)
Loss on debt amendments		(1,484	)		—			—			—			(1,484	)
Distributions from NCM		—			—			9,782			—			9,782
Interest expense - NCM		(9,892	)		—			—			—			(9,892	)
Equity in income of affiliates		128,908			6,963			13,919			(134,740	)		15,050
Other income (expense)		2,204			(7	)		(232	)		(693	)		1,272
Total other income (expense)		71,352			3,595			18,940			(134,740	)		(40,853	)
Income before income taxes		155,784			119,557			48,847			(134,740	)		189,448
Income taxes		10,576			26,940			6,239			—			43,755
Net income		145,208			92,617			42,608			(134,740	)		145,693
Less: Net income attributable to    noncontrolling interests		—			—			485			—			485
Net income attributable to Cinemark USA,    Inc.	$	145,208		$	92,617		$	42,123		$	(134,740	)	$	145,208

31

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	51,725		$	42,010	$	23,062		$	(64,501	)	$	52,296
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(95	)		—		(95	)		95			(95	)
Foreign currency translation adjustments		(18,401	)		—		(18,401	)		18,401			(18,401	)
Total other comprehensive loss, net of tax		(18,496	)		—		(18,496	)		18,496			(18,496	)
Total comprehensive income, net of tax	$	33,229		$	42,010	$	4,566		$	(46,005	)	$	33,800
Comprehensive income attributable to noncontrolling interests		—			—		(571	)		—			(571	)
Comprehensive income attributable to Cinemark USA, Inc.	$	33,229		$	42,010	$	3,995		$	(46,005	)	$	33,229

32

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	82,693		$	51,962	$	19,776		$	(71,409	)	$	83,022
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(116	)		—		(116	)		116			(116	)
Foreign currency translation adjustments		(56,248	)		—		(56,248	)		56,248			(56,248	)
Total other comprehensive loss, net of tax		(56,364	)		—		(56,364	)		56,364			(56,364	)
Total comprehensive income (loss), net of tax	$	26,329		$	51,962	$	(36,588	)	$	(15,045	)	$	26,658
Comprehensive income attributable to noncontrolling interests		—			—		(329	)		—			(329	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	26,329		$	51,962	$	(36,917	)	$	(15,045	)	$	26,329

33

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	131,825		$	101,911	$	48,587		$	(149,461	)	$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		103			—		103			(103	)		103
Foreign currency translation adjustments		(3,508	)		—		(3,508	)		3,508			(3,508	)
Total other comprehensive loss, net of tax		(3,405	)		—		(3,405	)		3,405			(3,405	)
Total comprehensive income, net of tax	$	128,420		$	101,911	$	45,182		$	(146,056	)	$	129,457
Comprehensive income attributable to noncontrolling interests		—			—		(1,037	)		—			(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	128,420		$	101,911	$	44,145		$	(146,056	)	$	128,420

34

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	145,208		$	92,617	$	42,608		$	(134,740	)	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		20			—		20			(20	)		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)		56,044			(56,044	)
Total other comprehensive loss, net of tax		(56,024	)		—		(56,024	)		56,024			(56,024	)
Total comprehensive income (loss), net of tax	$	89,184		$	92,617	$	(13,416	)	$	(78,716	)	$	89,669
Comprehensive income attributable to noncontrolling interests		—			—		(485	)		—			(485	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	89,184		$	92,617	$	(13,901	)	$	(78,716	)	$	89,184

35

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	131,825		$	101,911		$	48,587		$	(149,461	)	$	132,862
Adjustments to reconcile net income to cash provided by (used for) operating activities		(62,144	)		13,264			36,647			149,461			137,228
Changes in assets and liabilities		(83,338	)		38,444			10,170			—			(34,724	)
Net cash provided by (used for) operating activities		(13,657	)		153,619			95,404			—			235,366
Investing activities
Additions to theatre properties and equipment		(62,198	)		(92,383	)		(28,219	)		—			(182,800	)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(12,500	)		—			(28,329	)		—			(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,143			12,255			123			—			14,521
Dividends received from subsidiaries		127,300			6			—			(127,306	)		—
Investment in joint ventures and other		—			—			(466	)		—			(466	)
Net cash provided by (used for) investing activities		54,745			(80,122	)		(56,891	)		(127,306	)		(209,574	)
Financing activities
Dividends paid to parent		(67,250	)		(127,000	)		(306	)		127,306			(67,250	)
Repayments of long-term debt		(1,427	)		—			—			—			(1,427	)
Payments on capital leases		(3,628	)		(4,632	)		(1,883	)		—			(10,143	)
Other		(784	)		(2,921	)		(294	)		—			(3,999	)
Net cash used for financing activities		(73,089	)		(134,553	)		(2,483	)		127,306			(82,819	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(75	)		—			(75	)
Increase (decrease) in cash and cash equivalents		(32,001	)		(61,056	)		35,955			—			(57,102	)
Cash and cash equivalents:
Beginning of year		146,855			281,023			133,260			—			561,138
End of year	$	114,854		$	219,967		$	169,215		$	—		$	504,036

36

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	145,208		$	92,617		$	42,608		$	(134,740	)	$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		(73,458	)		62,445			38,412			134,740			162,139
Changes in assets and liabilities		230,402			(220,516	)		(38,073	)		—			(28,187	)
Net cash provided by (used for) operating activities		302,152			(65,454	)		42,947			—			279,645
Investing activities
Additions to theatre properties and equipment		(44,970	)		(79,756	)		(37,863	)		—			(162,589	)
Acquisition of theatres in international markets, net of cash acquired		—			—			(11,508	)		—			(11,508	)
Proceeds from sale of theatre properties and equipment and other		1,244			485			406			—			2,135
Proceeds from intercompany note repayment		1,867			—			—			(1,867	)		—
Investment in joint ventures and other		—			(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(41,859	)		(99,167	)		(48,536	)		(1,867	)		(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			—			(74,350	)
Repayments of long-term debt		(3,298	)		—			—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			—			(5,103	)
Repayment of intercompany note		—			—			(1,867	)		1,867			—
Payments on capital leases		(5,632	)		(4,386	)		(2,359	)		—			(12,377	)
Other		(704	)		(2,905	)		—			—			(3,609	)
Net cash used for financing activities		(89,087	)		(7,291	)		(4,226	)		1,867			(98,737	)
Effect of exchange rate changes on cash and    cash equivalents		—			—			(7,199	)		—			(7,199	)
Increase (decrease) in cash and cash    equivalents		171,206			(171,912	)		(17,014	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		130,590			180,623			211,202			—			522,415
End of year	$	301,796		$	8,711		$	194,188		$	—		$	504,695

*   *   *   *   *

37

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes and schedules included elsewhere in this report.

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of June 30, 2018, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 14 to our condensed consolidated financial statements.

We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising sales, transactional fees and other revenue streams, such as vendor marketing promotions and meeting rentals located in some of our theatres. We also offer alternative entertainment, such as live and pre-recorded sports programs, concert events, the Metropolitan Opera, in-theatre gaming and other special events in our theatres through AC JV, LLC. NCM provides our domestic theatres with various forms of in theatre advertising. Our Flix Media subsidiaries have also allowed us to expand our screen advertising and alternative content within our international circuit and to other international exhibitors.

Films leading the box office during the six months ended June 30, 2018 included the carryover of Jumanji: Welcome to the Jungle, The Greatest Showman and Star Wars: The Last Jedi and new releases such as Black Panther, Avengers: Infinity War, Incredibles 2, Deadpool 2, Jurassic World: Fallen Kingdom, Solo: A Star Wars Story, A Quiet Place, Ready Player One, Peter Rabbit, Ocean’s 8 and other films. Films scheduled for release during the remainder of 2018 include well-known franchise films such as Ralph Breaks the Internet, Dr. Seuss’ The Grinch, Fantastic Beasts: The Crimes of Grindelwald, Ant-Man and the Wasp, Mission Impossible – Fallout and Hotel Transylvania 3: Summer Vacation and original titles including AquaMan, Christopher Robin and Mary Poppins, among other films.

Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and renovated theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenues. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.

Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. In some international locations, staffing levels are also subject to local regulations.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under capital leases and the number of fee-owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, expenses for projection and sound equipment maintenance and monitoring, property taxes, janitorial costs, repairs, maintenance and security services.

General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company, including salaries and wages, incentive compensation and benefit costs for our corporate office personnel, facility expenses for our corporate offices, consulting fees, legal fees, audit fees, supplies and other costs that are not specifically associated with the operations of our theatres.

Recent Developments

On July 5, 2018 we acquired 10,738,740 common units of NCM from AMC for $78.4 million in cash, or approximately $7.30 per common unit.  As a result of the acquisition of these shares, our ownership of NCM increased from approximately 18% to 25%.  The amount paid for the additional common units will be recorded as an increase in our investment in NCM.  See Note 6 to our condensed consolidated financial statements for further discussion of the accounting for our investment in NCM.

Critical Accounting Policies

38

We adopted ASC Topic 606 effective January 1, 2018, therefore, our revenue recognition policy has been modified as discussed in Note 3 to our condensed consolidated financial statements.

39

Results of Operations

The following table sets forth, for the periods indicated, certain operating data and the percentage of revenues represented by certain items reflected in our condensed consolidated statements of income.

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Operating data (in millions):
Revenues
Admissions	$	508.9		$	449.9		$	961.5		$	926.4
Concession		305.3			262.3			567.1			530.5
Other		74.8			39.0			140.4			73.9
Total revenues	$	889.0		$	751.2		$	1,669.0		$	1,530.8
Cost of operations
Film rentals and advertising		287.1			246.6			528.1			499.4
Concession supplies		51.1			41.8			91.9			83.9
Salaries and wages		100.4			89.8			193.5			174.0
Facility lease expense		81.2			82.3			163.3			166.6
Utilities and other		115.6			91.0			225.0			179.4
General and administrative expenses		42.3			37.1			84.0			74.7
Depreciation and amortization		64.3			59.2			128.7			116.5
Impairment of long-lived assets		2.8			4.3			3.4			4.6
Loss on disposal of assets and other		16.9			0.1			20.8			0.9
Total cost of operations		761.7			652.2			1,438.7			1,300.0
Operating income	$	127.3		$	99.0		$	230.3		$	230.8
Operating data as a percentage of total revenues:
Revenues
Admissions		57.2	%		59.9	%		57.6	%		60.5	%
Concession		34.3	%		34.9	%		34.0	%		34.7	%
Other		8.5	%		5.2	%		8.4	%		4.8	%
Total revenues		100.0	%		100.0	%		100.0	%		100.0	%
Cost of operations (1)
Film rentals and advertising		56.4	%		54.8	%		54.9	%		53.9	%
Concession supplies		16.7	%		15.9	%		16.2	%		15.8	%
Salaries and wages		11.3	%		12.0	%		11.6	%		11.4	%
Facility lease expense		9.1	%		11.0	%		9.8	%		10.9	%
Utilities and other		13.0	%		12.1	%		13.5	%		11.7	%
General and administrative expenses		4.8	%		4.9	%		5.0	%		4.9	%
Depreciation and amortization		7.2	%		7.9	%		7.7	%		7.6	%
Impairment of long-lived assets		0.3	%		0.6	%		0.2	%		0.3	%
Loss on disposal of assets and other		1.9	%		—	%		1.2	%		0.1	%
Total cost of operations		85.7	%		86.8	%		86.2	%		84.9	%
Operating income		14.3	%		13.2	%		13.8	%		15.1	%

(1) All costs are expressed as a percentage of total revenues, except film rentals and advertising, which are expressed as a percentage of admissions revenues and concession supplies, which are expressed as a percentage of concession revenues.

40

Three months ended June 30, 2018 versus June 30, 2017

Revenues. Total revenues increased $137.8 million to $889.0 million for the three months ended June 30, 2018 (“second quarter of 2018”) from $751.2 million for the three months ended June 30, 2017 (“second quarter of 2017”), representing an 18.3% increase. The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the three months ended June 30, 2018 and 2017.

	U.S. Operating Segment							International Operating Segment												Consolidated
															Constant Currency (3)
	2018		2017		% Change			2018		2017		% Change			2018		% Change			2018		2017		% Change
Admissions revenues (1)	$	408.9	$	335.0		22.1	%	$	100.0	$	114.9		(13.0	)%	$	111.7		(2.8	)%	$	508.9	$	449.9		13.1	%
Concession revenues (1)	$	249.6	$	197.3		26.5	%	$	55.7	$	65.0		(14.3	)%	$	61.5		(5.4	)%	$	305.3	$	262.3		16.4	%
Other revenues (1)(2)	$	50.5	$	18.9		167.2	%	$	24.3	$	20.1		20.9	%	$	27.7		37.8	%	$	74.8	$	39.0		91.8	%
Total revenues (1)(2)	$	709.0	$	551.2		28.6	%	$	180.0	$	200.0		(10.0	)%	$	200.9		0.4	%	$	889.0	$	751.2		18.3	%
Attendance (1)		50.6		43.0		17.7	%		25.8		26.4		(2.3	)%							76.4		69.4		10.1	%
Average ticket price (1)	$	8.08	$	7.79		3.7	%	$	3.88	$	4.35		(10.8	)%	$	4.33		(0.5	)%	$	6.66	$	6.48		2.8	%
Concession revenues per patron (1)	$	4.93	$	4.59		7.4	%	$	2.16	$	2.46		(12.2	)%	$	2.38		(3.3	)%	$	4.00	$	3.78		5.8	%

(1) Revenues and attendance amounts in millions.  Average ticket price is calculated as admissions revenues divided by attendance.  Concession revenues per patron is calculated as concession revenues divided by attendance.  

(2) U.S. operating segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 14 to our condensed consolidated financial statements.

(3) Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2017. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results.   We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

• U.S.Admissions revenues grew $73.9 million primarily due to a 17.7% increase in attendance and a 3.7% increase in average ticket price. The increase in attendance was due to the number of blockbuster films in the second quarter of 2018 compared to the second quarter of 2017 as well as the favorable impact of luxury lounger conversions. Growth in average ticket price was primarily due to price increases. Concession revenues grew $52.3 million primarily due to the 17.7% increase in attendance and a 7.4% increase in concession revenues per patron. Concession revenues per patron grew primarily due to price increases and incremental sales.  Other revenues increased $31.6 million primarily due to the impact of changes in revenue recognition as discussed in Note 3 to our condensed consolidated financial statements.  

• International.Admissions revenues decreased $14.9 million as reported primarily due to a 2.3% decrease in attendance and a 10.8% decrease in average ticket price.  Admissions revenues decreased $3.2 million in constant currency. The decline in attendance was driven by weaker consumer appeal of the film slate during the second quarter of 2018 compared to the second quarter of 2017.  Concession revenues decreased $9.3 million as reported primarily due to the 2.3% decrease in attendance and a 12.2% decrease in concession revenues per patron.  Concession revenues decreased $3.5 million in constant currency. Average ticket price and concession revenues per patron decreased, as reported, primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate and the mix of film during the second quarter of 2018.  Other revenues increased primarily due to incremental screen advertising revenues as well as the impact of changes in revenue recognition as discussed in Note 3 to our condensed consolidated financial statements, partially offset by the impact of changes in foreign currency exchange rates in certain countries in which we operate.

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the three months ended June 30, 2018 and 2017.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2018		2017		2018		2017		Constant Currency 2018 (1)		2018		2017
Film rentals and advertising	$	238.7	$	190.4	$	48.4	$	56.2	$	54.3	$	287.1	$	246.6
Concession supplies	$	38.4	$	27.8	$	12.7	$	14.0	$	14.0		51.1		41.8
Salaries and wages	$	79.4	$	66.7	$	21.0	$	23.1	$	24.0		100.4		89.8
Facility lease expense	$	61.0	$	59.9	$	20.2	$	22.4	$	22.1		81.2		82.3
Utilities and other	$	83.7	$	61.1	$	31.9	$	29.9	$	36.0		115.6		91.0

(1) Constant currency expense amounts, which are non-GAAP measurements were calculated using the average exchange rate for the corresponding month for 2017. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

41

• U.S. Film rentals and advertising costs were $238.7 million, or 58.4% of admissions revenues, for the second quarter of 2018 compared to $190.4 million, or 56.8% of admissions revenues, for the second quarter of 2017. The increase in the film rentals and advertising rate was primarily due to the relative contribution of blockbuster films to overall box office during the second quarter of 2018. The second quarter of 2018 included such blockbuster releases as Avengers: Infinity War, Incredibles 2, Jurassic World: Fallen Kingdom and Deadpool 2, which grossed in excess of $600 million, $400 million, $300 million and $300 million, respectively, for the quarter.  Concession supplies expense was $38.4 million, or 15.4% of concession revenues, for the second quarter of 2018 compared to $27.8 million, or 14.1% of concession revenues, for the second quarter of 2017. The increase in the concessions supplies rate was primarily due to product mix.  

Salaries and wages increased to $79.4 million for the second quarter of 2018 from $66.7 million for the second quarter of 2017 primarily due to increased staffing levels to support the growth in attendance and expanded concession offerings, staffing at new and recently remodeled theatres, as well as increases in minimum and other wage rates. Facility lease expense increased to $61.0 million for the second quarter of 2018 from $59.9 million for the second quarter of 2017 primarily due to higher percentage rent due to the increase in revenues. Utilities and other costs increased to $83.7 million for the second quarter of 2018 from $61.1 million for the second quarter of 2017 primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

• International. Film rentals and advertising costs were $48.4 million ($54.3 million in constant currency), or 48.4% of admissions revenues, for the second quarter of 2018 compared to $56.2 million, or 48.9% of admissions revenues, for the second quarter of 2017. Concession supplies expense was $12.7 million ($14.0 million in constant currency), or 22.8% of concession revenues, for the second quarter of 2018 compared to $14.0 million, or 21.5% of concession revenues, for the second quarter of 2017. The increase in the concessions supplies rate was primarily due to product mix.  

Salaries and wages decreased to $21.0 million (increased to $24.0 million in constant currency) for the second quarter of 2018 compared to $23.1 million for the second quarter of 2017.  The as reported decrease was due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by increased local currency wages that were primarily driven by inflation, new theatres and limited flexibility in scheduling staff caused by shifting government regulations.  Facility lease expense decreased to $20.2 million ($22.1 million in constant currency) for the second quarter of 2018 compared to $22.4 million for the second quarter of 2017.  The as reported decrease was due to lower percentage rent due to the decline in revenues.  Utilities and other costs increased to $31.9 million ($36.0 million in constant currency) for the second quarter of 2018 compared to $29.9 million for the second quarter of 2017.  The as reported increase was primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).    

General and Administrative Expenses. General and administrative expenses increased to $42.3 million for the second quarter of 2018 from $37.1 million for the second quarter of 2017. The increase was primarily due to higher salaries, insurance costs, benefits costs and professional fees.

Depreciation and Amortization. Depreciation and amortization expense increased to $64.3 million during the second quarter of 2018 compared to $59.2 million during the second quarter of 2017. The increase was primarily due to theatre remodels and new theatres.

Impairment of Long-Lived Assets.  We recorded asset impairment charges on assets held and used of $2.8 million during the second quarter of 2018 compared to $4.3 million during the second quarter of 2017. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Impairment charges for the second quarter of 2018 impacted five of our twenty-seven reporting units. See Note 10 to our condensed consolidated financial statements.

Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $16.9 million during the second quarter of 2018 compared to $0.1 million during the second quarter of 2017. Activity for the second quarter of 2018 was primarily due to the retirement of assets related to theatre remodels and the accrual of a reserve for outstanding litigation (see Note 16 to the condensed consolidated financial statements).  Activity for the second quarter of 2017 was primarily due to the retirement of assets related to theatre remodels, offset by a gain on a landlord buyout of a theatre lease.

Interest Expense.  Interest costs incurred, including amortization of debt issue costs, were $28.5 million during the second quarter of 2018 compared to $26.5 million during the second quarter of 2017.  The increase was primarily due to an increase in the variable rate at which our term loan accrues interest.  

42

Distributions from NCM.  We recorded distributions from NCM of $3.4 million during the second quarter of 2018 compared to $2.8 million recorded during the second quarter of 2017, which were in excess of the carrying value of our Tranche 1 investment. See Note 6 to our condensed consolidated financial statements.  

Interest expense – NCM.  We recorded non-cash interest expense of $4.9 million for the second quarter of 2018 related to the significant financing component associated with certain of our agreements with NCM.  See Note 3 to our condensed consolidated financial statements for further discussion.

Equity in Income of Affiliates. We recorded equity in income of affiliates of $6.4 million during the second quarter of 2018 compared to $5.8 million during the second quarter of 2017. See Notes 6 and 7 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. Income tax expense of $18.5 million was recorded for the second quarter of 2018 compared to $29.7 million recorded for the second quarter of 2017. The effective tax rate was approximately 18.2% for the second quarter of 2018 compared to 36.3% for the second quarter of 2017. The effective tax rate in 2018 benefited from a lower U.S. federal tax rate.  On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, and (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries.  Additionally, the Company recorded a benefit to tax expense of $7.1 million for the second quarter of 2018 related to the settlement of audits in the non-U.S. tax jurisdiction of Chile.  

As of June 30, 2018, the amounts recorded for the Tax Act remain provisional for the transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. These estimates may be impacted by further analysis due to future clarification and guidance regarding earnings and profits computations, state tax conformity to federal tax changes, and potential tax planning options under consideration.

Income tax provisions for interim (quarterly) periods are based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Six months ended June 30, 2018 versus June 30, 2017

Revenues. Total revenues increased $138.2 million to $1,669.0 million for the six months ended June 30, 2018 (“2018 period”) from $1,530.8 million for the six months ended June 30, 2017 (“2017 period”), representing a 9.0% increase. The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the six months ended June 30, 2018 and 2017.

	U.S. Operating Segment							International Operating Segment												Consolidated
															Constant Currency (3)
	2018		2017		% Change			2018		2017		% Change			2018		% Change			2018		2017		% Change
Admissions revenues (1)	$	758.2	$	691.2		9.7	%	$	203.3	$	235.2		(13.6	)%	$	219.4		(6.7	)%	$	961.5	$	926.4		3.8	%
Concession revenues (1)	$	453.4	$	400.7		13.2	%	$	113.7	$	129.8		(12.4	)%	$	121.6		(6.3	)%	$	567.1	$	530.5		6.9	%
Other revenues (1)(2)	$	93.8	$	36.9		154.2	%	$	46.6	$	37.0		25.9	%	$	51.5		39.2	%	$	140.4	$	73.9		90.0	%
Total revenues (1)(2)	$	1,305.4	$	1,128.8		15.6	%	$	363.6	$	402.0		(9.6	)%	$	392.5		(2.4	)%	$	1,669.0	$	1,530.8		9.0	%
Attendance (1)		95.2		89.5		6.4	%		49.7		54.2		(8.3	)%							144.9		143.7		0.8	%
Average ticket price (1)	$	7.96	$	7.72		3.1	%	$	4.09	$	4.34		(5.8	)%	$	4.41		1.6	%	$	6.64	$	6.45		2.9	%
Concession revenues per patron (1)	$	4.76	$	4.48		6.2	%	$	2.29	$	2.39		(4.2	)%	$	2.45		2.5	%	$	3.91	$	3.69		6.0	%

(1) Revenues and attendance amounts in millions.  Average ticket price is calculated as admissions revenues divided by attendance.  Concession revenues per patron is calculated as concession revenues divided by attendance.  

(2) U.S. operating segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 14 to our condensed consolidated financial statements.

(3) Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2017. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results.   We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

• U.S.Admissions revenues grew $67.0 million primarily due to a 6.4% increase in attendance and a 3.1% increase in average ticket price. The growth in attendance was due to the number of blockbuster films in the 2018 period compared to the 2017 period as well as the favorable impact of luxury lounger conversions. Average ticket price growth was primarily due to price increases. The increase in concession revenues of $52.7 million was primarily due to the 6.4% increase in attendance and a

43

6.2% increase in concession revenues per patron. The increase in concession revenues per patron was primarily due to price increases and incremental sales.  Other revenues increased $56.9 million primarily due to the impact of changes in revenue recognition as discussed in Note 3 to our condensed consolidated financial statements.  

• International.Admissions revenues decreased $31.9 million as reported primarily due to an 8.3% decrease in attendance and a 5.8% decrease in average ticket price.  Admissions revenues decreased $15.8 million in constant currency. The decrease in attendance was driven by weaker consumer appeal of the film slate during the 2018 period compared to the 2017 period.  Concession revenues decreased $16.1 million as reported primarily due to the 8.3% decrease in attendance and a 4.2% decrease in concession revenues per patron.  Concession revenues decreased $8.2 million in constant currency.  Average ticket price and concession revenues per patron decreased, as reported, primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate and the mix of films during the 2018 period.  Other revenues increased $9.6 million primarily due to incremental screen advertising revenues as well as the impact of changes in revenue recognition as discussed in Note 3 to our condensed consolidated financial statements.

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the six months ended June 30, 2018 and 2017.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2018		2017		2018		2017		Constant Currency 2018 (1)		2018		2017
Film rentals and advertising	$	431.6	$	386.8	$	96.5	$	112.6	$	104.5	$	528.1	$	499.4
Concession supplies	$	66.9	$	55.9	$	25.0	$	28.0	$	26.8	$	91.9	$	83.9
Salaries and wages	$	151.1	$	129.9	$	42.4	$	44.1	$	46.7	$	193.5	$	174.0
Facility lease expense	$	122.0	$	121.3	$	41.3	$	45.3	$	43.8	$	163.3	$	166.6
Utilities and other	$	162.7	$	121.1	$	62.3	$	58.3	$	68.1	$	225.0	$	179.4

(1) Constant currency expense amounts, which are non-GAAP measurements were calculated using the average exchange rate for the corresponding month for 2017. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

• U.S. Film rentals and advertising costs were $431.6 million, or 56.9% of admissions revenues, for the 2018 period compared to $386.8 million, or 56.0% of admissions revenues, for the 2017 period. The increase in the film rentals and advertising rate was primarily due to the relative contribution of blockbuster films to overall box office during the 2018 period. The 2018 period included such blockbuster releases as Black Panther, Avengers: Infinity War, Incredibles 2, Jurassic World: Fallen Kingdom and Deadpool 2, which grossed in excess of $600 million, $600 million, $400 million, $300 million and $300 million, respectively, for the period.  Concession supplies expense was $66.9 million, or 14.8% of concession revenues, for the 2018 period compared to $55.9 million, or 14.0% of concession revenues, for the 2017 period. The increase in the concessions supplies rate was primarily due to product mix.

Salaries and wages increased to $151.1 million for the 2018 period from $129.9 million for the 2017 period primarily due to increased staffing levels to support the increased attendance and expanded concession offerings, staffing at new and recently remodeled theatres, increases in minimum and other wage rates. Facility lease expense increased to $122.0 million for the 2018 period from $121.3 million for the 2017 period primarily due to increased percentage rent due to the increase in revenues. Utilities and other costs increased to $162.7 million for the 2018 period from $121.1 million for the 2017 period primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

• International. Film rentals and advertising costs were $96.5 million ($104.5 million in constant currency), or 47.5% of admissions revenues, for the 2018 period compared to $112.6 million, or 47.9% of admissions revenues, for the 2017 period. Concession supplies expense was $25.0 million ($26.8 million in constant currency), or 22.0% of concession revenues, for the 2018 period compared to $28.0 million, or 21.6% of concession revenues, for the 2017 period.

Salaries and wages decreased to $42.4 million (increased to $46.7 million in constant currency) for the 2018 period compared to $44.1 million for the 2017 period.  The as reported decrease was due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by increased local currency wages that were primarily driven by inflation, new theatres and limited flexibility in scheduling staff caused by shifting government regulations.  Facility lease expense decreased to $41.3 million ($43.8 million in constant currency) for the 2018 period compared to $45.3 million for the 2017 period.  The as reported decrease was due to lower percentage rent due to the decline in revenues.  Utilities and other costs increased to $62.3 million ($68.1 million in constant currency) for the 2018 period compared to $58.3 million for the 2017 period.  The as reported increase was primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).    

44

General and Administrative Expenses. General and administrative expenses increased to $84.0 million for the 2018 period from $74.7 million for the 2017 period. The increase was primarily due to higher salaries, insurance costs, benefits costs and professional fees.

Depreciation and Amortization. Depreciation and amortization expense increased to $128.7 million during the 2018 period compared to $116.5 million during the 2017 period. The increase was primarily due to theatre remodels and new theatres.

Impairment of Long-Lived Assets.  We recorded asset impairment charges on assets held and used of $3.4 million during the 2018 period compared to $4.6 million during the 2017 period. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Impairment charges for the 2018 period impacted six of our twenty-seven reporting units. See Note 10 to our condensed consolidated financial statements.

Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $20.8 million during the 2018 period compared to $0.9 million during the 2017 period. Activity for the 2018 period was primarily due to the retirement of assets related to theatre remodels and the accrual of a reserve for outstanding litigation (see Note 16 to the condensed consolidated financial statements).  Activity for the 2017 period was primarily due to the retirement of assets related to theatre remodels, partially offset by gains related to the sale of excess land parcels and a gain on a landlord buyout of a theatre lease.  

Interest Expense.  Interest costs incurred, including amortization of debt issue costs, were $55.6 million during the 2018 period compared to $52.9 million during the 2017 period.  The increase was primarily due to an increase in the variable rate at which our term loan accrues interest.  

Loss on Debt Amendments.  We recorded a loss on debt amendments of $1.5 million for the 2018 period compared to $0.2 million for the 2017 period related to amendments to our senior secured credit facility.  See Note 4 to our condensed consolidated financial statements for further discussion.  

Distributions from NCM.  We recorded distributions from NCM of $9.8 million during the 2018 period compared to $9.6 million recorded during the 2017 period, which were in excess of the carrying value of our Tranche 1 investment. See Note 6 to our condensed consolidated financial statements.  

Interest expense – NCM.  We recorded non-cash interest expense of $9.9 million for the 2018 period related to the significant financing component associated with certain of our agreements with NCM.  See Note 3 to our condensed consolidated financial statements for further discussion.  

Equity in Income of Affiliates. We recorded equity in income of affiliates of $15.1 million during the 2018 period compared to $15.9 million during the 2017 period. See Notes 6 and 7 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. Income tax expense of $43.8 million was recorded for the 2018 period compared to $74.4 million recorded for the 2017 period. The effective tax rate was approximately 23.1% for the 2018 period compared to 35.9% for the 2017 period. The effective tax rate in 2018 benefited from a lower U.S. federal tax rate.  On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, and (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries.  Additionally, the Company recorded a benefit to tax expense of $7.1 million for the 2018 period related to the settlement of audits in the non-U.S. tax jurisdiction of Chile.  

As of June 30, 2018, the amounts recorded for the Tax Act remain provisional for the transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. These estimates may be impacted by further analysis due to future clarification and guidance regarding earnings and profits computations, state tax conformity to federal tax changes, and potential tax planning options under consideration.

Income tax provisions for interim (quarterly) periods are based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

45

Liquidity and Capital Resources

Operating Activities

We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. In addition, nearly all of our theatres provide the patron a choice of using a credit card, debit card or advanced-sale type certificates such as a gift card, in place of cash. Because our revenues are received in cash prior to the payment of related expenses, we have an operating “float” and historically have not required traditional working capital financing. Cash provided by operating activities was $279.6million for the six months ended June 30, 2018 compared to $235.4million for the six months ended June 30, 2017. The increase in cash provided by operating activities was primarily due to the increase in net income and the timing of payments to suppliers.

Investing Activities

Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $191.4 million for the six months ended June 30, 2018 compared to $209.6 million for the six months ended June 30, 2017.  The decrease was primarily due to a decrease in capital expenditures and a decrease in cash paid related to the acquisition of theatres.    

Capital expenditures for the six months ended June 30, 2018 and 2017 were as follows (in millions):

Period	New Theatres		Existing Theatres (1)		Total
Six Months Ended June 30, 2018	$	31.5	$	131.1	$	162.6
Six Months Ended June 30, 2017	$	31.1	$	151.7	$	182.8

(1) The amounts for the six months ended June 30, 2018 and 2017 include $4.3 million and $5.9 million, respectively, related to the remodel of our corporate headquarters building in Plano, TX.

Capital expenditures for existing properties in the table above includes the costs of remodeling certain of our existing theatres to include Luxury Loungers and expanded concession offerings.  During the six months ended June 30, 2018 and 2017, we had an average of 78 and 132 of our domestic screens, respectively, temporarily closed for such remodels.

Our U.S. theatre circuit consisted of 339 theatres with 4,566 screens at June 30, 2018. During the six months ended June 30, 2018, we built one new theatre and twelve screens and closed one theatre with seven screens. At June 30, 2018, we had signed commitments to open three new theatres and 30 screens in domestic markets during the remainder of 2018 and open nine new theatres with 95 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 125 domestic screens will be approximately $99 million.

Our international theatre circuit consisted of 200 theatres with 1,432 screens at June 30, 2018.  During the six months ended June 30, 2018, we built three theatres and fifteen screens and acquired three theatres and nineteen screens. At June 30, 2018, we had signed commitments to open five new theatres and 29 screens in international markets during the remainder of 2018 and open seven new theatres and 51 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 80 international screens will be approximately $46 million.

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities.  We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, and proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

46

Financing Activities

Cash used for financing activities was $98.7 million for the six months ended June 30, 2018 compared to $82.8 million for the six months ended June 30, 2017.  The increase was primarily due to the payment of debt issuance costs associated with the amendment of our senior secured credit facility (see Note 4 to our condensed consolidated financial statements) and the increase in the dividends paid to Cinemark Holdings, Inc.

We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities. Long-term debt consisted of the following as of June 30, 2018 (in millions):

Cinemark USA, Inc. term loan	$	656.2
Cinemark USA, Inc. 5.125% senior notes due 2022		400.0
Cinemark USA, Inc. 4.875% senior notes due 2023		755.0
Other	2.8
Total long-term debt	$	1,814.0
Less current portion		8.0
Subtotal long-term debt, less current portion	$	1,806.0
Less:  Debt discounts and debt issuance costs, net of accumulated amortization		31.2
Long-term debt, less current portion, net of debt issuance costs	$	1,774.8

As of June 30, 2018, Cinemark USA, Inc. had $100.0 million in available borrowing capacity on our revolving credit line.

Contractual Obligations

In March 2018, we amended our senior secured credit facility, which extended the maturity of the term loan to March 2025. Included below is an updated summary of long-term debt obligations and related estimated scheduled interest payment obligations as of June 30, 2018, reflecting the amended agreement.

	Payments Due by Period
	(in millions)
			Less Than						After
Contractual Obligations	Total		One Year		1 - 3 Years		3 - 5 Years		5 Years
Long-term debt (1)	$	1,814.0	$	8.0	$	14.6	$	413.2	$	1,378.2
Scheduled interest payments on long-term debt(2)	$	437.4	$	82.6	$	164.2	$	148.9	$	41.7

(1) Amounts are presented before adjusting for debt issuance costs.

(2) Amounts include scheduled interest payments on fixed rate and variable rate debt agreements.  Estimates for the variable rate interest payments were based on interest rates in effect on June 30, 2018. The average interest rates in effect on our fixed rate and variable rate debt are 5.0% and 3.9%, respectively, as of June 30, 2018.

There have been no other material changes in our contractual obligations previously disclosed in “Liquidity and Capital Resources” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

Off-Balance Sheet Arrangements

Other than operating leases and purchase commitments disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018, we do not have any off-balance sheet arrangements.

Senior Secured Credit Facility

Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan, with a maturity date of March 2025, and a $100.0 million revolving credit line, with a maturity date of December 2022 (collectively referred to as the “Credit Agreement”).

47

On March 29, 2018, Cinemark USA, Inc., amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25%and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025.

Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.  

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,790.4 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Credit Agreement, subject to its available cash and other borrowing restrictions outlined in the agreement.

At June 30, 2018, there was $656.2 million outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had $100.0 million in available borrowing capacity on the revolving credit line. The average interest rate on outstanding term loan borrowings under the Credit Agreement at June 30, 2018 was approximately 3.9 % per annum.

Cinemark USA, Inc. 5.125% Senior Notes

On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% Senior Notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

The indenture to the 5.125% Senior Notes contains covenants including limitations on the amount of dividends that could be paid by Cinemark USA, Inc. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,442.4 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of June 30, 2018 was approximately 6.3 to 1.

Cinemark USA, Inc. 4.875% Senior Notes

On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% Senior Notes due 2023, at par value (the “4.875% Senior Notes”). On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate

48

principal amount of the 4.875% Senior Notes at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s $200.0 million 7.375% Senior Subordinated Notes. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as the Company’s existing 4.875% Senior Notes.  Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year.  The 4.875% Senior Notes mature on June 1, 2023.  

The indenture to the 4.875% Senior Notes contains covenants that include limitations on the amount of dividends that Cinemark USA, Inc. can pay. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,437.1 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of June 30, 2018 was approximately 6.3 to 1.

Covenant Compliance

As of June 30, 2018, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

Seasonality

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. Generally, the most successful motion pictures have been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year.  In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can impact this seasonality trend. The timing and quality of film releases can have a significant impact on our results of operations, and the results of one period are not necessarily indicative of results for the following period or for the same period in the following year.

49

Item 3.Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in interest rates, foreign currency exchange rates and other relevant market prices.  

Interest Rate Risk

We are currently party to a variable rate debt facility.  An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt. At June 30, 2018, we had an aggregate of approximately $656.2 million of variable rate debt outstanding. Based on the interest rates in effect on the variable rate debt outstanding at June 30, 2018, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $6.6 million.

The table below provides information about our fixed rate and variable rate long-term debt agreements as of June 30, 2018:

	Expected Maturity for the Twelve-Month Periods Ending June 30,																Average
	(in millions)																Interest
	2019		2020		2021		2022		2023		Thereafter		Total		Fair Value		Rate
Fixed rate	$	1.4	$	1.4	$	—	$	—	$	400.0	$	755.0	$	1,157.8	$	1,143.8		5.0	%
Variable rate		6.6		6.6		6.6		6.6		6.6		623.2		656.2		657.0		3.9	%
Total debt	$	8.0	$	8.0	$	6.6	$	6.6	$	406.6	$	1,378.2	$	1,814.0	$	1,800.8

Foreign Currency Exchange Rate Risk

Other than the devaluation of the Argentine peso, discussed in Note 12 to the condensed consolidated financial statements, there have been no material changes in foreign currency exchange rate risk previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

Item 4. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of June 30, 2018, we carried out an evaluation required by the Exchange Act, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2018, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended June 30, 2018 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

50

PART II - OTHER INFORMATION

Item 1.Legal Proceedings

Other than the recent developments noted at Note 16, there have been no material changes from legal proceedings previously reported under “Business – Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

Item 1A. Risk Factors

There have been no material changes from risk factors previously disclosed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

Item 5. Other Information

Supplemental Schedules Specified by the Senior Notes Indentures

As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes, the Company has included in this filing, interim financial information for its subsidiaries that have been designated as unrestricted subsidiaries, as defined by the indentures. As required by these indentures, the Company has included an unaudited condensed consolidating balance sheet and unaudited condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. The following supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures.

	Page
Unaudited Condensed Consolidating Balance Sheet Information as of June 30, 2018	52
Unaudited Condensed Consolidating Statement of Income Information for the six months ended June 30, 2018	53
Unaudited Condensed Consolidating Statement of Comprehensive Income Information for the six months ended June 30, 2018	54
Unaudited Condensed Consolidating Statement of Cash Flows Information for the six months ended June 30, 2018	55

51

CINEMARK USA, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

JUNE 30, 2018

(In thousands)

	Restricted		Unrestricted
	Group		Group			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	471,072	$	33,623		$	—		$	504,695
Other current assets		242,473		(91,824	)		(8,224	)		142,425
Total current assets		713,545		(58,201	)		(8,224	)		647,120
Theatre properties and equipment, net		1,817,737		—			—			1,817,737
Other assets		1,847,599		507,734			(346,019	)		2,009,314
Total assets	$	4,378,881	$	449,533		$	(354,243	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	1,389		$	—		$	7,984
Current portion of capital lease obligations		26,671		—			—			26,671
Accounts payable and accrued expenses		412,692		311			(8,224	)		404,779
Total current liabilities		445,958		1,700			(8,224	)		439,434
Long-term liabilities
Long-term debt, less current portion		2,012,393		1,389			(239,000	)		1,774,782
Capital lease obligations, less current portion		239,005		—			—			239,005
Other long-term liabilities and deferrals		474,191		62,997			—			537,188
Total long-term liabilities		2,725,589		64,386			(239,000	)		2,550,975
Commitments and contingencies
Equity		1,207,334		383,447			(107,019	)		1,483,762
Total liabilities and equity	$	4,378,881	$	449,533		$	(354,243	)	$	4,474,171

Note:  “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

52

CINEMARK USA, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

(In thousands)

	Restricted			Unrestricted
	Group			Group			Eliminations		Consolidated
Revenues	$	1,669,024		$	—		$	—	$	1,669,024
Cost of operations										—
Theatre operating costs		1,201,795			—			—		1,201,795
General and administrative expenses		84,030			(6	)		—		84,024
Depreciation and amortization		128,685			—			—		128,685
Impairment of long-lived assets		3,379			—			—		3,379
Loss on disposal of assets and other		20,840			—			—		20,840
Total cost of operations		1,438,729			(6	)		—		1,438,723
Operating income		230,295			6			—		230,301
Other income (expense)		(78,544	)		37,691			—		(40,853	)
Income before income taxes		151,751			37,697			—		189,448
Income taxes		32,357			11,398			—		43,755
Net income		119,394			26,299			—		145,693
Less:  Net income attributable to noncontrolling interests		485			—			—		485
Net income attributable to Cinemark USA, Inc.	$	118,909		$	26,299		$	—	$	145,208

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

53

CINEMARK USA, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

(In thousands)

	Restricted			Unrestricted
	Group			Group		Eliminations		Consolidated
Net income	$	119,394		$	26,299	$	—	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income in equity method investments		—			20		—		20
Foreign currency translation adjustments		(56,044	)		—		—		(56,044	)
Total other comprehensive income (loss), net of tax		(56,044	)		20		—		(56,024	)
Total comprehensive income, net of tax		63,350			26,319		—		89,669
Comprehensive income attributable to noncontrolling interests		(485	)		—		—		(485	)
Comprehensive income attributable to Cinemark USA, Inc.	$	62,865		$	26,319	$	—	$	89,184

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

54

CINEMARK USA, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

(In thousands)

	Restricted			Unrestricted
	Group			Group			Eliminations			Consolidated
Operating activities
Net income	$	119,394		$	26,299		$	—		$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		162,782			(643	)		—			162,139
Changes in assets and liabilities		6,172			(34,359	)		—			(28,187	)
Net cash provided by (used for) operating activities		288,348			(8,703	)		—			279,645
Investing activities
Additions to theatre properties and equipment		(162,589	)		—			—			(162,589	)
Acquisitions of theatres in international markets, net of cash acquired		(11,508	)								(11,508	)
Proceeds from sale of theatre properties and equipment and other		2,135			—			—			2,135
Loans to affiliates		—			(19,000	)		19,000			—
(Investment in) return of investment from joint ventures and other, net		(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(191,858	)		(18,571	)		19,000			(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			(74,350	)
Borrowings from affiliates		19,000			—			(19,000	)		—
Repayments of long-term debt		(3,298	)		—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			(5,103	)
Payments on capital leases		(12,377	)		—			—			(12,377	)
Other		(3,609	)		—			—			(3,609	)
Net cash used for financing activities		(79,737	)		—			(19,000	)		(98,737	)
Effect of exchange rate changes on cash and cash equivalents		(7,199	)		—			—			(7,199	)
Increase (decrease) in cash and cash equivalents		9,554			(27,274	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		461,518			60,897			—			522,415
End of year	$	471,072		$	33,623		$	—		$	504,695

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

55

Item 6. Exhibits

10.1	Limited Liability Company Agreement of FE Concepts, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.2	Management Services Agreement by and between FE Concepts, LLC and Cinema Operations, L.L.C. dated as of April 20, 2018 (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.3	Theatre Services Agreement by and between FE Concepts, LLC and CNMK Texas Properties, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.3 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
*31.1	Certification of Mark Zoradi, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.2	Certification of Sean Gamble, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*32.1	Certification of Mark Zoradi, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*32.2	Certification of Sean Gamble, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
* 101	Financial Statements from the quarterly report on Form 10-Q of Cinemark USA, Inc. for the quarter ended June 30, 2018, filed August 9, 2018, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements tagged as detailed text.

* filed herewith.

56

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CINEMARK USA, INC.
		Registrant
DATE:	August 9, 2018
		/s/Mark Zoradi
		Mark Zoradi
		Chief Executive Officer
		/s/Sean Gamble
		Sean Gamble
		Chief Financial Officer

57

EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES - OXLEY ACT OF 2002

I, Mark Zoradi, certify that:

1. I have reviewed this report on Form 10-Q of Cinemark USA, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	August 9, 2018
By:	/s/Mark Zoradi
Mark Zoradi
Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES – OXLEY ACT OF 2002

I, Sean Gamble, certify that:

1. I have reviewed this report on Form 10-Q of Cinemark USA, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and    procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	August 9, 2018
By:	/s/Sean Gamble
Sean Gamble
Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY SECTION 906 OF THE

SARBANES - OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the “Form 10-Q”) for the quarter ended June 30, 2018 of Cinemark USA, Inc. (the “Issuer”).

I, Mark Zoradi, the Chief Executive Officer of Issuer certify that to the best of my knowledge:

(i) the Form 10-Q fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated:	August 9, 2018
/s/Mark Zoradi
Mark Zoradi
Chief Executive Officer

Subscribed and sworn to before me this 9^th day of August 2018.

/s/ Matthew Creed
Name:	Matthew Creed
Title:	Notary Public
My commission expires: 12/27/2020

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY SECTION 906 OF THE

SARBANES – OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the “Form 10-Q”) for the quarter ended June 30, 2018 of Cinemark USA, Inc. (the “Issuer”).

I, Sean Gamble, the Chief Financial Officer of Issuer certify that to the best of my knowledge:

(i) the Form 10-Q fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated:	August 9, 2018
/s/Sean Gamble
Sean Gamble
Chief Financial Officer

Subscribed and sworn to before me this 9^th day of August 2018.

/s/ Matthew Creed
Name:	Matthew Creed
Title:	Notary Public
My commission expires: 12/27/2020

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Jul. 31, 2018
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	0000885975
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jun. 30, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents		$ 504,695	$ 522,415
Inventories		17,685	17,507
Accounts receivable		80,305	89,248
Current income tax receivable		4,815	11,730
Prepaid expenses and other		20,657	16,536
Accounts receivable from parent		18,963	14,581
Total current assets		647,120	672,017
Theatre properties and equipment		3,362,779	3,328,589
Less: accumulated depreciation and amortization		1,545,042	1,500,535
Theatre properties and equipment, net		1,817,737	1,828,054
Other assets
Goodwill	[1]	1,281,170	1,284,079
Intangible assets - net		332,506	336,761
Investments in and advances to affiliates		145,081	120,045
Long-term deferred tax asset		4,050	4,067
Deferred charges and other assets - net		47,488	39,767
Total other assets		2,009,314	1,985,269
Total assets		4,474,171	4,485,340
Current liabilities
Current portion of long-term debt		7,984	7,099
Current portion of capital lease obligations		26,671	25,511
Current income tax payable		6,850	5,509
Current liability for uncertain tax positions		3,650	11,873
Accounts payable and accrued expenses		394,279	418,294
Total current liabilities		439,434	468,286
Long-term liabilities
Long-term debt, less current portion		1,774,782	1,780,381
Capital lease obligations, less current portion		239,005	251,151
Long-term deferred tax liability		141,307	121,787
Long-term liability for uncertain tax positions		13,405	8,358
Deferred lease expenses		39,750	40,929
Other long-term liabilities		47,462	41,247
Total long-term liabilities		2,550,975	2,595,559
Commitments and contingencies (see Note 16)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,270,927	1,264,505
Retained earnings		484,453	373,069
Accumulated other comprehensive loss		(309,306)	(253,282)
Total Cinemark USA, Inc.'s stockholder's equity		1,471,384	1,409,602
Noncontrolling interests		12,378	11,893
Total equity		1,483,762	1,421,495
Total liabilities and equity		4,474,171	4,485,340
NCM
Other assets
Investment in NCM		199,019	200,550
Long-term liabilities
Deferred revenue - NCM		295,264	351,706
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0	0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		$ 49,543	$ 49,543

[1] Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Treasury stock, shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648
Common stock, par value	$ 0	$ 0

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues
Total revenues		$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Cost of operations
Film rentals and advertising		287,206	246,556	528,121	499,374
Concession supplies		51,033	41,839	91,857	83,939
Salaries and wages		100,344	89,812	193,502	174,013
Facility lease expense		81,190	82,388	163,281	166,650
Utilities and other		115,602	91,053	225,034	179,410
General and administrative expenses		42,293	37,051	84,024	74,667
Depreciation and amortization		64,290	59,137	128,685	116,493
Impairment of long-lived assets		2,788	4,301	3,379	4,574
Loss on disposal of assets and other		16,901	54	20,840	888
Total cost of operations		761,647	652,191	1,438,723	1,300,008
Operating income		127,406	99,004	230,301	230,797
Other income (expense)
Interest expense	[1]	(28,466)	(26,522)	(55,581)	(52,891)
Loss on debt amendments			(246)	(1,484)	(246)
Interest income		2,858	1,380	5,093	2,713
Foreign currency exchange gain (loss)		(5,199)	(155)	(3,821)	1,434
Equity in income of affiliates		6,414	5,805	15,050	15,865
Total other expense		(25,882)	(16,966)	(40,853)	(23,565)
Income before income taxes		101,524	82,038	189,448	207,232
Income taxes		18,502	29,742	43,755	74,370
Net income		83,022	52,296	145,693	132,862
Less: Net income attributable to noncontrolling interests		329	571	485	1,037
Net income attributable to Cinemark USA, Inc.		82,693	51,725	145,208	131,825
Admissions
Revenues
Total revenues		508,870	449,880	961,494	926,349
Concession
Revenues
Total revenues		305,306	262,322	567,078	530,546
Other
Revenues
Total revenues		74,877	38,993	140,452	73,910
NCM
Other income (expense)
Distributions from NCM		3,424	2,772	9,782	9,560
Interest expense - NCM		(4,913)		(9,892)
Equity in income of affiliates		$ 495	$ 176	$ 4,511	$ 3,065

[1] Includes amortization of debt issue costs.

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 83,022	$ 52,296	$ 145,693	$ 132,862
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	26,658	33,800	89,669	129,457
Comprehensive income attributable to noncontrolling interests	(329)	(571)	(485)	(1,037)
Comprehensive income attributable to Cinemark USA, Inc.	$ 26,329	$ 33,229	$ 89,184	$ 128,420

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017
Operating activities
Net income		$ 145,693	$ 132,862
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		126,981	115,755
Amortization of intangible and other assets and favorable/unfavorable leases		1,704	738
Amortization of long-term prepaid rents		1,236	989
Amortization of debt issue costs		2,913	3,063
Loss on debt amendments		1,484	246
Amortization of deferred revenues, deferred lease incentives and other		(10,762)	(7,923)
Impairment of long-lived assets		3,379	4,574
Share based awards compensation expense		6,422	6,051
Loss on disposal of assets and other		20,840	888
Deferred lease expenses		(932)	(722)
Equity in income of affiliates		(15,050)	(15,865)
Deferred income tax expenses		7,669	14,515
Distributions from equity investees	[1]	16,255	14,919
Changes in assets and liabilities and other		(28,187)	(34,724)
Net cash provided by operating activities		279,645	235,366
Investing activities
Additions to theatre properties and equipment		(162,589)	(182,800)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(11,508)	(40,829)
Proceeds from sale of theatre properties and equipment and other		2,135	14,521
Investment in joint ventures and other, net		(19,467)	(466)
Net cash used for investing activities		(191,429)	(209,574)
Financing activities
Dividends paid to parent		(74,350)	(67,250)
Payroll taxes paid as a result of stock withholdings		(2,905)	(2,921)
Repayments of long-term debt		(3,298)	(1,427)
Payment of debt issue costs		(5,103)	(521)
Fees paid related to debt amendments		(704)	(246)
Payments on capital leases		(12,377)	(10,143)
Other			(311)
Net cash used for financing activities		(98,737)	(82,819)
Effect of exchange rate changes on cash and cash equivalents		(7,199)	(75)
Increase (decrease) in cash and cash equivalents		(17,720)	(57,102)
Cash and cash equivalents:
Beginning of period		522,415	561,138
End of period		$ 504,695	$ 504,036

[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment.

XML

The Company and Basis of Presentation

6 Months Ended

Jun. 30, 2018

Organization Consolidation And Presentation Of Financial Statements [Abstract]

The Company and Basis of Presentation

1. The Company and Basis of Presentation

Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

The accompanying condensed consolidated balance sheet as of December 31, 2017, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.  

These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Annual Report on Form 10-K filed March 2, 2018 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be achieved for the full year.

XML

New Accounting Pronouncements

6 Months Ended

Jun. 30, 2018

Accounting Changes And Error Corrections [Abstract]

New Accounting Pronouncements

2. New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC Topic 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers.  ASC Topic 606 replaces most existing revenue recognition guidance in U.S. generally accepted accounting principles.  In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from the contracts with customers.  The Company adopted ASC Topic 606 effective January 1, 2018.  See Note 3 for further discussion.  

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), (“ASU 2016-02”). The purpose of ASU 2016-02 is to provide financial statement users a better understanding of the amount, timing, and uncertainty of cash flows arising from leases. The adoption of ASU 2016-02 will result in the recognition of a right-of-use asset and a lease liability for most operating leases.  New disclosure requirements include qualitative and quantitative information about the amounts recorded in the financial statements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. ASU 2016-02 requires a modified retrospective transition by means of a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year in which the guidance is effective with the option to elect certain practical expedients. Early adoption is permitted. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, (“ASU 2018-10”). The amendments in ASU 2018-10 provide clarification of narrow aspects of the guidance issued in ASU 2016-02.  In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842), Targeted Improvements, (“ASU 2018-11”). The amendments in ASU 2018-11 provide an additional transition method to adopt the amendments in ASU 2016-02.  Under this new transition method, an entity initially applies the amendments in ASU 2016-02 at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.  Under this transition method, an entity is not required to use the modified transition method described in ASU 2016-02.  The Company plans to adopt the additional transition method provided in ASU 2018-11.  The Company is currently evaluating the impact of ASU 2016-02, ASU 2018-10 and ASU 2018-11 on its condensed consolidated financial statements.  The most significant impact of these amendments will be the recognition of new right-of-use assets and lease liabilities for assets related to leased theatres and certain leased equipment that are currently classified as operating leases.   The Company will adopt the amendments in ASU 2016-02, ASU 2018-10 and ASU 2018-11 in the first quarter of 2019.  

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230):  Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force, (“ASU 2016-15”). The purpose of ASU 2016-15 is to reduce the diversity in practice regarding how certain cash receipts and cash payments are presented and classified in the statement of cash flows.  ASU 2016-15 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year.  A retrospective transition method should be used in the application of the amendments within ASU 2016-15.  The Company adopted ASU 2016-15 effective January 1, 2018.  As a result of the adoption of ASU 2016-15, cash paid of $246 related to the June 2017 amendment of the Company’s senior secured credit facility was reclassified from operating activities to financing activities for the six months ended June 30, 2017.  

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, (“ASU 2016-16”).  The purpose of ASU 2016-16 is to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory.  ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year.  A modified retrospective transition method should be used in the application of the amendments within ASU 2016-16 with a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption.  ASU 2016-16 did not have a material impact on the Company’s condensed consolidated financial statements.  

XML

Revenue Recognition

6 Months Ended

Jun. 30, 2018

Revenue From Contract With Customer [Abstract]

Revenue Recognition

3. Revenue Recognition

Revenue Recognition Policy

The Company recognizes admissions and concession revenues when sales are made at the box office and concession stand, respectively.  Other revenues include screen advertising, transactional fees and other ancillary revenues such as vendor marketing promotions and meeting rentals located in the Company’s theatres.  The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. Additionally, the Company recognizes unredeemed gift cards and other advanced sale-type certificates, as a proportion of actual redemptions, as other revenues, which is an estimate primarily based on the Company’s historical experience with such cards and certificates.

Screen advertising revenues are generally recognized over the period that the related advertising is delivered on-screen or in-theatre. Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts.

See additional revenue recognition policy considerations, updated for the adoption of ASC Topic 606, below.  

Adoption of ASC Topic 606

The Company adopted ASC 606, Revenue from Contracts with Customers, effective January 1, 2018 under the modified retrospective method (cumulative-effect) and therefore, revenue amounts as presented on the condensed consolidated statements of income have not been adjusted for prior periods presented.

Changes to the way in which the Company recognizes revenue resulted in the following impacts to the condensed consolidated statements of income:

a)   Recording of incremental other revenue and interest expense related to the significant financing component of the Company’s Exhibitor Services Agreement (“ESA”) with NCM, LLC (“NCM”).  See further discussion below, including the estimated interest rates assumed in determining the amount of interest expense.

b) Deferral of a portion of admissions and concession revenues for transactions that include the issuance of loyalty points to customers. To determine the amount of revenues to defer upon issuance of points to customers under its points-based loyalty programs, the Company estimated the values of the rewards expected to be redeemed by its customers for those points.  The estimates are based on the rewards that have historically been offered under the loyalty programs, which the Company believes is representative of the rewards to be offered in the future.

c) Increase in other revenues and an increase in utilities and other expenses due to presentation of transactional fees on a gross versus net basis.

d) Increase in other revenues due to the change in amortization methodology for deferred revenue – NCM that is now amortized on a straight-line basis and effective for the entire term of the ESA.  As a result of the change in amortization method, the Company recorded a cumulative effect of accounting change adjustment of $40,526, net of taxes, in retained earnings on January 1, 2018 (see also Note 5).

The above noted changes increased (decreased) admissions, concession and other revenue for the three and six months ended June 30, 2018 as follows:

	Three Months Ended			Six Months Ended
	June 30, 2018			June 30, 2018
Admissions revenues	$	(1,898	)	$	(3,200	)
Concession revenues	$	(662	)	$	(1,207	)
Other revenues	$	32,710		$	60,169

The Company applied the practical expedient to exclude sales and other similar taxes collected from customers from its transaction price for purposes of recording revenues, as such revenues are presented net of such taxes.

Disaggregation of Revenue

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on major type of good or service and by reportable operating segment.

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Admissions revenues	$	408,863	$	100,007	$	508,870	$	758,215	$	203,279	$	961,494
Concession revenues		249,618		55,688		305,306		453,368		113,710		567,078
Screen advertising and promotional revenues		21,051		15,446		36,497		39,230		29,715		68,945
Other revenues		29,542		8,838		38,380		54,604		16,903		71,507
Total revenues	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on timing of revenue recognition (see Revenue Recognition Policy above).

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	686,463	$	161,350	$	847,813	$	1,262,289	$	327,499	$	1,589,788
Goods and services transferred over time		22,611		18,629		41,240		43,128		36,108		79,236
Total	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

Deferred Revenues

The following table presents changes in the Company’s deferred revenues for the six months ended June 30, 2018.  

Deferred Revenues	Deferred Revenue - NCM			Other Deferred Revenues (1)			Total
Balance at January 1, 2018	$	351,706		$	86,498		$	438,204
Impact of adoption of ASC Topic 606		(53,605	)		—			(53,605	)
Amounts recognized as accounts receivable		—			11,349			11,349
Cash received from customers in advance		—			53,398			53,398
Common units received from NCM (see Note 7)		5,012			—			5,012
Revenue recognized during period		(7,849	)		(64,996	)		(72,845	)
Foreign currency translation adjustments		—			(1,689	)		(1,689	)
Balance at June 30, 2018	$	295,264		$	84,560		$	379,824

(1) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of June 30, 2018 and when the Company expects to recognize this revenue.

	Twelve Months Ended June 30,
Remaining Performance Obligations	2019		2020		2021		2022		2023		Thereafter		Total
Deferred revenue - NCM	$	15,831	$	15,831	$	15,831	$	15,831	$	15,831	$	216,109	$	295,264
Deferred revenue - other		72,053		12,039		282		186		—		—		84,560
Total	$	87,884	$	27,870	$	16,113	$	16,017	$	15,831	$	216,109	$	379,824

Accounts receivable as of June 30, 2018 included approximately $48,631 of receivables related to contracts with customers.  The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the six months ended June 30, 2018.

Significant Financing Component

As discussed further in Note 6, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM.  The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2037.  In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA.  See Note 6 for additional information regarding the common unit adjustment and related accounting.   Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606.  

As a result of the significant financing component on deferred revenue - NCM, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $4,913 and $9,892 during the three and six months ended June 30, 2018, respectively. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 5.5% to 8.0%.

XML

Long Term Debt Activity

6 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

Long Term Debt Activity

4. Long Term Debt Activity

Senior Secured Credit Facility

On March 29, 2018, the Company amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The Company incurred debt issue costs of approximately $4,962 in connection with the amendment, which are reflected as a reduction of long term debt on the condensed consolidated balance sheet as of June 30, 2018.  As a result of the amendment, the Company wrote-off $780 of unamortized debt issue costs and incurred approximately $704 in legal and other fees, both of which are reflected as loss on debt amendments on the condensed consolidated statements of income for the six months ended June 30, 2018.  

Fair Value of Long-Term Debt

The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”). The carrying value of the Company’s long-term debt was $1,813,997 and $1,817,295 as of June 30, 2018 and December 31, 2017, respectively, excluding unamortized debt discounts and debt issue costs. The fair value of the Company’s long-term debt was $1,800,830 and $1,840,918 as of June 30, 2018 and December 31, 2017, respectively.

XML

Equity

6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Equity

5. Equity

Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the six months ended June 30, 2018 and 2017:

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling		Total
	Equity			Interests		Equity
Balance at January 1, 2018	$	1,409,602		$	11,893	$	1,421,495
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)		40,526			—		40,526
Share based awards compensation expense		6,422			—		6,422
Dividends paid to parent		(74,350	)		—		(74,350	)
Net income		145,208			485		145,693
Other comprehensive income in equity method investees		20			—		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)
Balance at June 30, 2018	$	1,471,384		$	12,378	$	1,483,762

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling			Total
	Equity			Interests			Equity
Balance at January 1, 2017	$	1,272,938		$	11,142		$	1,284,080
Share based awards compensation expense		6,051		―				6,051
Dividends paid to parent		(67,250	)	―				(67,250	)
Dividends paid to noncontrolling interests	―				(294	)		(294	)
Net income		131,825			1,037			132,862
Other comprehensive income in equity method investees		103		―				103
Foreign currency translation adjustments		(5,059	)	―				(5,059	)
Balance at June 30, 2017	$	1,338,608		$	11,885		$	1,350,493

XML

Investment in National CineMedia

6 Months Ended

Jun. 30, 2018

NCM

Investment in National CineMedia

6. Investment in National CineMedia

The Company has an investment in National Cinemedia, LLC (“NCM”).  NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. Upon joining NCM, the Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM provides advertising and promotions to our theatres.As described further in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. Following the NCM, Inc. IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM.  The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

	Investment in NCM			Deferred Revenue			Distributions from NCM			Equity in Earnings			Other Revenue			Interest Expense - NCM (3)		Cash Received
Balance as of January 1, 2018	$	200,550		$	(351,706	)
Impact of adoption of ASC Topic 606 (1)		—			53,605		$	—		$	—		$	—		$	—	$	—
Receipt of common units due to annual common    unit adjustment ("CUA")		5,012			(5,012	)		—			—			—			—		—
Revenues earned under ESA (2) (3)		—			—			—			—			(16,074	)		9,892		6,182
Receipt of excess cash distributions		(8,760	)		—			(7,735	)		—			—			—		16,495
Receipt under tax receivable agreement		(2,294	)		—			(2,047	)		—			—			—		4,341
Equity in earnings		4,511			—			—			(4,511	)		—			—		—
Amortization of deferred revenue		—			7,849			—			—			(7,849	)		—		—
Balance as of and for the six months ended June 30, 2018	$	199,019		$	(295,264	)	$	(9,782	)	$	(4,511	)	$	(23,923	)	$	9,892	$	27,018

(1) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and Common Unit Adjustment agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption.  The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings (see also Note 5).  See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.  

(2) Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $6,227.

(3)   Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements.  See Note 3.  

During the three months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $495 and $176, respectively.  During the six months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $4,511 and $3,065, respectively.

The Company made payments to NCM of $60 and $50 during the six months ended June 30, 2018 and 2017, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre properties and equipment on the condensed consolidated balance sheets.  

Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC Entertainment, Inc. (“AMC”) and Regal Entertainment Group (“Regal”) (collectively, “Founding Members”), annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As further discussed in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis.

During March 2018, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2018, the Company received an additional 908,042 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $5,012. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.  The deferred revenue will be recognized on a straight-line basis over the remaining term of the ESA, which is approximately 19 years.

As of June 30, 2018, the Company owned a total of 28,779,904 common units of NCM, representing an ownership interest of approximately 18%. The estimated fair value of the Company’s investment in NCM was approximately $241,751 based on the price of NCMI common stock as of June 30, 2018 of $8.40 per share (Level 1 input as defined in FASB ASC Topic 820).  See Note 17 for discussion of subsequent event related to the acquisition of additional NCM common units from AMC.  

Below is summary financial information for NCM for the periods indicated:

	ThreeMonths Ended				Six Months Ended
	June 28, 2018		June 29, 2017		June 28, 2018		June 29, 2017
Gross revenues	$	113,700	$	97,100	$	193,900	$	169,000
Operating income	$	40,100	$	28,300	$	51,100	$	33,400
Net income	$	25,000	$	15,400	$	22,000	$	7,500

	As of			As of
	June 28, 2018			December 28, 2017
Current assets	$	142,800		$	174,400
Noncurrent assets	$	758,800		$	758,300
Current liabilities	$	84,800		$	123,300
Noncurrent liabilities	$	943,500		$	925,400
Members deficit	$	(126,700	)	$	(116,000	)

XML

Other Investments

6 Months Ended

Jun. 30, 2018

Financial Support For Nonconsolidated Legal Entity [Abstract]

Other Investments

7. Other Investments

Below is a summary of activity for each of the Company’s other investments for the six months ended June 30, 2018:

	DCIP			ACJV, LLC		DCDC			FE Concepts			Other		Total
Balance at January 1, 2018	$	106,215		$	5,916	$	3,598		$	104		$	4,212	$	120,045
Cash contributions made		739			—		—			20,000					20,739
Cash distributions received		(5,201	)		—		—			—			—		(5,201	)
Equity in income (loss)		9,727			408		481			(77	)		—		10,539
Equity in other comprehensive income		20			—		—			—			—		20
Other		—			—		(1,168	)		(104	)		211		(1,061	)
Balance at June 30, 2018	$	111,500		$	6,324	$	2,911		$	19,923		$	4,423	$	145,081

Digital Cinema Implementation Partners LLC (“DCIP”)

On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of June 30, 2018, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting.

Below is summary financial information for DCIP for the periods indicated:

	Three Months Ended				Six Months Ended
	June 30, 2018		June 30, 2017		June 30, 2018		June 30, 2017
Gross revenues	$	42,521	$	47,095	$	83,554	$	92,574
Operating income	$	25,049	$	29,393	$	48,494	$	57,872
Net income	$	22,169	$	25,616	$	43,703	$	49,757

	As of
	June 30, 2018		December 31, 2017
Current assets	$	51,546	$	56,296
Noncurrent assets	$	725,399	$	772,438
Current liabilities	$	63,982	$	59,153
Noncurrent liabilities	$	213,795	$	296,889
Members' equity	$	499,168	$	472,692

As of June 30, 2018, the Company had 3,818 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and six months ended June 30, 2018 and 2017:

	ThreeMonths Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Equipment lease payments	$	1,243		$	1,511		$	2,460		$	2,881
Warranty reimbursements from DCIP	$	(2,617	)	$	(2,023	)	$	(5,118	)	$	(3,907	)
Management service fees	$	184		$	206		$	378		$	412

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM.  The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $5,588 and $6,763 for the six months ended June 30, 2018 and 2017, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income.  Additionally, the remaining outstanding balance of a note payable from the Company to NCM, related to the formation of AC, was $2,778 as of June 30, 2018.

Digital Cinema Distribution Coalition

Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal.  DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $461 and $446 to DCDC during the six months ended June 30, 2018 and 2017, respectively, related to content delivery services provided by DCDC.  These fees are included in film rentals and advertising costs on the condensed consolidated statements of income.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities.  The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts.  The Company accounts for its investment in FE Concepts under the equity method of accounting.

XML

Share Based Awards

6 Months Ended

Jun. 30, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Share Based Awards

8. Share Based Awards

Restricted Stock – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted 321,406 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $35.81 to $39.26 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. The restricted stock awards vest over periods ranging from one to four years.  The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Below is a summary of restricted stock activity for the six months ended June 30, 2018:

	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2018		650,581		$	35.81
Granted		321,406		$	38.79
Vested		(242,945	)	$	31.16
Forfeited		(18,643	)	$	38.33
Outstanding at June 30, 2018		710,399		$	38.68
Unvested restricted stock at June 30, 2018		710,399		$	38.68

	Six Months Ended June 30,
	2018		2017
Compensation expense recognized by the Company during the period	$	4,342	$	3,901
Additional compensation expense recognized by Cinemark Holdings, Inc. during the period	$	456	$	393
Fair value of restricted shares held by Company employees that vested during the period	$	7,013	$	7,174
Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period	$	802	$	917
Income tax benefit recognized upon vesting of restricted stock awards held by Company employees	$	1,550	$	2,247
Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors	$	201	$	386

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $19,408, of which $18,528 will be recognized by the Company and $880 will be recognized by Cinemark Holdings, Inc.  The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Restricted Stock Units – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted restricted stock units representing 228,194 hypothetical shares of its common stock to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2019 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee of Cinemark Holdings, Inc.’s board of directors prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 7%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 9.5%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 13%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR.  All restricted stock units granted during 2018 will vest subject to an additional two-year service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest.  

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the six months ended June 30, 2018at each of the three target levels of financial performance (excluding forfeiture assumptions):

	Number of
	Shares		Value at
	Vesting		Grant
at IRR of at least 7%		76,065	$	2,967
at IRR of at least 9.5%		152,129	$	5,934
at IRR of at least 13%		228,194	$	8,901

Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2018 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $37.55 to $39.03 per share. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period.

	Six Months Ended June 30,
	2018		2017
Number of restricted stock unit awards that vested during    the period		127,084		97,115
Fair value of restricted stock unit awards that vested during    the period	$	4,846	$	4,155
Accumulated dividends paid upon vesting of restricted stock    unit awards	$	501	$	313
Compensation expense recognized during the period	$	2,080	$	2,150
Income tax benefit recognized upon vesting of restricted stock    unit awards	$	740	$	1,745

During the six months ended June 30, 2018, the Company determined that the IRR reached for the restricted stock units granted in February 2016 was 7.2%, compared to a target IRR of 8.0%.  The Company recorded a reduction in compensation expense of $69 during the six months ended June 30, 2018 to reflect the revised number of shares expected to vest in February 2020 for the 2016 restricted stock unit grant.  

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $9,854. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of June 30, 2018, the Company had restricted stock units outstanding that represented a total of 594,266 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 18,667 units, assuming an IRR of 7.2% was achieved for the 2016 grants and the maximum IRR level is achieved for all other grants outstanding.

XML

Goodwill and Other Intangible Assets

6 Months Ended

Jun. 30, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

9. Goodwill and Other Intangible Assets

The Company’s goodwill was as follows:

	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2018 (1)	$	1,174,041	$	110,038		$	1,284,079
Acquisition of theatres in Brazil (2)		—		11,508			11,508
Foreign currency translation adjustments		—		(14,417	)		(14,417	)
Balance at June 30, 2018 (1)	$	1,174,041	$	107,129		$	1,281,170

(1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

(2) Amount represents preliminary purchase price allocation for theatres acquired in Brazil.

The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable.  The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations).  For the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment on all reporting units, in accordance with ASC Topic 350-20-35.  No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of goodwill might exceed its estimated fair value.

Intangible assets consisted of the following:

	Balance at											Balance at
	January 1,											June 30,
	2018			Additions (1)		Amortization			Other (2)			2018
Intangible assets with finite lives:
Gross carrying amount	$	105,895		$	—	$	—		$	(1,645	)	$	104,250
Accumulated amortization		(68,869	)	―			(2,932	)	―				(71,801	)
Total net intangible assets with finite lives	$	37,026		$	—	$	(2,932	)	$	(1,645	)	$	32,449
Intangible assets with indefinite lives:
Tradename and other		299,735			608	―				(286	)		300,057
Total intangible assets — net	$	336,761		$	608	$	(2,932	)	$	(1,931	)	$	332,506

(1) Amount represents the acquisition of tradeable liquor licenses.

(2) Amount represents foreign currency translation adjustments.

For the year ended December 31, 2017, the Company performed a quantitative assessment for all definite and indefinite-lived tradename assets.  No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of its tradename assets might exceed their estimated fair values.

Estimated aggregate future amortization expense for intangible assets is as follows:

For the six months ended December 31, 2018	$	2,661
For the twelve months ended December 31, 2019		5,152
For the twelve months ended December 31, 2020		5,310
For the twelve months ended December 31, 2021		3,574
For the twelve months ended December 31, 2022		3,207
Thereafter		12,545
Total	$	32,449

XML

Impairment of Long-Lived Assets

6 Months Ended

Jun. 30, 2018

Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]

Impairment of Long-Lived Assets

10. Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K.  As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the six months ended June 30, 2018 and 2017. As of June 30, 2018, the estimated aggregate fair value of the long-lived assets impaired during the six months ended June 30, 2018 was $871.

The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre.

Below is a summary of impairment charges for the periods presented:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
U.S. theatre properties	$	1,187	$	84	$	1,778	$	357
International theatre properties		1,601		4,217		1,601		4,217
Impairment of long-lived assets	$	2,788	$	4,301	$	3,379	$	4,574

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

11. Fair Value Measurements

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

The Company did not have any assets or liabilities measured at fair value on a recurring basis under ASC Topic 820 as of December 31, 2017 or June 30, 2018.  

The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 9 and Note 10). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed March 2, 2018.  There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the six months ended June 30, 2018.  

XML

Foreign Currency Translation

6 Months Ended

Jun. 30, 2018

Foreign Currency [Abstract]

Foreign Currency Translation

12. Foreign Currency Translation

The accumulated other comprehensive loss account in stockholder’s equity of $309,306 and $253,282 as of June 30, 2018 and December 31, 2017, respectively, primarily includes cumulative foreign currency adjustments of $309,609 and $253,565, respectively, from translating the financial statements of the Company’s international subsidiaries.

As of June 30, 2018, all foreign countries where the Company has operations are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss.  

A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity.  There has been a steady devaluation of the Argentine peso relative to the U.S. dollar in recent years.  As of June 30, 2018, the Company did not designate Argentina as highly inflationary for accounting purposes.  However, the Company has determined that Argentina will be deemed highly inflationary beginning July 1, 2018.  The financial information of the Company’s Argentina subsidiaries will be remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective July 1, 2018.    

Below is a summary of the impact of translating the June 30, 2018 financial statements of the Company’s international subsidiaries:

					Other
					Comprehensive
					Income (Loss) for the
	Exchange Rate as of				Six Months Ended
Country	June 30, 2018		December 31, 2017		June 30, 2018
Brazil		3.88		3.31	$	(34,511	)
Argentina		28.94		18.65		(16,896	)
Peru		3.28		3.24		(580	)
Chile		654.28		615.97		(4,372	)
All other						315
					$	(56,044	)

XML

Supplemental Cash Flow Information

6 Months Ended

Jun. 30, 2018

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

13. Supplemental Cash Flow Information

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

	Six Months Ended
	June 30,
	2018			2017
Cash paid for interest	$	51,562		$	49,603
Cash paid for income taxes, net of refunds received	$	28,477		$	55,371
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the    acquisition of theatre properties and equipment (1)	$	2,898		$	(4,959	)
Theatre properties acquired under capital lease	$	4,035		$	7,089
Interest expense - NCM (see Note 3)	$	(9,892	)	$	—
Investment in NCM – receipt of common units (see    Note 6)	$	5,012		$	18,363

(1) Additions to theatre properties and equipment included in accounts payable as of June 30, 2018 and December 31, 2017 were $34,174 and $31,276, respectively.

XML

Segments

6 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Segments

14. Segments

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments.

Below is a breakdown of selected financial information by reportable operating segment:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Revenues
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
International		179,979			199,926			363,607			401,994
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total revenues	$	889,053		$	751,195		$	1,669,024		$	1,530,805
Adjusted EBITDA
U.S.	$	188,920		$	129,976		$	345,190		$	295,038
International		33,192			41,285			70,778			88,511
Total Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549
Capital expenditures
U.S.	$	59,675		$	77,175		$	129,646		$	155,992
International		22,751			14,438			32,943			26,808
Total capital expenditures	$	82,426		$	91,613		$	162,589		$	182,800

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Add (deduct):		-			-
Income taxes		18,502			29,742			43,755			74,370
Interest expense (1)		28,466			26,522			55,581			52,891
Other (income) expense (2)		840			(7,030	)		(6,430	)		(20,012	)
Loss on debt amendments		—			246			1,484			246
Other cash distributions from equity investees (3)		3,932			2,870			16,255			14,919
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Deferred lease expenses		(449	)		(375	)		(932	)		(722	)
Amortization of long-term prepaid rents		597			496			1,236			989
Share based awards compensation expense		3,223			3,002			6,422			6,051
Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549

(1) Includes amortization of debt issue costs.

(2) Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.

(3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7).  These distributions are reported entirely within the U.S. operating segment.

(4) The adoption of ASC Topic 606 impacted how the Company records certain revenues.  See Note 3 for discussion of the impact of ASC Topic 606.  

Financial Information About Geographic Areas

Below is a breakdown of selected financial information by geographic area:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
Revenues	2018			2017			2018			2017
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
Brazil		72,977			87,841			153,113			182,540
Other international countries		107,002			112,085			210,494			219,454
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total	$	889,053		$	751,195		$	1,669,024		$	1,530,805

	As of		As of
Theatre Properties and Equipment-net	June 30, 2018		December 31, 2017
U.S.	$	1,465,915	$	1,439,168
Brazil		146,467		179,669
Other international countries		205,355		209,217
Total	$	1,817,737	$	1,828,054

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2018

Related Party Transactions [Abstract]

Related Party Transactions

15. Related Party Transactions

The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $327 and $305 of management fee revenues during the six months ended June 30, 2018 and 2017, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip.  For the six months ended June 30, 2018 and 2017, the aggregate amounts paid to Copper Beech for the use of the aircraft was $51 and $63, respectively.

The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the six months ended June 30, 2018 and 2017, the Company paid total rent of approximately $12,980 and $13,420, respectively, to Syufy.

The Company has paid certain fees on behalf of its parent, Cinemark Holdings, Inc., and Cinemark Holdings, Inc. has paid income taxes and other items on behalf of the Company.  The net receivable from Cinemark Holdings, Inc. as of June 30, 2018 and December 31, 2017 was $18,963 and $14,581, respectively.  The Company paid Cinemark Holdings, Inc. cash dividends of $74,350 and $67,250 during the six months ended June 30, 2018 and 2017, respectively.  

The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities.  See Note 7 for further discussion.  

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2018

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

16. Commitments and Contingencies

Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for penalties and attorney's fees arising from alleged violations of the California wage statement law.  The claim is also asserted as a representative action under the California Private Attorney General Act (PAGA) for penalties. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims.  The company denies any violation of law and plans to vigorously defend against all claims.  The parties are awaiting the Court's ruling on Plaintiff's motion for class certification. The Company is unable to predict the outcome of this litigation or the range of potential loss.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles.  Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships.  Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest.  Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016.  The Company denied the allegations.  In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims.  The trial court granted that motion and dismissed Plaintiff’s claims.  Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.”  Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets.  Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim.  Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims.  That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice.  Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court.  The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction.  The case returned to the trial court on October 6, 2016.  On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards.  Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees.  During the three and six months ended June 30, 2018, the Company recorded a litigation reserve based on an estimate of the jury award, which is reflected in loss on disposal of assets and other on the condensed consolidated income statement.  The Company has filed a motion for a judgment notwithstanding the verdict and a motion for a new trial. Depending on the ruling on these motions, the Company intends to appeal any final judgment.  Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals.

The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures.  The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

From time to time, the Company is involved in various other legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

XML

Subsequent Event

6 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Event

17. Subsequent Event – Acquisition of common units of NCM

On July 5, 2018 the Company acquired 10,738,740 common units of NCM from AMC for $78,400 in cash, or approximately $7.30 per common unit.  As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%.  The amount paid for the additional common units will be recorded as an increase in the Company’s investment in NCM.  See Note 6 for further discussion of the accounting for the Company’s investment in NCM.

XML

Condensed Consolidating Financial Information of Subsidiary Guarantors

6 Months Ended

Jun. 30, 2018

Statement Of Financial Position [Abstract]

Condensed Consolidating Financial Information of Subsidiary Guarantors

18. Condensed Consolidating Financial Information of Subsidiary Guarantors

As of June 30, 2018, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023,  or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.:

Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC.

The following supplemental condensed consolidating financial information presents:

a. Condensed consolidating balance sheet information as of December 31, 2017 and June 30, 2018, condensed consolidating statements of income information for the three and six months ended June 30, 2017 and 2018, condensed consolidating statements of comprehensive income (loss) information for the three and six months ended June 30, 2017 and 2018 and condensed consolidating statements of cash flows information for the six months ended June 30, 2017 and 2018.

b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column.

c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

DECEMBER 31, 2017

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	130,590	$	180,623	$	211,202	$	—		$	522,415
Other current assets		59,661		17,841		76,789		(19,270	)		135,021
Accounts receivable from parent or subsidiaries		117,972		119,616		—		(223,007	)		14,581
Total current assets		308,223		318,080		287,991		(242,277	)		672,017
Theatre properties and equipment - net		650,783		765,500		411,771		—			1,828,054
Investment in subsidiaries		1,691,626		121,795		—		(1,813,421	)		—
Other assets		1,427,328		134,845		536,816		(113,720	)		1,985,269
Total assets	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	5,710	$	—	$	1,389	$	—		$	7,099
Current portion of capital lease obligations		9,532		11,124		4,855		—			25,511
Accounts payable and accrued expenses		215,580		116,409		110,089		(6,402	)		435,676
Accounts payable to parent or subsidiaries		—		—		223,007		(223,007	)		—
Total current liabilities		230,822		127,533		339,340		(229,409	)		468,286
Long-term liabilities
Long-term debt, less current portion		1,878,992		—		11,211		(109,822	)		1,780,381
Capital lease obligations, less current    portion		132,189		75,767		43,195		—			251,151
Other long-term liabilities and deferrals		426,355		60,567		93,871		(16,766	)		564,027
Total long-term liabilities		2,437,536		136,334		148,277		(126,588	)		2,595,559
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,360,059		618,985		726,830		(1,345,815	)		1,360,059
Total Cinemark USA, Inc. stockholder's    equity		1,409,602		1,076,353		737,068		(1,813,421	)		1,409,602
Noncontrolling interests		—		—		11,893		—			11,893
Total equity		1,409,602		1,076,353		748,961		(1,813,421	)		1,421,495
Total liabilities and equity	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

JUNE 30, 2018

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	301,796	$	8,711	$	194,188	$	—		$	504,695
Other current assets		70,203		21,043		67,168		(34,952	)		123,462
Accounts receivable from parent or subsidiaries		—		324,697		—		(305,734	)		18,963
Total current assets		371,999		354,451		261,356		(340,686	)		647,120
Theatre properties and equipment - net		670,573		769,293		377,871		—			1,817,737
Investment in subsidiaries		1,763,463		89,214		—		(1,852,677	)		—
Other assets		1,427,050		154,648		540,294		(112,678	)		2,009,314
Total assets	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	—	$	1,389	$	—		$	7,984
Current portion of capital lease obligations		12,192		9,579		4,900		—			26,671
Accounts payable and accrued expenses		237,615		101,384		96,104		(30,324	)		404,779
Accounts payable to parent or subsidiaries		101,094		—		204,640		(305,734	)		—
Total current liabilities		357,496		110,963		307,033		(336,058	)		439,434
Long-term liabilities
Long-term debt, less current portion		1,873,393		—		9,343		(107,954	)		1,774,782
Capital lease obligations, less current portion		129,201		67,623		42,181		—			239,005
Other long-term liabilities and deferrals		401,611		59,509		85,420		(9,352	)		537,188
Total long-term liabilities		2,404,205		127,132		136,944		(117,306	)		2,550,975
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,421,841		672,143		712,928		(1,385,071	)		1,421,841
Total Cinemark USA, Inc. stockholder's equity		1,471,384		1,129,511		723,166		(1,852,677	)		1,471,384
Noncontrolling interests		—		—		12,378		—			12,378
Total equity		1,471,384		1,129,511		735,544		(1,852,677	)		1,483,762
Total liabilities and equity	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	247,821		$	305,019		$	209,998		$	(11,643	)	$	751,195
Cost of operations
Theatre operating expenses		197,345			210,406			155,540			(11,643	)		551,648
General and administrative expenses		2,365			20,872			13,814			—			37,051
Depreciation and amortization		20,193			21,767			17,177			—			59,137
Impairment of long-lived assets		41			43			4,217			—			4,301
(Gain) loss on disposal of assets and other		5,072			(4,866	)		(152	)		—			54
Total cost of operations		225,016			248,222			190,596			(11,643	)		652,191
Operating income		22,805			56,797			19,402			—			99,004
Other income (expense)
Interest expense		(23,473	)		(1,836	)		(1,571	)		358			(26,522	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			2,772			—			2,772
Equity in income of affiliates		52,156			12,299			5,851			(64,501	)		5,805
Other income		224			162			1,197			(358	)		1,225
Total other income (expense)		28,661			10,625			8,249			(64,501	)		(16,966	)
Income before income taxes		51,466			67,422			27,651			(64,501	)		82,038
Income taxes		(259	)		25,412			4,589			—			29,742
Net income		51,725			42,010			23,062			(64,501	)		52,296
Less: Net income attributable to    noncontrolling interests		—			—			571			—			571
Net income attributable to Cinemark USA,    Inc.	$	51,725		$	42,010		$	22,491		$	(64,501	)	$	51,725

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	332,976		$	385,703		$	191,616		$	(21,242	)	$	889,053
Cost of operations
Theatre operating expenses		255,711			255,943			144,963			(21,242	)		635,375
General and administrative expenses		3,651			25,097			13,545			—			42,293
Depreciation and amortization		22,216			24,049			18,025			—			64,290
Impairment of long-lived assets		1,187			—			1,601			—			2,788
Loss on disposal of assets and other		2,462			13,978			461			—			16,901
Total cost of operations		285,227			319,067			178,595			(21,242	)		761,647
Operating income		47,749			66,636			13,021			—			127,406
Other income (expense)
Interest expense		(24,156	)		(1,703	)		(2,949	)		342			(28,466	)
Distributions from NCM		—			—			3,424			—			3,424
Interest expense - NCM		(4,913	)		—			—			—			(4,913	)
Equity in income of affiliates		68,807			2,677			6,339			(71,409	)		6,414
Other income (expense)		1,392			(62	)		(3,329	)		(342	)		(2,341	)
Total other income (expense)		41,130			912			3,485			(71,409	)		(25,882	)
Income before income taxes		88,879			67,548			16,506			(71,409	)		101,524
Income taxes		6,186			15,586			(3,270	)		—			18,502
Net income		82,693			51,962			19,776			(71,409	)		83,022
Less: Net income attributable to    noncontrolling interests		—			—			329			—			329
Net income attributable to Cinemark USA,    Inc.	$	82,693		$	51,962		$	19,447		$	(71,409	)	$	82,693

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	517,702		$	615,975		$	421,993		$	(24,865	)	$	1,530,805
Cost of operations
Theatre operating expenses		402,576			417,589			308,086			(24,865	)		1,103,386
General and administrative expenses		6,625			41,209			26,833			—			74,667
Depreciation and amortization		39,851			42,161			34,481			—			116,493
Impairment of long-lived assets		286			71			4,217			—			4,574
(Gain) loss on disposal of assets and other		5,505			(4,682	)		65			—			888
Total cost of operations		454,843			496,348			373,682			(24,865	)		1,300,008
Operating income		62,859			119,627			48,311			—			230,797
Other income (expense)
Interest expense		(46,783	)		(3,733	)		(3,090	)		715			(52,891	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			9,560			—			9,560
Equity in income of affiliates		120,245			29,754			15,327			(149,461	)		15,865
Other income		1,887			162			2,813			(715	)		4,147
Total other income (expense)		75,103			26,183			24,610			(149,461	)		(23,565	)
Income before income taxes		137,962			145,810			72,921			(149,461	)		207,232
Income taxes		6,137			43,899			24,334			—			74,370
Net income		131,825			101,911			48,587			(149,461	)		132,862
Less: Net income attributable to    noncontrolling interests		—			—			1,037			—			1,037
Net income attributable to Cinemark USA,    Inc.	$	131,825		$	101,911		$	47,550		$	(149,461	)	$	131,825

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	615,305		$	704,124		$	384,221		$	(34,626	)	$	1,669,024
Cost of operations
Theatre operating expenses		474,489			474,473			287,459			(34,626	)		1,201,795
General and administrative expenses		6,760			49,950			27,314			—			84,024
Depreciation and amortization		43,655			48,330			36,700			—			128,685
Impairment of long-lived assets		1,201			—			2,178			—			3,379
Loss on disposal of assets and other		4,768			15,409			663			—			20,840
Total cost of operations		530,873			588,162			354,314			(34,626	)		1,438,723
Operating income		84,432			115,962			29,907			—			230,301
Other income (expense)
Interest expense		(48,384	)		(3,361	)		(4,529	)		693			(55,581	)
Loss on debt amendments		(1,484	)		—			—			—			(1,484	)
Distributions from NCM		—			—			9,782			—			9,782
Interest expense - NCM		(9,892	)		—			—			—			(9,892	)
Equity in income of affiliates		128,908			6,963			13,919			(134,740	)		15,050
Other income (expense)		2,204			(7	)		(232	)		(693	)		1,272
Total other income (expense)		71,352			3,595			18,940			(134,740	)		(40,853	)
Income before income taxes		155,784			119,557			48,847			(134,740	)		189,448
Income taxes		10,576			26,940			6,239			—			43,755
Net income		145,208			92,617			42,608			(134,740	)		145,693
Less: Net income attributable to    noncontrolling interests		—			—			485			—			485
Net income attributable to Cinemark USA,    Inc.	$	145,208		$	92,617		$	42,123		$	(134,740	)	$	145,208

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	51,725		$	42,010	$	23,062		$	(64,501	)	$	52,296
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(95	)		—		(95	)		95			(95	)
Foreign currency translation adjustments		(18,401	)		—		(18,401	)		18,401			(18,401	)
Total other comprehensive loss, net of tax		(18,496	)		—		(18,496	)		18,496			(18,496	)
Total comprehensive income, net of tax	$	33,229		$	42,010	$	4,566		$	(46,005	)	$	33,800
Comprehensive income attributable to noncontrolling interests		—			—		(571	)		—			(571	)
Comprehensive income attributable to Cinemark USA, Inc.	$	33,229		$	42,010	$	3,995		$	(46,005	)	$	33,229

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	82,693		$	51,962	$	19,776		$	(71,409	)	$	83,022
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(116	)		—		(116	)		116			(116	)
Foreign currency translation adjustments		(56,248	)		—		(56,248	)		56,248			(56,248	)
Total other comprehensive loss, net of tax		(56,364	)		—		(56,364	)		56,364			(56,364	)
Total comprehensive income (loss), net of tax	$	26,329		$	51,962	$	(36,588	)	$	(15,045	)	$	26,658
Comprehensive income attributable to noncontrolling interests		—			—		(329	)		—			(329	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	26,329		$	51,962	$	(36,917	)	$	(15,045	)	$	26,329

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	131,825		$	101,911	$	48,587		$	(149,461	)	$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		103			—		103			(103	)		103
Foreign currency translation adjustments		(3,508	)		—		(3,508	)		3,508			(3,508	)
Total other comprehensive loss, net of tax		(3,405	)		—		(3,405	)		3,405			(3,405	)
Total comprehensive income, net of tax	$	128,420		$	101,911	$	45,182		$	(146,056	)	$	129,457
Comprehensive income attributable to noncontrolling interests		—			—		(1,037	)		—			(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	128,420		$	101,911	$	44,145		$	(146,056	)	$	128,420

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	145,208		$	92,617	$	42,608		$	(134,740	)	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		20			—		20			(20	)		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)		56,044			(56,044	)
Total other comprehensive loss, net of tax		(56,024	)		—		(56,024	)		56,024			(56,024	)
Total comprehensive income (loss), net of tax	$	89,184		$	92,617	$	(13,416	)	$	(78,716	)	$	89,669
Comprehensive income attributable to noncontrolling interests		—			—		(485	)		—			(485	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	89,184		$	92,617	$	(13,901	)	$	(78,716	)	$	89,184

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	131,825		$	101,911		$	48,587		$	(149,461	)	$	132,862
Adjustments to reconcile net income to cash provided by (used for) operating activities		(62,144	)		13,264			36,647			149,461			137,228
Changes in assets and liabilities		(83,338	)		38,444			10,170			—			(34,724	)
Net cash provided by (used for) operating activities		(13,657	)		153,619			95,404			—			235,366
Investing activities
Additions to theatre properties and equipment		(62,198	)		(92,383	)		(28,219	)		—			(182,800	)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(12,500	)		—			(28,329	)		—			(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,143			12,255			123			—			14,521
Dividends received from subsidiaries		127,300			6			—			(127,306	)		—
Investment in joint ventures and other		—			—			(466	)		—			(466	)
Net cash provided by (used for) investing activities		54,745			(80,122	)		(56,891	)		(127,306	)		(209,574	)
Financing activities
Dividends paid to parent		(67,250	)		(127,000	)		(306	)		127,306			(67,250	)
Repayments of long-term debt		(1,427	)		—			—			—			(1,427	)
Payments on capital leases		(3,628	)		(4,632	)		(1,883	)		—			(10,143	)
Other		(784	)		(2,921	)		(294	)		—			(3,999	)
Net cash used for financing activities		(73,089	)		(134,553	)		(2,483	)		127,306			(82,819	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(75	)		—			(75	)
Increase (decrease) in cash and cash equivalents		(32,001	)		(61,056	)		35,955			—			(57,102	)
Cash and cash equivalents:
Beginning of year		146,855			281,023			133,260			—			561,138
End of year	$	114,854		$	219,967		$	169,215		$	—		$	504,036

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	145,208		$	92,617		$	42,608		$	(134,740	)	$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		(73,458	)		62,445			38,412			134,740			162,139
Changes in assets and liabilities		230,402			(220,516	)		(38,073	)		—			(28,187	)
Net cash provided by (used for) operating activities		302,152			(65,454	)		42,947			—			279,645
Investing activities
Additions to theatre properties and equipment		(44,970	)		(79,756	)		(37,863	)		—			(162,589	)
Acquisition of theatres in international markets, net of cash acquired		—			—			(11,508	)		—			(11,508	)
Proceeds from sale of theatre properties and equipment and other		1,244			485			406			—			2,135
Proceeds from intercompany note repayment		1,867			—			—			(1,867	)		—
Investment in joint ventures and other		—			(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(41,859	)		(99,167	)		(48,536	)		(1,867	)		(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			—			(74,350	)
Repayments of long-term debt		(3,298	)		—			—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			—			(5,103	)
Repayment of intercompany note		—			—			(1,867	)		1,867			—
Payments on capital leases		(5,632	)		(4,386	)		(2,359	)		—			(12,377	)
Other		(704	)		(2,905	)		—			—			(3,609	)
Net cash used for financing activities		(89,087	)		(7,291	)		(4,226	)		1,867			(98,737	)
Effect of exchange rate changes on cash and    cash equivalents		—			—			(7,199	)		—			(7,199	)
Increase (decrease) in cash and cash    equivalents		171,206			(171,912	)		(17,014	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		130,590			180,623			211,202			—			522,415
End of year	$	301,796		$	8,711		$	194,188		$	—		$	504,695

*   *   *   *   *

XML

Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2018

Revenue Initial Application Period Cumulative Effect Transition [Line Items]

Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on major type of good or service and by reportable operating segment.

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Admissions revenues	$	408,863	$	100,007	$	508,870	$	758,215	$	203,279	$	961,494
Concession revenues		249,618		55,688		305,306		453,368		113,710		567,078
Screen advertising and promotional revenues		21,051		15,446		36,497		39,230		29,715		68,945
Other revenues		29,542		8,838		38,380		54,604		16,903		71,507
Total revenues	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on timing of revenue recognition (see Revenue Recognition Policy above).

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	686,463	$	161,350	$	847,813	$	1,262,289	$	327,499	$	1,589,788
Goods and services transferred over time		22,611		18,629		41,240		43,128		36,108		79,236
Total	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

(1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 14 for additional information on intercompany eliminations.

Changes in Deferred Revenues

The following table presents changes in the Company’s deferred revenues for the six months ended June 30, 2018.  

Deferred Revenues	Deferred Revenue - NCM			Other Deferred Revenues (1)			Total
Balance at January 1, 2018	$	351,706		$	86,498		$	438,204
Impact of adoption of ASC Topic 606		(53,605	)		—			(53,605	)
Amounts recognized as accounts receivable		—			11,349			11,349
Cash received from customers in advance		—			53,398			53,398
Common units received from NCM (see Note 7)		5,012			—			5,012
Revenue recognized during period		(7,849	)		(64,996	)		(72,845	)
Foreign currency translation adjustments		—			(1,689	)		(1,689	)
Balance at June 30, 2018	$	295,264		$	84,560		$	379,824

(1) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of June 30, 2018 and when the Company expects to recognize this revenue.

	Twelve Months Ended June 30,
Remaining Performance Obligations	2019		2020		2021		2022		2023		Thereafter		Total
Deferred revenue - NCM	$	15,831	$	15,831	$	15,831	$	15,831	$	15,831	$	216,109	$	295,264
Deferred revenue - other		72,053		12,039		282		186		—		—		84,560
Total	$	87,884	$	27,870	$	16,113	$	16,017	$	15,831	$	216,109	$	379,824

Adoption of ASC Topic 606

Revenue Initial Application Period Cumulative Effect Transition [Line Items]

Schedule of Changes Increased (Decreased) Admissions, Concession and Other Revenue

The above noted changes increased (decreased) admissions, concession and other revenue for the three and six months ended June 30, 2018 as follows:

	Three Months Ended			Six Months Ended
	June 30, 2018			June 30, 2018
Admissions revenues	$	(1,898	)	$	(3,200	)
Concession revenues	$	(662	)	$	(1,207	)
Other revenues	$	32,710		$	60,169

XML

Equity (Tables)

6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Summary of Changes in Stockholder’s Equity

Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the six months ended June 30, 2018 and 2017:

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling		Total
	Equity			Interests		Equity
Balance at January 1, 2018	$	1,409,602		$	11,893	$	1,421,495
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)		40,526			—		40,526
Share based awards compensation expense		6,422			—		6,422
Dividends paid to parent		(74,350	)		—		(74,350	)
Net income		145,208			485		145,693
Other comprehensive income in equity method investees		20			—		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)
Balance at June 30, 2018	$	1,471,384		$	12,378	$	1,483,762

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling			Total
	Equity			Interests			Equity
Balance at January 1, 2017	$	1,272,938		$	11,142		$	1,284,080
Share based awards compensation expense		6,051		―				6,051
Dividends paid to parent		(67,250	)	―				(67,250	)
Dividends paid to noncontrolling interests	―				(294	)		(294	)
Net income		131,825			1,037			132,862
Other comprehensive income in equity method investees		103		―				103
Foreign currency translation adjustments		(5,059	)	―				(5,059	)
Balance at June 30, 2017	$	1,338,608		$	11,885		$	1,350,493

XML

Investment in National CineMedia (Tables) - NCM

6 Months Ended

Jun. 30, 2018

Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

	Investment in NCM			Deferred Revenue			Distributions from NCM			Equity in Earnings			Other Revenue			Interest Expense - NCM (3)		Cash Received
Balance as of January 1, 2018	$	200,550		$	(351,706	)
Impact of adoption of ASC Topic 606 (1)		—			53,605		$	—		$	—		$	—		$	—	$	—
Receipt of common units due to annual common    unit adjustment ("CUA")		5,012			(5,012	)		—			—			—			—		—
Revenues earned under ESA (2) (3)		—			—			—			—			(16,074	)		9,892		6,182
Receipt of excess cash distributions		(8,760	)		—			(7,735	)		—			—			—		16,495
Receipt under tax receivable agreement		(2,294	)		—			(2,047	)		—			—			—		4,341
Equity in earnings		4,511			—			—			(4,511	)		—			—		—
Amortization of deferred revenue		—			7,849			—			—			(7,849	)		—		—
Balance as of and for the six months ended June 30, 2018	$	199,019		$	(295,264	)	$	(9,782	)	$	(4,511	)	$	(23,923	)	$	9,892	$	27,018

(1) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and Common Unit Adjustment agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption.  The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings (see also Note 5).  See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.  

(2) Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $6,227.

(3)   Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements.  See Note 3.  

Summary Financial Information

Below is summary financial information for NCM for the periods indicated:

	ThreeMonths Ended				Six Months Ended
	June 28, 2018		June 29, 2017		June 28, 2018		June 29, 2017
Gross revenues	$	113,700	$	97,100	$	193,900	$	169,000
Operating income	$	40,100	$	28,300	$	51,100	$	33,400
Net income	$	25,000	$	15,400	$	22,000	$	7,500

	As of			As of
	June 28, 2018			December 28, 2017
Current assets	$	142,800		$	174,400
Noncurrent assets	$	758,800		$	758,300
Current liabilities	$	84,800		$	123,300
Noncurrent liabilities	$	943,500		$	925,400
Members deficit	$	(126,700	)	$	(116,000	)

XML

Other Investments (Tables)

6 Months Ended

Jun. 30, 2018

Summary of Activity for Each of Company's Other Investments

Below is a summary of activity for each of the Company’s other investments for the six months ended June 30, 2018:

	DCIP			ACJV, LLC		DCDC			FE Concepts			Other		Total
Balance at January 1, 2018	$	106,215		$	5,916	$	3,598		$	104		$	4,212	$	120,045
Cash contributions made		739			—		—			20,000					20,739
Cash distributions received		(5,201	)		—		—			—			—		(5,201	)
Equity in income (loss)		9,727			408		481			(77	)		—		10,539
Equity in other comprehensive income		20			—		—			—			—		20
Other		—			—		(1,168	)		(104	)		211		(1,061	)
Balance at June 30, 2018	$	111,500		$	6,324	$	2,911		$	19,923		$	4,423	$	145,081

Digital Cinema Implementation Partners

Summary Financial Information

Below is summary financial information for DCIP for the periods indicated:

	Three Months Ended				Six Months Ended
	June 30, 2018		June 30, 2017		June 30, 2018		June 30, 2017
Gross revenues	$	42,521	$	47,095	$	83,554	$	92,574
Operating income	$	25,049	$	29,393	$	48,494	$	57,872
Net income	$	22,169	$	25,616	$	43,703	$	49,757

	As of
	June 30, 2018		December 31, 2017
Current assets	$	51,546	$	56,296
Noncurrent assets	$	725,399	$	772,438
Current liabilities	$	63,982	$	59,153
Noncurrent liabilities	$	213,795	$	296,889
Members' equity	$	499,168	$	472,692

Transactions with DCIP

The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and six months ended June 30, 2018 and 2017:

	ThreeMonths Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Equipment lease payments	$	1,243		$	1,511		$	2,460		$	2,881
Warranty reimbursements from DCIP	$	(2,617	)	$	(2,023	)	$	(5,118	)	$	(3,907	)
Management service fees	$	184		$	206		$	378		$	412

XML

Share Based Awards (Tables)

6 Months Ended

Jun. 30, 2018

Summary of Restricted Stock Activity

Below is a summary of restricted stock activity for the six months ended June 30, 2018:

	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2018		650,581		$	35.81
Granted		321,406		$	38.79
Vested		(242,945	)	$	31.16
Forfeited		(18,643	)	$	38.33
Outstanding at June 30, 2018		710,399		$	38.68
Unvested restricted stock at June 30, 2018		710,399		$	38.68

Summary of Restricted Stock Unit Award Activity

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the six months ended June 30, 2018at each of the three target levels of financial performance (excluding forfeiture assumptions):

	Number of
	Shares		Value at
	Vesting		Grant
at IRR of at least 7%		76,065	$	2,967
at IRR of at least 9.5%		152,129	$	5,934
at IRR of at least 13%		228,194	$	8,901

Restricted Stock

Summary of Restricted Stock Award Activity

	Six Months Ended June 30,
	2018		2017
Compensation expense recognized by the Company during the period	$	4,342	$	3,901
Additional compensation expense recognized by Cinemark Holdings, Inc. during the period	$	456	$	393
Fair value of restricted shares held by Company employees that vested during the period	$	7,013	$	7,174
Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period	$	802	$	917
Income tax benefit recognized upon vesting of restricted stock awards held by Company employees	$	1,550	$	2,247
Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors	$	201	$	386

Restricted Stock Units (RSUs)

Summary of Restricted Stock Unit Award Activity

	Six Months Ended June 30,
	2018		2017
Number of restricted stock unit awards that vested during    the period		127,084		97,115
Fair value of restricted stock unit awards that vested during    the period	$	4,846	$	4,155
Accumulated dividends paid upon vesting of restricted stock    unit awards	$	501	$	313
Compensation expense recognized during the period	$	2,080	$	2,150
Income tax benefit recognized upon vesting of restricted stock    unit awards	$	740	$	1,745

XML

Goodwill and Other Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Goodwill

The Company’s goodwill was as follows:

	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2018 (1)	$	1,174,041	$	110,038		$	1,284,079
Acquisition of theatres in Brazil (2)		—		11,508			11,508
Foreign currency translation adjustments		—		(14,417	)		(14,417	)
Balance at June 30, 2018 (1)	$	1,174,041	$	107,129		$	1,281,170

(1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

(2) Amount represents preliminary purchase price allocation for theatres acquired in Brazil.

Intangible Assets

Intangible assets consisted of the following:

	Balance at											Balance at
	January 1,											June 30,
	2018			Additions (1)		Amortization			Other (2)			2018
Intangible assets with finite lives:
Gross carrying amount	$	105,895		$	—	$	—		$	(1,645	)	$	104,250
Accumulated amortization		(68,869	)	―			(2,932	)	―				(71,801	)
Total net intangible assets with finite lives	$	37,026		$	—	$	(2,932	)	$	(1,645	)	$	32,449
Intangible assets with indefinite lives:
Tradename and other		299,735			608	―				(286	)		300,057
Total intangible assets — net	$	336,761		$	608	$	(2,932	)	$	(1,931	)	$	332,506

(1) Amount represents the acquisition of tradeable liquor licenses.

(2) Amount represents foreign currency translation adjustments.

Estimated Aggregate Future Amortization Expense for Intangible Assets

Estimated aggregate future amortization expense for intangible assets is as follows:

For the six months ended December 31, 2018	$	2,661
For the twelve months ended December 31, 2019		5,152
For the twelve months ended December 31, 2020		5,310
For the twelve months ended December 31, 2021		3,574
For the twelve months ended December 31, 2022		3,207
Thereafter		12,545
Total	$	32,449

XML

Impairment of Long-Lived Assets (Tables)

6 Months Ended

Jun. 30, 2018

Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]

Long-Lived Asset Impairment Charges

Below is a summary of impairment charges for the periods presented:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2018		2017		2018		2017
U.S. theatre properties	$	1,187	$	84	$	1,778	$	357
International theatre properties		1,601		4,217		1,601		4,217
Impairment of long-lived assets	$	2,788	$	4,301	$	3,379	$	4,574

XML

Foreign Currency Translation (Tables)

6 Months Ended

Jun. 30, 2018

Fair Value Disclosures [Abstract]

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries

Below is a summary of the impact of translating the June 30, 2018 financial statements of the Company’s international subsidiaries:

					Other
					Comprehensive
					Income (Loss) for the
	Exchange Rate as of				Six Months Ended
Country	June 30, 2018		December 31, 2017		June 30, 2018
Brazil		3.88		3.31	$	(34,511	)
Argentina		28.94		18.65		(16,896	)
Peru		3.28		3.24		(580	)
Chile		654.28		615.97		(4,372	)
All other						315
					$	(56,044	)

XML

Supplemental Cash Flow Information (Tables)

6 Months Ended

Jun. 30, 2018

Supplemental Cash Flow Elements [Abstract]

Supplemental Information to Condensed Consolidated Statements of Cash Flows

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

	Six Months Ended
	June 30,
	2018			2017
Cash paid for interest	$	51,562		$	49,603
Cash paid for income taxes, net of refunds received	$	28,477		$	55,371
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the    acquisition of theatre properties and equipment (1)	$	2,898		$	(4,959	)
Theatre properties acquired under capital lease	$	4,035		$	7,089
Interest expense - NCM (see Note 3)	$	(9,892	)	$	—
Investment in NCM – receipt of common units (see    Note 6)	$	5,012		$	18,363

(1) Additions to theatre properties and equipment included in accounts payable as of June 30, 2018 and December 31, 2017 were $34,174 and $31,276, respectively.

XML

Segments (Tables)

6 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Selected Financial Information by Reportable Operating Segment

Below is a breakdown of selected financial information by reportable operating segment:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Revenues
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
International		179,979			199,926			363,607			401,994
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total revenues	$	889,053		$	751,195		$	1,669,024		$	1,530,805
Adjusted EBITDA
U.S.	$	188,920		$	129,976		$	345,190		$	295,038
International		33,192			41,285			70,778			88,511
Total Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549
Capital expenditures
U.S.	$	59,675		$	77,175		$	129,646		$	155,992
International		22,751			14,438			32,943			26,808
Total capital expenditures	$	82,426		$	91,613		$	162,589		$	182,800

Reconciliation of Net Income to Adjusted EBITDA

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Add (deduct):		-			-
Income taxes		18,502			29,742			43,755			74,370
Interest expense (1)		28,466			26,522			55,581			52,891
Other (income) expense (2)		840			(7,030	)		(6,430	)		(20,012	)
Loss on debt amendments		—			246			1,484			246
Other cash distributions from equity investees (3)		3,932			2,870			16,255			14,919
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Deferred lease expenses		(449	)		(375	)		(932	)		(722	)
Amortization of long-term prepaid rents		597			496			1,236			989
Share based awards compensation expense		3,223			3,002			6,422			6,051
Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549

(1) Includes amortization of debt issue costs.

(2) Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.

(3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7).  These distributions are reported entirely within the U.S. operating segment.

(4) The adoption of ASC Topic 606 impacted how the Company records certain revenues.  See Note 3 for discussion of the impact of ASC Topic 606.  

Selected Financial Information by Geographic Area

Below is a breakdown of selected financial information by geographic area:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
Revenues	2018			2017			2018			2017
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
Brazil		72,977			87,841			153,113			182,540
Other international countries		107,002			112,085			210,494			219,454
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total	$	889,053		$	751,195		$	1,669,024		$	1,530,805

	As of		As of
Theatre Properties and Equipment-net	June 30, 2018		December 31, 2017
U.S.	$	1,465,915	$	1,439,168
Brazil		146,467		179,669
Other international countries		205,355		209,217
Total	$	1,817,737	$	1,828,054

XML

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)

6 Months Ended

Jun. 30, 2018

Statement Of Financial Position [Abstract]

Condensed Consolidating Balance Sheet Information

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

DECEMBER 31, 2017

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	130,590	$	180,623	$	211,202	$	—		$	522,415
Other current assets		59,661		17,841		76,789		(19,270	)		135,021
Accounts receivable from parent or subsidiaries		117,972		119,616		—		(223,007	)		14,581
Total current assets		308,223		318,080		287,991		(242,277	)		672,017
Theatre properties and equipment - net		650,783		765,500		411,771		—			1,828,054
Investment in subsidiaries		1,691,626		121,795		—		(1,813,421	)		—
Other assets		1,427,328		134,845		536,816		(113,720	)		1,985,269
Total assets	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	5,710	$	—	$	1,389	$	—		$	7,099
Current portion of capital lease obligations		9,532		11,124		4,855		—			25,511
Accounts payable and accrued expenses		215,580		116,409		110,089		(6,402	)		435,676
Accounts payable to parent or subsidiaries		—		—		223,007		(223,007	)		—
Total current liabilities		230,822		127,533		339,340		(229,409	)		468,286
Long-term liabilities
Long-term debt, less current portion		1,878,992		—		11,211		(109,822	)		1,780,381
Capital lease obligations, less current    portion		132,189		75,767		43,195		—			251,151
Other long-term liabilities and deferrals		426,355		60,567		93,871		(16,766	)		564,027
Total long-term liabilities		2,437,536		136,334		148,277		(126,588	)		2,595,559
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,360,059		618,985		726,830		(1,345,815	)		1,360,059
Total Cinemark USA, Inc. stockholder's    equity		1,409,602		1,076,353		737,068		(1,813,421	)		1,409,602
Noncontrolling interests		—		—		11,893		—			11,893
Total equity		1,409,602		1,076,353		748,961		(1,813,421	)		1,421,495
Total liabilities and equity	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

JUNE 30, 2018

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	301,796	$	8,711	$	194,188	$	—		$	504,695
Other current assets		70,203		21,043		67,168		(34,952	)		123,462
Accounts receivable from parent or subsidiaries		—		324,697		—		(305,734	)		18,963
Total current assets		371,999		354,451		261,356		(340,686	)		647,120
Theatre properties and equipment - net		670,573		769,293		377,871		—			1,817,737
Investment in subsidiaries		1,763,463		89,214		—		(1,852,677	)		—
Other assets		1,427,050		154,648		540,294		(112,678	)		2,009,314
Total assets	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	—	$	1,389	$	—		$	7,984
Current portion of capital lease obligations		12,192		9,579		4,900		—			26,671
Accounts payable and accrued expenses		237,615		101,384		96,104		(30,324	)		404,779
Accounts payable to parent or subsidiaries		101,094		—		204,640		(305,734	)		—
Total current liabilities		357,496		110,963		307,033		(336,058	)		439,434
Long-term liabilities
Long-term debt, less current portion		1,873,393		—		9,343		(107,954	)		1,774,782
Capital lease obligations, less current portion		129,201		67,623		42,181		—			239,005
Other long-term liabilities and deferrals		401,611		59,509		85,420		(9,352	)		537,188
Total long-term liabilities		2,404,205		127,132		136,944		(117,306	)		2,550,975
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,421,841		672,143		712,928		(1,385,071	)		1,421,841
Total Cinemark USA, Inc. stockholder's equity		1,471,384		1,129,511		723,166		(1,852,677	)		1,471,384
Noncontrolling interests		—		—		12,378		—			12,378
Total equity		1,471,384		1,129,511		735,544		(1,852,677	)		1,483,762
Total liabilities and equity	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171

Condensed Consolidating Statement of Income Information

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	247,821		$	305,019		$	209,998		$	(11,643	)	$	751,195
Cost of operations
Theatre operating expenses		197,345			210,406			155,540			(11,643	)		551,648
General and administrative expenses		2,365			20,872			13,814			—			37,051
Depreciation and amortization		20,193			21,767			17,177			—			59,137
Impairment of long-lived assets		41			43			4,217			—			4,301
(Gain) loss on disposal of assets and other		5,072			(4,866	)		(152	)		—			54
Total cost of operations		225,016			248,222			190,596			(11,643	)		652,191
Operating income		22,805			56,797			19,402			—			99,004
Other income (expense)
Interest expense		(23,473	)		(1,836	)		(1,571	)		358			(26,522	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			2,772			—			2,772
Equity in income of affiliates		52,156			12,299			5,851			(64,501	)		5,805
Other income		224			162			1,197			(358	)		1,225
Total other income (expense)		28,661			10,625			8,249			(64,501	)		(16,966	)
Income before income taxes		51,466			67,422			27,651			(64,501	)		82,038
Income taxes		(259	)		25,412			4,589			—			29,742
Net income		51,725			42,010			23,062			(64,501	)		52,296
Less: Net income attributable to    noncontrolling interests		—			—			571			—			571
Net income attributable to Cinemark USA,    Inc.	$	51,725		$	42,010		$	22,491		$	(64,501	)	$	51,725

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	332,976		$	385,703		$	191,616		$	(21,242	)	$	889,053
Cost of operations
Theatre operating expenses		255,711			255,943			144,963			(21,242	)		635,375
General and administrative expenses		3,651			25,097			13,545			—			42,293
Depreciation and amortization		22,216			24,049			18,025			—			64,290
Impairment of long-lived assets		1,187			—			1,601			—			2,788
Loss on disposal of assets and other		2,462			13,978			461			—			16,901
Total cost of operations		285,227			319,067			178,595			(21,242	)		761,647
Operating income		47,749			66,636			13,021			—			127,406
Other income (expense)
Interest expense		(24,156	)		(1,703	)		(2,949	)		342			(28,466	)
Distributions from NCM		—			—			3,424			—			3,424
Interest expense - NCM		(4,913	)		—			—			—			(4,913	)
Equity in income of affiliates		68,807			2,677			6,339			(71,409	)		6,414
Other income (expense)		1,392			(62	)		(3,329	)		(342	)		(2,341	)
Total other income (expense)		41,130			912			3,485			(71,409	)		(25,882	)
Income before income taxes		88,879			67,548			16,506			(71,409	)		101,524
Income taxes		6,186			15,586			(3,270	)		—			18,502
Net income		82,693			51,962			19,776			(71,409	)		83,022
Less: Net income attributable to    noncontrolling interests		—			—			329			—			329
Net income attributable to Cinemark USA,    Inc.	$	82,693		$	51,962		$	19,447		$	(71,409	)	$	82,693

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	517,702		$	615,975		$	421,993		$	(24,865	)	$	1,530,805
Cost of operations
Theatre operating expenses		402,576			417,589			308,086			(24,865	)		1,103,386
General and administrative expenses		6,625			41,209			26,833			—			74,667
Depreciation and amortization		39,851			42,161			34,481			—			116,493
Impairment of long-lived assets		286			71			4,217			—			4,574
(Gain) loss on disposal of assets and other		5,505			(4,682	)		65			—			888
Total cost of operations		454,843			496,348			373,682			(24,865	)		1,300,008
Operating income		62,859			119,627			48,311			—			230,797
Other income (expense)
Interest expense		(46,783	)		(3,733	)		(3,090	)		715			(52,891	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			9,560			—			9,560
Equity in income of affiliates		120,245			29,754			15,327			(149,461	)		15,865
Other income		1,887			162			2,813			(715	)		4,147
Total other income (expense)		75,103			26,183			24,610			(149,461	)		(23,565	)
Income before income taxes		137,962			145,810			72,921			(149,461	)		207,232
Income taxes		6,137			43,899			24,334			—			74,370
Net income		131,825			101,911			48,587			(149,461	)		132,862
Less: Net income attributable to    noncontrolling interests		—			—			1,037			—			1,037
Net income attributable to Cinemark USA,    Inc.	$	131,825		$	101,911		$	47,550		$	(149,461	)	$	131,825

CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Revenues	$	615,305		$	704,124		$	384,221		$	(34,626	)	$	1,669,024
Cost of operations
Theatre operating expenses		474,489			474,473			287,459			(34,626	)		1,201,795
General and administrative expenses		6,760			49,950			27,314			—			84,024
Depreciation and amortization		43,655			48,330			36,700			—			128,685
Impairment of long-lived assets		1,201			—			2,178			—			3,379
Loss on disposal of assets and other		4,768			15,409			663			—			20,840
Total cost of operations		530,873			588,162			354,314			(34,626	)		1,438,723
Operating income		84,432			115,962			29,907			—			230,301
Other income (expense)
Interest expense		(48,384	)		(3,361	)		(4,529	)		693			(55,581	)
Loss on debt amendments		(1,484	)		—			—			—			(1,484	)
Distributions from NCM		—			—			9,782			—			9,782
Interest expense - NCM		(9,892	)		—			—			—			(9,892	)
Equity in income of affiliates		128,908			6,963			13,919			(134,740	)		15,050
Other income (expense)		2,204			(7	)		(232	)		(693	)		1,272
Total other income (expense)		71,352			3,595			18,940			(134,740	)		(40,853	)
Income before income taxes		155,784			119,557			48,847			(134,740	)		189,448
Income taxes		10,576			26,940			6,239			—			43,755
Net income		145,208			92,617			42,608			(134,740	)		145,693
Less: Net income attributable to    noncontrolling interests		—			—			485			—			485
Net income attributable to Cinemark USA,    Inc.	$	145,208		$	92,617		$	42,123		$	(134,740	)	$	145,208

Condensed Consolidating Statement of Comprehensive Income (Loss) Information

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

THREE MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	51,725		$	42,010	$	23,062		$	(64,501	)	$	52,296
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(95	)		—		(95	)		95			(95	)
Foreign currency translation adjustments		(18,401	)		—		(18,401	)		18,401			(18,401	)
Total other comprehensive loss, net of tax		(18,496	)		—		(18,496	)		18,496			(18,496	)
Total comprehensive income, net of tax	$	33,229		$	42,010	$	4,566		$	(46,005	)	$	33,800
Comprehensive income attributable to noncontrolling interests		—			—		(571	)		—			(571	)
Comprehensive income attributable to Cinemark USA, Inc.	$	33,229		$	42,010	$	3,995		$	(46,005	)	$	33,229

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

THREE MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	82,693		$	51,962	$	19,776		$	(71,409	)	$	83,022
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(116	)		—		(116	)		116			(116	)
Foreign currency translation adjustments		(56,248	)		—		(56,248	)		56,248			(56,248	)
Total other comprehensive loss, net of tax		(56,364	)		—		(56,364	)		56,364			(56,364	)
Total comprehensive income (loss), net of tax	$	26,329		$	51,962	$	(36,588	)	$	(15,045	)	$	26,658
Comprehensive income attributable to noncontrolling interests		—			—		(329	)		—			(329	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	26,329		$	51,962	$	(36,917	)	$	(15,045	)	$	26,329

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	131,825		$	101,911	$	48,587		$	(149,461	)	$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		103			—		103			(103	)		103
Foreign currency translation adjustments		(3,508	)		—		(3,508	)		3,508			(3,508	)
Total other comprehensive loss, net of tax		(3,405	)		—		(3,405	)		3,405			(3,405	)
Total comprehensive income, net of tax	$	128,420		$	101,911	$	45,182		$	(146,056	)	$	129,457
Comprehensive income attributable to noncontrolling interests		—			—		(1,037	)		—			(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	128,420		$	101,911	$	44,145		$	(146,056	)	$	128,420

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated
Net income	$	145,208		$	92,617	$	42,608		$	(134,740	)	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		20			—		20			(20	)		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)		56,044			(56,044	)
Total other comprehensive loss, net of tax		(56,024	)		—		(56,024	)		56,024			(56,024	)
Total comprehensive income (loss), net of tax	$	89,184		$	92,617	$	(13,416	)	$	(78,716	)	$	89,669
Comprehensive income attributable to noncontrolling interests		—			—		(485	)		—			(485	)
Comprehensive income attributable to    Cinemark USA, Inc.	$	89,184		$	92,617	$	(13,901	)	$	(78,716	)	$	89,184

Condensed Consolidating Statement of Cash Flows Information

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2017

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	131,825		$	101,911		$	48,587		$	(149,461	)	$	132,862
Adjustments to reconcile net income to cash provided by (used for) operating activities		(62,144	)		13,264			36,647			149,461			137,228
Changes in assets and liabilities		(83,338	)		38,444			10,170			—			(34,724	)
Net cash provided by (used for) operating activities		(13,657	)		153,619			95,404			—			235,366
Investing activities
Additions to theatre properties and equipment		(62,198	)		(92,383	)		(28,219	)		—			(182,800	)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(12,500	)		—			(28,329	)		—			(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,143			12,255			123			—			14,521
Dividends received from subsidiaries		127,300			6			—			(127,306	)		—
Investment in joint ventures and other		—			—			(466	)		—			(466	)
Net cash provided by (used for) investing activities		54,745			(80,122	)		(56,891	)		(127,306	)		(209,574	)
Financing activities
Dividends paid to parent		(67,250	)		(127,000	)		(306	)		127,306			(67,250	)
Repayments of long-term debt		(1,427	)		—			—			—			(1,427	)
Payments on capital leases		(3,628	)		(4,632	)		(1,883	)		—			(10,143	)
Other		(784	)		(2,921	)		(294	)		—			(3,999	)
Net cash used for financing activities		(73,089	)		(134,553	)		(2,483	)		127,306			(82,819	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(75	)		—			(75	)
Increase (decrease) in cash and cash equivalents		(32,001	)		(61,056	)		35,955			—			(57,102	)
Cash and cash equivalents:
Beginning of year		146,855			281,023			133,260			—			561,138
End of year	$	114,854		$	219,967		$	169,215		$	—		$	504,036

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION

SIX MONTHS ENDED JUNE 30, 2018

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated
Operating activities
Net income	$	145,208		$	92,617		$	42,608		$	(134,740	)	$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		(73,458	)		62,445			38,412			134,740			162,139
Changes in assets and liabilities		230,402			(220,516	)		(38,073	)		—			(28,187	)
Net cash provided by (used for) operating activities		302,152			(65,454	)		42,947			—			279,645
Investing activities
Additions to theatre properties and equipment		(44,970	)		(79,756	)		(37,863	)		—			(162,589	)
Acquisition of theatres in international markets, net of cash acquired		—			—			(11,508	)		—			(11,508	)
Proceeds from sale of theatre properties and equipment and other		1,244			485			406			—			2,135
Proceeds from intercompany note repayment		1,867			—			—			(1,867	)		—
Investment in joint ventures and other		—			(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(41,859	)		(99,167	)		(48,536	)		(1,867	)		(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			—			(74,350	)
Repayments of long-term debt		(3,298	)		—			—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			—			(5,103	)
Repayment of intercompany note		—			—			(1,867	)		1,867			—
Payments on capital leases		(5,632	)		(4,386	)		(2,359	)		—			(12,377	)
Other		(704	)		(2,905	)		—			—			(3,609	)
Net cash used for financing activities		(89,087	)		(7,291	)		(4,226	)		1,867			(98,737	)
Effect of exchange rate changes on cash and    cash equivalents		—			—			(7,199	)		—			(7,199	)
Increase (decrease) in cash and cash    equivalents		171,206			(171,912	)		(17,014	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		130,590			180,623			211,202			—			522,415
End of year	$	301,796		$	8,711		$	194,188		$	—		$	504,695

*   *   *   *   *

XML

The Company and Basis of Presentation - Additional Information (Detail)	Jun. 30, 2018
Minimum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	20.00%
Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%

XML

New Accounting Pronouncements - Additional Information (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2017 USD ($)
ASU 2016-15 | Reclassified from Operating Activities to Financing Activities | June 2017 Amendment of Senior Secured Credit Facility
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Cash paid	$ 246

XML

Revenue Recognition - Additional Information (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Jan. 01, 2018
Revenue Recognition [Line Items]
Cumulative effect of accounting change adjustment net of taxes, in retained earnings			$ 40,526,000
Receivables related to contracts with customers	$ 48,631,000	$ 48,631,000
Assets related to costs to obtain or fulfill contract with customers	0	0
NCM
Revenue Recognition [Line Items]
Remaining performance obligations	174,000,000	$ 174,000,000
Deferred revenue amortization year and month		2037-02
Recognized incremental screen advertising revenue and offsetting interest expense	$ 4,913,000	$ 9,892,000
NCM | Minimum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates		5.50%
NCM | Maximum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates		8.00%

XML

Revenue Recognition - Schedule of Changes Increased (Decreased) Admissions, Concession and Other Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Admissions Revenues
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	508,870	449,880	961,494	926,349
Admissions Revenues | Adoption of ASC Topic 606 | Adjustments due to Adoption of ASC Topic 606
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	(1,898)		(3,200)
Concession Revenues
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	305,306	$ 262,322	567,078	$ 530,546
Concession Revenues | Adoption of ASC Topic 606 | Adjustments due to Adoption of ASC Topic 606
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	(662)		(1,207)
Other Revenue
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	38,380		71,507
Other Revenue | Adoption of ASC Topic 606 | Adjustments due to Adoption of ASC Topic 606
Increase Decrease in Revenues ASU 2014-09 Transition [Line Items]
Revenues	$ 32,710		$ 60,169

XML

Revenue Recognition - Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Disaggregation of Revenue [Line Items]
Total revenues		$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		508,870	449,880	961,494	926,349
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		305,306	$ 262,322	567,078	$ 530,546
Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		36,497		68,945
Other Revenue
Disaggregation of Revenue [Line Items]
Total revenues		38,380		71,507
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	709,074		1,305,417
U.S. Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	408,863		758,215
U.S. Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	249,618		453,368
U.S. Operating Segment | Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[1]	21,051		39,230
U.S. Operating Segment | Other Revenue
Disaggregation of Revenue [Line Items]
Total revenues	[1]	29,542		54,604
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		179,979		363,607
International Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		100,007		203,279
International Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		55,688		113,710
International Operating Segment | Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		15,446		29,715
International Operating Segment | Other Revenue
Disaggregation of Revenue [Line Items]
Total revenues		$ 8,838		$ 16,903

[1] U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 14 for additional information on intercompany eliminations.

XML

Revenue Recognition - Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Disaggregation of Revenue [Line Items]
Total revenues		$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	709,074		1,305,417
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		179,979		363,607
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		847,813		1,589,788
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	686,463		1,262,289
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		161,350		327,499
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		41,240		79,236
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	22,611		43,128
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 18,629		$ 36,108

[1] U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 14 for additional information on intercompany eliminations.

XML

Revenue Recognition - Changes in Deferred Revenues (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018	$ 438,204
Impact of adoption of ASC Topic 606	(53,605)
Amounts recognized as accounts receivable	11,349
Cash received from customers in advance	53,398
Common units received from NCM (see Note 7)	5,012
Revenue recognized during period	(72,845)
Foreign currency translation adjustments	(1,689)
Balance at June 30, 2018	379,824
Deferred Revenue
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 7)	(5,012)
Deferred Revenue | NCM
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018	351,706
Impact of adoption of ASC Topic 606	(53,605)
Common units received from NCM (see Note 7)	5,012
Revenue recognized during period	(7,849)
Balance at June 30, 2018	295,264
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018	86,498	[1]
Amounts recognized as accounts receivable	11,349	[1]
Cash received from customers in advance	53,398	[1]
Revenue recognized during period	(64,996)	[1]
Foreign currency translation adjustments	(1,689)	[1]
Balance at June 30, 2018	$ 84,560	[1]

[1] Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

XML

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) $ in Thousands	Jun. 30, 2018 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 87,884
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 27,870
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 16,113
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 16,017
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Remaining performance obligations	$ 216,109
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: (nil)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	379,824
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	216,109
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: (nil)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	295,264
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	72,053
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	12,039
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	282
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-07-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	186
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: (nil)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 84,560

XML

Long Term Debt Activity - Additional Information (Detail) - USD ($) $ in Thousands		6 Months Ended
	Mar. 29, 2018	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Debt Instrument [Line Items]
Incurred debt issue costs		$ 5,103	$ 521
Carrying value of long-term debt		1,813,997		$ 1,817,295
Fair value of long-term debt		1,800,830		$ 1,840,918
Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Debt instrument, reduction in interest rate	0.25%
Quarterly principal payments due	$ 1,649
Last quarterly payment date	Dec. 31, 2024
Final principal payment	$ 613,351
Incurred debt issue costs		4,962
Wrote-off of unamortized debt issuance costs		780
Loss on debt amendments		$ 704
Amended Senior Secured Credit Facility | Term Loan Credit facility
Debt Instrument [Line Items]
Final principal payment due date	Mar. 29, 2025

XML

Summary of Changes in Stockholders Equity (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jan. 01, 2018
Shareholders Equity [Line Items]
Cinemark USA, Inc. stockholder's equity, Beginning Balance			$ 1,409,602
Noncontrolling Interests, Beginning balance			11,893
Total Equity, Beginning Balance			1,421,495	$ 1,284,080
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)					$ 40,526
Share based awards compensation expense			6,422	6,051
Dividends paid to parent			(74,350)	(67,250)
Dividends paid to noncontrolling interests				(294)
Net income attributable to Cinemark USA, Inc.	$ 82,693	$ 51,725	145,208	131,825
Net income attributable to Noncontrolling Interests	(329)	(571)	(485)	(1,037)
Net income	83,022	52,296	145,693	132,862
Other comprehensive income in equity method investees	(116)	(95)	20	103
Foreign currency translation adjustments			(56,044)	(5,059)
Cinemark USA, Inc. stockholder's equity, Ending Balance	1,471,384		1,471,384
Noncontrolling Interests, Ending Balance	12,378		12,378
Total Equity, Ending Balance	1,483,762	1,350,493	1,483,762	1,350,493
Cinemark USA, Inc. Stockholder's Equity
Shareholders Equity [Line Items]
Cinemark USA, Inc. stockholder's equity, Beginning Balance			1,409,602	1,272,938
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)					$ 40,526
Share based awards compensation expense			6,422	6,051
Dividends paid to parent			(74,350)	(67,250)
Net income attributable to Cinemark USA, Inc.			145,208	131,825
Other comprehensive income in equity method investees			20	103
Foreign currency translation adjustments			(56,044)	(5,059)
Cinemark USA, Inc. stockholder's equity, Ending Balance	1,471,384	1,338,608	1,471,384	1,338,608
Noncontrolling Interests
Shareholders Equity [Line Items]
Noncontrolling Interests, Beginning balance			11,893	11,142
Dividends paid to noncontrolling interests				(294)
Net income attributable to Noncontrolling Interests			485	1,037
Noncontrolling Interests, Ending Balance	$ 12,378	$ 11,885	$ 12,378	$ 11,885

XML

Summary of Changes in Stockholders Equity (Parenthetical) (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Equity [Abstract]
Cumulative effect of change in accounting principle, taxes	$ 13,079

XML

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jan. 01, 2018
Schedule Of Equity Method Investments [Line Items]
Impact of adoption of ASC Topic 606						$ 40,526
Receipt of common units due to annual common unit adjustment ("CUA")				$ 5,012
Equity in earnings		$ 6,414	$ 5,805	15,050	$ 15,865
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				200,550
Beginning Balance				(351,706)
Equity in earnings		495	$ 176	4,511	$ 3,065
Ending Balance		199,019		199,019
Ending Balance		(295,264)		(295,264)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				200,550
Receipt of common units due to annual common unit adjustment ("CUA")				5,012
Receipt of excess cash distributions				(8,760)
Receipt under tax receivable agreement				(2,294)
Equity in earnings				4,511
Ending Balance		199,019		199,019
Deferred Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				(351,706)
Impact of adoption of ASC Topic 606	[1]					$ 53,605
Receipt of common units due to annual common unit adjustment ("CUA")				(5,012)
Ending Balance		(295,264)		(295,264)
Deferred Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment ("CUA")				5,012
Amortization of deferred revenue				7,849
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of excess cash distributions				(7,735)
Receipt under tax receivable agreement				(2,047)
Ending Balance		(9,782)		(9,782)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Ending Balance		(4,511)		(4,511)
Equity in Earnings | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings				(4,511)
Other Revenue
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[2],[3]			(16,074)
Ending Balance		(23,923)		(23,923)
Other Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of deferred revenue				(7,849)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[2],[3]			9,892
Ending Balance	[3]	9,892		9,892
Cash Received
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[2],[3]			6,182
Receipt of excess cash distributions				16,495
Receipt under tax receivable agreement				4,341
Ending Balance		$ 27,018		$ 27,018

[1] As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and Common Unit Adjustment agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings (see also Note 5). See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.

[2] Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $6,227.

[3] Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements. See Note 3.

XML

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Equity Method Investments And Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 6,227

XML

Investment in National CineMedia - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018 USD ($) $ / shares shares	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($) $ / shares shares	Jun. 30, 2017 USD ($)
Schedule Of Equity Method Investments [Line Items]
Equity in earnings	$ 6,414	$ 5,805	$ 15,050	$ 15,865
Number of additional common units of NCM received under common unit adjustment agreement | shares	908,042
Value of common units received from NCM	$ 5,012		$ 5,012	18,363
Remaining term of exhibitor services agreement	19 years
Number of common units of NCM owned by Company | shares	28,779,904		28,779,904
Interest in common units of NCM owned by Company	18.00%		18.00%
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings			$ 4,511
Common unit convertible into share of NCMI common stock, conversion ratio	1		1
Estimated fair value of investment using NCM's stock price	$ 241,751		$ 241,751
NCMI common stock price | $ / shares	$ 8.40		$ 8.40
NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings	$ 495	$ 176	$ 4,511	3,065
Interest in common units of NCM owned by Company	18.00%		18.00%
NCM | Theatre Properties and Equipment
Schedule Of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising			$ 60	$ 50

XML

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 28, 2018	Jun. 29, 2017	Jun. 28, 2018	Jun. 29, 2017	Dec. 28, 2017
Schedule Of Equity Method Investments [Line Items]
Gross revenues	$ 113,700	$ 97,100	$ 193,900	$ 169,000
Operating income	40,100	28,300	51,100	33,400
Net income	25,000	$ 15,400	22,000	$ 7,500
Current assets	142,800		142,800		$ 174,400
Noncurrent assets	758,800		758,800		758,300
Current liabilities	84,800		84,800		123,300
Noncurrent liabilities	943,500		943,500		925,400
Members deficit	$ (126,700)		$ (126,700)		$ (116,000)

XML

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				$ 120,045
Cash distributions received	[1]	$ (3,932)	$ (2,870)	(16,255)	$ (14,919)
Equity in income (loss)		6,414	5,805	15,050	15,865
Equity in other comprehensive income		(116)	$ (95)	20	$ 103
Investments, ending balance		145,081		145,081
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				120,045
Cash contributions made				20,739
Cash distributions received				(5,201)
Equity in income (loss)				10,539
Equity in other comprehensive income				20
Other				(1,061)
Investments, ending balance		145,081		145,081
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				106,215
Cash contributions made				739
Cash distributions received				(5,201)
Equity in income (loss)				9,727
Equity in other comprehensive income				20
Other				0
Investments, ending balance		111,500		111,500
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				5,916
Cash contributions made				0
Cash distributions received				0
Equity in income (loss)				408
Equity in other comprehensive income				0
Other				0
Investments, ending balance		6,324		6,324
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				3,598
Cash contributions made				0
Cash distributions received				0
Equity in income (loss)				481
Equity in other comprehensive income				0
Other				(1,168)
Investments, ending balance		2,911		2,911
Other Affiliates | FE Concepts, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				104
Cash contributions made				20,000
Cash distributions received				0
Equity in income (loss)				(77)
Equity in other comprehensive income				0
Other				(104)
Investments, ending balance		19,923		19,923
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				4,212
Cash contributions made				0
Cash distributions received				0
Equity in income (loss)				0
Equity in other comprehensive income				0
Other				211
Investments, ending balance		$ 4,423		$ 4,423

[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment.

XML

Other Investments - Additional Information (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($) ProjectionSystem	Jun. 30, 2017 USD ($)	Apr. 30, 2018 USD ($)
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	33.00%
Economic interest in Digital Cinema Implementation Partners	24.30%
Number of equipment being leased under master equipment lease agreement | ProjectionSystem	3,818
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Remaining outstanding balance of note payable	$ 2,778
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees	$ 5,588	$ 6,763
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	14.60%
Payments for content delivery services	$ 461	$ 446
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest			50.00%
Investment in joint venture			$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest			50.00%
Investment in joint venture			$ 20,000

XML

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Gross revenues	$ 42,521	$ 47,095	$ 83,554	$ 92,574
Operating income	25,049	29,393	48,494	57,872
Net income	22,169	$ 25,616	43,703	$ 49,757
Current assets	51,546		51,546		$ 56,296
Noncurrent assets	725,399		725,399		772,438
Current liabilities	63,982		63,982		59,153
Noncurrent liabilities	213,795		213,795		296,889
Members' equity	$ 499,168		$ 499,168		$ 472,692

XML

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	$ 1,243	$ 1,511	$ 2,460	$ 2,881
Warranty reimbursements from DCIP	(2,617)	(2,023)	(5,118)	(3,907)
Management service fees	$ 184	$ 206	$ 378	$ 412

XML

Share Based Awards - Additional Information (Detail) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($) $ / shares shares
Restricted Stock
Stockholders Equity Note [Line Items]
Number of restricted shares	321,406
Market value of common stock on the dates of grant | $ / shares	$ 38.79
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 35.81
Forfeiture rate for restricted stock awards	0.00%
Award vesting period for restricted stock	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 39.26
Forfeiture rate for restricted stock awards	10.00%
Award vesting period for restricted stock	4 years
Unvested Restricted Stock Awards
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 19,408
Remaining Compensation Expense recognition period (in years)	2 years
Unvested Restricted Stock Awards | Cinemark USA, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 18,528
Unvested Restricted Stock Awards | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	880
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 9,854
Remaining Compensation Expense recognition period (in years)	2 years
Number of hypothetical shares of common stock	228,194
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2019 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee of Cinemark Holdings, Inc.’s board of directors prior to the grant date
Internal rate of return, performance period	2 years
Percentage of IRR, which is the threshold	7.00%
Percentage of IRR, which is the target	9.50%
Percentage of IRR, which is the maximum	13.00%
Percentage of IRR expected	11.00%
Share-based compensation arrangement by share-based payment award, vesting condition	All restricted stock units granted during 2018 will vest subject to an additional two-year service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date
Number of hypothetical shares of common stock at maximum IRR level	594,266
Actual cumulative forfeitures (in units)	18,667
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Percentage of IRR, which is the target	8.00%
Achieved Percentage of IRR	7.20%
Reduction in compensation expense | $	$ 69
Restricted Stock Units (RSUs) | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 37.55
Expected forfeiture rate	0.00%
Restricted Stock Units (RSUs) | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant | $ / shares	$ 39.03
Expected forfeiture rate	5.00%
Restricted Stock Units (RSUs) | Maximum | Threshold IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	76,065
Restricted Stock Units (RSUs) | Maximum | Targeted IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	152,129
Restricted Stock Units (RSUs) | Maximum | Maximum IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	100.00%

XML

Summary of Restricted Stock Activity (Detail) - Restricted Stock	6 Months Ended
	Jun. 30, 2018 $ / shares shares
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance | shares	650,581
Shares of Restricted Stock, Granted | shares	321,406
Shares of Restricted Stock, Vested | shares	(242,945)
Shares of Restricted Stock, Forfeited | shares	(18,643)
Shares of Restricted Stock, Ending balance | shares	710,399
Shares of Restricted Stock, Unvested restricted stock | shares	710,399
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning | $ / shares	$ 35.81
Weighted Average Grant Date Fair Value, Granted | $ / shares	38.79
Weighted Average Grant Date Fair Value, Vested | $ / shares	31.16
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	38.33
Weighted Average Grant Date Fair Value Outstanding, Ending | $ / shares	38.68
Weighted Average Grant Date Fair Value, Unvested restricted stock | $ / shares	$ 38.68

XML

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	$ 4,342	$ 3,901
Number of restricted stock unit awards that vested during the period	242,945
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of share based awards that vested during the period	$ 7,013	7,174
Income tax benefit recognized upon vesting of restricted stock awards	1,550	2,247
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	456	393
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of share based awards that vested during the period	802	917
Income tax benefit recognized upon vesting of restricted stock awards	201	386
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	2,080	2,150
Fair value of share based awards that vested during the period	4,846	4,155
Income tax benefit recognized upon vesting of restricted stock awards	$ 740	$ 1,745
Number of restricted stock unit awards that vested during the period	127,084	97,115
Accumulated dividends paid upon vesting of restricted stock unit awards	$ 501	$ 313

XML

Summary of Potential Number of Shares Vesting under Restricted Stock Unit Awards (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($) shares
Disclosure Of Restricted Stock Unit [Abstract]
Number of shares vesting at IRR of at least 7% | shares	76,065
Number of shares vesting at IRR of at least 9.5% | shares	152,129
Number of shares vesting at IRR of at least 13% | shares	228,194
Value at grant at IRR of at least 7% | $	$ 2,967
Value at grant at IRR of at least 9.5% | $	5,934
Value at grant at IRR of at least 13% | $	$ 8,901

XML

Summary of Goodwill (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Goodwill [Line Items]
Beginning Balance	$ 1,284,079	[1]
Acquisition of theatres in Brazil	11,508	[2]
Foreign currency translation adjustments	(14,417)
Ending Balance	1,281,170	[1]
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	1,174,041	[1]
Ending Balance	1,174,041	[1]
International Operating Segment
Goodwill [Line Items]
Beginning Balance	110,038	[1]
Acquisition of theatres in Brazil	11,508	[2]
Foreign currency translation adjustments	(14,417)
Ending Balance	$ 107,129	[1]

[1] Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

[2] Amount represents preliminary purchase price allocation for theatres acquired in Brazil.

XML

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Jun. 30, 2018 USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

XML

Goodwill and Other Intangible Assets - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2018 Community Country
U.S. Operating Segment
Goodwill [Line Items]
Number of reporting unit | Community	19
International Operating Segment
Goodwill [Line Items]
Number of reporting unit | Country	7

XML

Intangible Assets (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible assets with finite lives, Beginning balance	$ 105,895
Other, Gross carrying amount	(1,645)	[1]
Intangible assets with finite lives, Ending balance	104,250
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(68,869)
Accumulated amortization additions	0	[2]
Accumulated amortization	(2,932)
Other Accumulated Amortization of Intangible Assets	0	[1]
Intangible assets with finite lives, Accumulated amortization, Ending balance	(71,801)
Net intangible assets with finite lives, Beginning balance	37,026
Intangible assets with finite lives, additions	0	[2]
Amortization, intangible assets	(2,932)
Other, Finite lived intangible assets	(1,645)	[1]
Net intangible assets with finite lives, Ending balance	32,449
Indefinite-lived Intangible Assets, Tradename and other, Beginning Balance	299,735
Indefinite lived intangible assets, additions	608	[2]
Other, Tradename and other	(286)	[1]
Indefinite-lived Intangible Assets, Tradename and other, Ending Balance	300,057
Total intangible assets - net, Beginning balance	336,761
Other, Total intangible assets - net	(1,931)	[1]
Total intangible assets - net, Ending balance	$ 332,506

[1] Amount represents foreign currency translation adjustments.

[2] Amount represents the acquisition of tradeable liquor licenses.

XML

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Finite Lived Intangible Assets Net [Abstract]
For the six months ended December 31, 2018	$ 2,661
For the twelve months ended December 31, 2019	5,152
For the twelve months ended December 31, 2020	5,310
For the twelve months ended December 31, 2021	3,574
For the twelve months ended December 31, 2022	3,207
Thereafter	12,545
Total	$ 32,449	$ 37,026

XML

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2018 USD ($)	Jun. 30, 2017
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 871
Multiple of cash flows used to estimate fair value of long-lived asset	6.5	6.5

XML

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 2,788	$ 4,301	$ 3,379	$ 4,574
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	1,187	84	1,778	357
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 1,601	$ 4,217	$ 1,601	$ 4,217

XML

Fair Value Measurements - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Fair value of assets transfers in or out, level 1 to level 2	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0
Fair value, asset transfers into Level 3	0
Fair value, asset transfers out of Level 3	0
Fair Value, Measurements, Recurring
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Assets at fair value on recurring basis	0	$ 0
Liabilities at fair value on recurring basis	$ 0	$ 0

XML

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Foreign Currency [Abstract]
Accumulated other comprehensive income (loss)	$ 309,306	$ 253,282
Cumulative foreign currency adjustments	$ 309,609	$ 253,565
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years

XML

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Dec. 31, 2017
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (56,248)	$ (18,401)	$ (56,044)	$ (3,508)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	3.88		3.88		3.31
Other comprehensive Income (Loss)			$ (34,511)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	28.94		28.94		18.65
Other comprehensive Income (Loss)			$ (16,896)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.28		3.28		3.24
Other comprehensive Income (Loss)			$ (580)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	654.28		654.28		615.97
Other comprehensive Income (Loss)			$ (4,372)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)			315
International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)			$ (56,044)

XML

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
		Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2017
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest			$ 51,562	$ 49,603
Cash paid for income taxes, net of refunds received			28,477	55,371
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]		2,898	(4,959)
Theatre properties acquired under capital lease			4,035	7,089
Investment in NCM – receipt of common units (see Note 6)		$ 5,012	5,012	$ 18,363
NCM
Noncash investing and financing activities:
Interest expense - NCM (see Note 3)		$ (4,913)	$ (9,892)

[1] Additions to theatre properties and equipment included in accounts payable as of June 30, 2018 and December 31, 2017 were $34,174 and $31,276, respectively.

XML

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 34,174	$ 31,276

XML

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting Information [Line Items]
Revenues		$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Adjusted EBITDA		222,112	171,261	415,968	383,549
Capital expenditures		82,426	91,613	162,589	182,800
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[1]	709,074		1,305,417
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		179,979		363,607
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		712,483	554,929	1,312,128	1,136,138
Adjusted EBITDA		188,920	129,976	345,190	295,038
Capital expenditures		59,675	77,175	129,646	155,992
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		179,979	199,926	363,607	401,994
Adjusted EBITDA		33,192	41,285	70,778	88,511
Capital expenditures		22,751	14,438	32,943	26,808
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (3,409)	$ (3,660)	$ (6,711)	$ (7,327)

[1] U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 14 for additional information on intercompany eliminations.

XML

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting [Abstract]
Net income		$ 83,022	$ 52,296	$ 145,693	$ 132,862
Add (deduct):
Income taxes		18,502	29,742	43,755	74,370
Interest expense	[1]	28,466	26,522	55,581	52,891
Other (income) expense	[2]	840	(7,030)	(6,430)	(20,012)
Loss on debt amendments			246	1,484	246
Other cash distributions from equity investees	[3]	3,932	2,870	16,255	14,919
Depreciation and amortization		64,290	59,137	128,685	116,493
Impairment of long-lived assets		2,788	4,301	3,379	4,574
Loss on disposal of assets and other		16,901	54	20,840	888
Deferred lease expenses		(449)	(375)	(932)	(722)
Amortization of long-term prepaid rents		597	496	1,236	989
Share based awards compensation expense		3,223	3,002	6,422	6,051
Adjusted EBITDA		$ 222,112	$ 171,261	$ 415,968	$ 383,549

[1] Includes amortization of debt issue costs.

[2] Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.

[3] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 6 and 7). These distributions are reported entirely within the U.S. operating segment.

XML

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Theatre Properties and Equipment - net	1,817,737		1,817,737		$ 1,828,054
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	712,483	554,929	1,312,128	1,136,138
Theatre Properties and Equipment - net	1,465,915		1,465,915		1,439,168
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	72,977	87,841	153,113	182,540
Theatre Properties and Equipment - net	146,467		146,467		179,669
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	107,002	112,085	210,494	219,454
Theatre Properties and Equipment - net	205,355		205,355		$ 209,217
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (3,409)	$ (3,660)	$ (6,711)	$ (7,327)

XML

Related Party Transactions - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2018 USD ($) Theatre Facility Lease	Jun. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)
Related Party Transaction [Line Items]
Net receivable from Cinemark Holdings, Inc.	$ 18,963,000		$ 14,581,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 74,350,000	$ 67,250,000
FE Concepts LLC
Related Party Transaction [Line Items]
Equity method investment, ownership percentage	50.00%
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	327,000	305,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 51,000	63,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 12,980,000	13,420,000
Cinemark Holdings, Inc.
Related Party Transaction [Line Items]
Net receivable from Cinemark Holdings, Inc.	18,963,000		$ 14,581,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 74,350,000	$ 67,250,000

XML

Subsequent Event - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Jul. 05, 2018	Jun. 30, 2018
Subsequent Event [Line Items]
Interest in common units of NCM owned by Company		18.00%
NCM
Subsequent Event [Line Items]
Interest in common units of NCM owned by Company		18.00%
NCM | Subsequent Event
Subsequent Event [Line Items]
Number of common units of NCM acquired by Company	10,738,740
Value of common units in cash	$ 78,400
Common unit price per share	$ 7.30
Interest in common units of NCM owned by Company	25.00%

XML

Condensed Consolidating Financial Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Jun. 30, 2018 USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

XML

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 504,695	$ 522,415
Other current assets	123,462	135,021
Accounts receivable from parent or subsidiaries	18,963	14,581
Total current assets	647,120	672,017
Theatre properties and equipment - net	1,817,737	1,828,054
Investment in subsidiaries	0	0
Other assets	2,009,314	1,985,269
Total assets	4,474,171	4,485,340
Current liabilities
Current portion of long-term debt	7,984	7,099
Current portion of capital lease obligations	26,671	25,511
Accounts payable and accrued expenses	404,779	435,676
Accounts payable to parent or subsidiaries	0	0
Total current liabilities	439,434	468,286
Long-term liabilities
Long-term debt, less current portion	1,774,782	1,780,381
Capital lease obligations, less current portion	239,005	251,151
Other long-term liabilities and deferrals	537,188	564,027
Total long-term liabilities	2,550,975	2,595,559
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,421,841	1,360,059
Total Cinemark USA, Inc.'s stockholder's equity	1,471,384	1,409,602
Noncontrolling interests	12,378	11,893
Total equity	1,483,762	1,421,495	$ 1,350,493	$ 1,284,080
Total liabilities and equity	4,474,171	4,485,340
Eliminations
Current assets
Cash and cash equivalents	0	0
Other current assets	(34,952)	(19,270)
Accounts receivable from parent or subsidiaries	(305,734)	(223,007)
Total current assets	(340,686)	(242,277)
Theatre properties and equipment - net	0	0
Investment in subsidiaries	(1,852,677)	(1,813,421)
Other assets	(112,678)	(113,720)
Total assets	(2,306,041)	(2,169,418)
Current liabilities
Current portion of long-term debt	0	0
Current portion of capital lease obligations	0	0
Accounts payable and accrued expenses	(30,324)	(6,402)
Accounts payable to parent or subsidiaries	(305,734)	(223,007)
Total current liabilities	(336,058)	(229,409)
Long-term liabilities
Long-term debt, less current portion	(107,954)	(109,822)
Capital lease obligations, less current portion	0	0
Other long-term liabilities and deferrals	(9,352)	(16,766)
Total long-term liabilities	(117,306)	(126,588)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	(467,606)	(467,606)
Other stockholder's equity	(1,385,071)	(1,345,815)
Total Cinemark USA, Inc.'s stockholder's equity	(1,852,677)	(1,813,421)
Noncontrolling interests	0	0
Total equity	(1,852,677)	(1,813,421)
Total liabilities and equity	(2,306,041)	(2,169,418)
Parent Company
Current assets
Cash and cash equivalents	301,796	130,590
Other current assets	70,203	59,661
Accounts receivable from parent or subsidiaries	0	117,972
Total current assets	371,999	308,223
Theatre properties and equipment - net	670,573	650,783
Investment in subsidiaries	1,763,463	1,691,626
Other assets	1,427,050	1,427,328
Total assets	4,233,085	4,077,960
Current liabilities
Current portion of long-term debt	6,595	5,710
Current portion of capital lease obligations	12,192	9,532
Accounts payable and accrued expenses	237,615	215,580
Accounts payable to parent or subsidiaries	101,094	0
Total current liabilities	357,496	230,822
Long-term liabilities
Long-term debt, less current portion	1,873,393	1,878,992
Capital lease obligations, less current portion	129,201	132,189
Other long-term liabilities and deferrals	401,611	426,355
Total long-term liabilities	2,404,205	2,437,536
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,421,841	1,360,059
Total Cinemark USA, Inc.'s stockholder's equity	1,471,384	1,409,602
Noncontrolling interests	0	0
Total equity	1,471,384	1,409,602
Total liabilities and equity	4,233,085	4,077,960
Subsidiary Guarantors
Current assets
Cash and cash equivalents	8,711	180,623
Other current assets	21,043	17,841
Accounts receivable from parent or subsidiaries	324,697	119,616
Total current assets	354,451	318,080
Theatre properties and equipment - net	769,293	765,500
Investment in subsidiaries	89,214	121,795
Other assets	154,648	134,845
Total assets	1,367,606	1,340,220
Current liabilities
Current portion of long-term debt	0	0
Current portion of capital lease obligations	9,579	11,124
Accounts payable and accrued expenses	101,384	116,409
Accounts payable to parent or subsidiaries	0	0
Total current liabilities	110,963	127,533
Long-term liabilities
Long-term debt, less current portion	0	0
Capital lease obligations, less current portion	67,623	75,767
Other long-term liabilities and deferrals	59,509	60,567
Total long-term liabilities	127,132	136,334
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	457,368	457,368
Other stockholder's equity	672,143	618,985
Total Cinemark USA, Inc.'s stockholder's equity	1,129,511	1,076,353
Noncontrolling interests	0	0
Total equity	1,129,511	1,076,353
Total liabilities and equity	1,367,606	1,340,220
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	194,188	211,202
Other current assets	67,168	76,789
Accounts receivable from parent or subsidiaries	0	0
Total current assets	261,356	287,991
Theatre properties and equipment - net	377,871	411,771
Investment in subsidiaries	0	0
Other assets	540,294	536,816
Total assets	1,179,521	1,236,578
Current liabilities
Current portion of long-term debt	1,389	1,389
Current portion of capital lease obligations	4,900	4,855
Accounts payable and accrued expenses	96,104	110,089
Accounts payable to parent or subsidiaries	204,640	223,007
Total current liabilities	307,033	339,340
Long-term liabilities
Long-term debt, less current portion	9,343	11,211
Capital lease obligations, less current portion	42,181	43,195
Other long-term liabilities and deferrals	85,420	93,871
Total long-term liabilities	136,944	148,277
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	10,238	10,238
Other stockholder's equity	712,928	726,830
Total Cinemark USA, Inc.'s stockholder's equity	723,166	737,068
Noncontrolling interests	12,378	11,893
Total equity	735,544	748,961
Total liabilities and equity	$ 1,179,521	$ 1,236,578

XML

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Condensed Financial Statements, Captions [Line Items]
Revenues		$ 889,053	$ 751,195	$ 1,669,024	$ 1,530,805
Cost of operations
Theatre operating expenses		635,375	551,648	1,201,795	1,103,386
General and administrative expenses		42,293	37,051	84,024	74,667
Depreciation and amortization		64,290	59,137	128,685	116,493
Impairment of long-lived assets		2,788	4,301	3,379	4,574
(Gain) loss on disposal of assets and other		16,901	54	20,840	888
Total cost of operations		761,647	652,191	1,438,723	1,300,008
Operating income		127,406	99,004	230,301	230,797
Other income (expense)
Interest expense	[1]	(28,466)	(26,522)	(55,581)	(52,891)
Loss on debt amendments			(246)	(1,484)	(246)
Equity in income of affiliates		6,414	5,805	15,050	15,865
Other income (expense)		(2,341)	1,225	1,272	4,147
Total other expense		(25,882)	(16,966)	(40,853)	(23,565)
Income before income taxes		101,524	82,038	189,448	207,232
Income taxes		18,502	29,742	43,755	74,370
Net income		83,022	52,296	145,693	132,862
Less: Net income attributable to noncontrolling interests		329	571	485	1,037
Net income attributable to Cinemark USA, Inc.		82,693	51,725	145,208	131,825
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenues		(21,242)	(11,643)	(34,626)	(24,865)
Cost of operations
Theatre operating expenses		(21,242)	(11,643)	(34,626)	(24,865)
General and administrative expenses		0	0	0	0
Depreciation and amortization		0	0	0	0
Impairment of long-lived assets		0	0	0	0
(Gain) loss on disposal of assets and other		0	0	0	0
Total cost of operations		(21,242)	(11,643)	(34,626)	(24,865)
Operating income		0	0	0	0
Other income (expense)
Interest expense		342	358	693	715
Loss on debt amendments			0	0	0
Equity in income of affiliates		(71,409)	(64,501)	(134,740)	(149,461)
Other income (expense)		(342)	(358)	(693)	(715)
Total other expense		(71,409)	(64,501)	(134,740)	(149,461)
Income before income taxes		(71,409)	(64,501)	(134,740)	(149,461)
Income taxes		0	0	0	0
Net income		(71,409)	(64,501)	(134,740)	(149,461)
Less: Net income attributable to noncontrolling interests		0	0	0	0
Net income attributable to Cinemark USA, Inc.		(71,409)	(64,501)	(134,740)	(149,461)
NCM
Other income (expense)
Distributions from NCM		3,424	2,772	9,782	9,560
Interest expense - NCM		(4,913)		(9,892)
Equity in income of affiliates		495	176	4,511	3,065
NCM | Eliminations
Other income (expense)
Distributions from NCM		0	0	0	0
Interest expense - NCM		0		0
Parent Company
Condensed Financial Statements, Captions [Line Items]
Revenues		332,976	247,821	615,305	517,702
Cost of operations
Theatre operating expenses		255,711	197,345	474,489	402,576
General and administrative expenses		3,651	2,365	6,760	6,625
Depreciation and amortization		22,216	20,193	43,655	39,851
Impairment of long-lived assets		1,187	41	1,201	286
(Gain) loss on disposal of assets and other		2,462	5,072	4,768	5,505
Total cost of operations		285,227	225,016	530,873	454,843
Operating income		47,749	22,805	84,432	62,859
Other income (expense)
Interest expense		(24,156)	(23,473)	(48,384)	(46,783)
Loss on debt amendments			(246)	(1,484)	(246)
Equity in income of affiliates		68,807	52,156	128,908	120,245
Other income (expense)		1,392	224	2,204	1,887
Total other expense		41,130	28,661	71,352	75,103
Income before income taxes		88,879	51,466	155,784	137,962
Income taxes		6,186	(259)	10,576	6,137
Net income		82,693	51,725	145,208	131,825
Less: Net income attributable to noncontrolling interests		0	0	0	0
Net income attributable to Cinemark USA, Inc.		82,693	51,725	145,208	131,825
Parent Company | NCM
Other income (expense)
Distributions from NCM		0	0	0	0
Interest expense - NCM		(4,913)		(9,892)
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues		385,703	305,019	704,124	615,975
Cost of operations
Theatre operating expenses		255,943	210,406	474,473	417,589
General and administrative expenses		25,097	20,872	49,950	41,209
Depreciation and amortization		24,049	21,767	48,330	42,161
Impairment of long-lived assets		0	43	0	71
(Gain) loss on disposal of assets and other		13,978	(4,866)	15,409	(4,682)
Total cost of operations		319,067	248,222	588,162	496,348
Operating income		66,636	56,797	115,962	119,627
Other income (expense)
Interest expense		(1,703)	(1,836)	(3,361)	(3,733)
Loss on debt amendments			0	0	0
Equity in income of affiliates		2,677	12,299	6,963	29,754
Other income (expense)		(62)	162	(7)	162
Total other expense		912	10,625	3,595	26,183
Income before income taxes		67,548	67,422	119,557	145,810
Income taxes		15,586	25,412	26,940	43,899
Net income		51,962	42,010	92,617	101,911
Less: Net income attributable to noncontrolling interests		0	0	0	0
Net income attributable to Cinemark USA, Inc.		51,962	42,010	92,617	101,911
Subsidiary Guarantors | NCM
Other income (expense)
Distributions from NCM		0	0	0	0
Interest expense - NCM		0		0
Subsidiary Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues		191,616	209,998	384,221	421,993
Cost of operations
Theatre operating expenses		144,963	155,540	287,459	308,086
General and administrative expenses		13,545	13,814	27,314	26,833
Depreciation and amortization		18,025	17,177	36,700	34,481
Impairment of long-lived assets		1,601	4,217	2,178	4,217
(Gain) loss on disposal of assets and other		461	(152)	663	65
Total cost of operations		178,595	190,596	354,314	373,682
Operating income		13,021	19,402	29,907	48,311
Other income (expense)
Interest expense		(2,949)	(1,571)	(4,529)	(3,090)
Loss on debt amendments			0	0	0
Equity in income of affiliates		6,339	5,851	13,919	15,327
Other income (expense)		(3,329)	1,197	(232)	2,813
Total other expense		3,485	8,249	18,940	24,610
Income before income taxes		16,506	27,651	48,847	72,921
Income taxes		(3,270)	4,589	6,239	24,334
Net income		19,776	23,062	42,608	48,587
Less: Net income attributable to noncontrolling interests		329	571	485	1,037
Net income attributable to Cinemark USA, Inc.		19,447	22,491	42,123	47,550
Subsidiary Non-Guarantors | NCM
Other income (expense)
Distributions from NCM		3,424	$ 2,772	9,782	$ 9,560
Interest expense - NCM		$ 0		$ 0

[1] Includes amortization of debt issue costs.

XML

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Condensed Statement Of Income Captions [Line Items]
Net income	$ 83,022	$ 52,296	$ 145,693	$ 132,862
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	26,658	33,800	89,669	129,457
Comprehensive income attributable to noncontrolling interests	(329)	(571)	(485)	(1,037)
Comprehensive income attributable to Cinemark USA, Inc.	26,329	33,229	89,184	128,420
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	26,658	33,800	89,669	129,457
Comprehensive income attributable to noncontrolling interests	(329)	(571)	(485)	(1,037)
Comprehensive income attributable to Cinemark USA, Inc.	26,329	33,229	89,184	128,420
Eliminations
Condensed Statement Of Income Captions [Line Items]
Net income	(71,409)	(64,501)	(134,740)	(149,461)
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) of equity method investments	116	95	(20)	(103)
Foreign currency translation adjustments	56,248	18,401	56,044	3,508
Total other comprehensive loss, net of tax	56,364	18,496	56,024	3,405
Total comprehensive income, net of tax	(15,045)	(46,005)	(78,716)	(146,056)
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	(15,045)	(46,005)	(78,716)	(146,056)
Other comprehensive income (loss) of equity method investments	116	95	(20)	(103)
Foreign currency translation adjustments	56,248	18,401	56,044	3,508
Total other comprehensive loss, net of tax	56,364	18,496	56,024	3,405
Total comprehensive income, net of tax	(15,045)	(46,005)	(78,716)	(146,056)
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	(15,045)	(46,005)	(78,716)	(146,056)
Parent Company
Condensed Statement Of Income Captions [Line Items]
Net income	82,693	51,725	145,208	131,825
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	26,329	33,229	89,184	128,420
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	26,329	33,229	89,184	128,420
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	26,329	33,229	89,184	128,420
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	26,329	33,229	89,184	128,420
Subsidiary Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	51,962	42,010	92,617	101,911
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) of equity method investments	0	0	0	0
Foreign currency translation adjustments	0	0	0	0
Total other comprehensive loss, net of tax	0	0	0	0
Total comprehensive income, net of tax	51,962	42,010	92,617	101,911
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	51,962	42,010	92,617	101,911
Other comprehensive income (loss) of equity method investments	0	0	0	0
Foreign currency translation adjustments	0	0	0	0
Total other comprehensive loss, net of tax	0	0	0	0
Total comprehensive income, net of tax	51,962	42,010	92,617	101,911
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	51,962	42,010	92,617	101,911
Subsidiary Non-Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	19,776	23,062	42,608	48,587
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	(36,588)	4,566	(13,416)	45,182
Comprehensive income attributable to noncontrolling interests	(329)	(571)	(485)	(1,037)
Comprehensive income attributable to Cinemark USA, Inc.	(36,917)	3,995	(13,901)	44,145
Other comprehensive income (loss) of equity method investments	(116)	(95)	20	103
Foreign currency translation adjustments	(56,248)	(18,401)	(56,044)	(3,508)
Total other comprehensive loss, net of tax	(56,364)	(18,496)	(56,024)	(3,405)
Total comprehensive income, net of tax	(36,588)	4,566	(13,416)	45,182
Comprehensive income attributable to noncontrolling interests	(329)	(571)	(485)	(1,037)
Comprehensive income attributable to Cinemark USA, Inc.	$ (36,917)	$ 3,995	$ (13,901)	$ 44,145

XML

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Operating activities
Net income	$ 83,022	$ 52,296	$ 145,693	$ 132,862
Adjustments to reconcile net income to cash provided by (used for) operating activities			162,139	137,228
Changes in assets and liabilities			(28,187)	(34,724)
Net cash provided by operating activities			279,645	235,366
Investing activities
Additions to theatre properties and equipment	(82,426)	(91,613)	(162,589)	(182,800)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired			(11,508)	(40,829)
Proceeds from sale of theatre properties and equipment and other			2,135	14,521
Dividends received from subsidiaries				0
Proceeds from intercompany note repayment			0
Investment in joint ventures and other, net			(19,467)	(466)
Net cash used for investing activities			(191,429)	(209,574)
Financing activities
Dividends paid to parent			(74,350)	(67,250)
Repayments of long-term debt			(3,298)	(1,427)
Payment of debt issue costs			(5,103)	(521)
Repayment of intercompany note			0
Payments on capital leases			(12,377)	(10,143)
Other			(3,609)	(3,999)
Net cash used for financing activities			(98,737)	(82,819)
Effect of exchange rate changes on cash and cash equivalents			(7,199)	(75)
Increase (decrease) in cash and cash equivalents			(17,720)	(57,102)
Cash and cash equivalents:
Beginning of period			522,415	561,138
End of period	504,695	504,036	504,695	504,036
Eliminations
Operating activities
Net income	(71,409)	(64,501)	(134,740)	(149,461)
Adjustments to reconcile net income to cash provided by (used for) operating activities			134,740	149,461
Changes in assets and liabilities			0	0
Net cash provided by operating activities				0
Investing activities
Additions to theatre properties and equipment			0	0
Acquisitions of theatres in the U.S. and international markets, net of cash acquired			0	0
Proceeds from sale of theatre properties and equipment and other			0	0
Dividends received from subsidiaries				(127,306)
Proceeds from intercompany note repayment			(1,867)
Investment in joint ventures and other, net			0	0
Net cash used for investing activities			(1,867)	(127,306)
Financing activities
Dividends paid to parent			0	127,306
Repayments of long-term debt			0	0
Payment of debt issue costs			0
Repayment of intercompany note			1,867
Payments on capital leases			0	0
Other			0	0
Net cash used for financing activities			1,867	127,306
Effect of exchange rate changes on cash and cash equivalents			0	0
Increase (decrease) in cash and cash equivalents			0	0
Cash and cash equivalents:
Beginning of period				0
End of period		0		0
Parent Company
Operating activities
Net income	82,693	51,725	145,208	131,825
Adjustments to reconcile net income to cash provided by (used for) operating activities			(73,458)	(62,144)
Changes in assets and liabilities			230,402	(83,338)
Net cash provided by operating activities			302,152	(13,657)
Investing activities
Additions to theatre properties and equipment			(44,970)	(62,198)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired			0	(12,500)
Proceeds from sale of theatre properties and equipment and other			1,244	2,143
Dividends received from subsidiaries				127,300
Proceeds from intercompany note repayment			1,867
Investment in joint ventures and other, net			0	0
Net cash used for investing activities			(41,859)	54,745
Financing activities
Dividends paid to parent			(74,350)	(67,250)
Repayments of long-term debt			(3,298)	(1,427)
Payment of debt issue costs			(5,103)
Repayment of intercompany note			0
Payments on capital leases			(5,632)	(3,628)
Other			(704)	(784)
Net cash used for financing activities			(89,087)	(73,089)
Effect of exchange rate changes on cash and cash equivalents			0	0
Increase (decrease) in cash and cash equivalents			171,206	(32,001)
Cash and cash equivalents:
Beginning of period			130,590	146,855
End of period	301,796	114,854	301,796	114,854
Subsidiary Guarantors
Operating activities
Net income	51,962	42,010	92,617	101,911
Adjustments to reconcile net income to cash provided by (used for) operating activities			62,445	13,264
Changes in assets and liabilities			(220,516)	38,444
Net cash provided by operating activities			(65,454)	153,619
Investing activities
Additions to theatre properties and equipment			(79,756)	(92,383)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired			0	0
Proceeds from sale of theatre properties and equipment and other			485	12,255
Dividends received from subsidiaries				6
Proceeds from intercompany note repayment			0
Investment in joint ventures and other, net			(19,896)	0
Net cash used for investing activities			(99,167)	(80,122)
Financing activities
Dividends paid to parent			0	(127,000)
Repayments of long-term debt			0	0
Payment of debt issue costs			0
Repayment of intercompany note			0
Payments on capital leases			(4,386)	(4,632)
Other			(2,905)	(2,921)
Net cash used for financing activities			(7,291)	(134,553)
Effect of exchange rate changes on cash and cash equivalents			0	0
Increase (decrease) in cash and cash equivalents			(171,912)	(61,056)
Cash and cash equivalents:
Beginning of period			180,623	281,023
End of period	8,711	219,967	8,711	219,967
Subsidiary Non-Guarantors
Operating activities
Net income	19,776	23,062	42,608	48,587
Adjustments to reconcile net income to cash provided by (used for) operating activities			38,412	36,647
Changes in assets and liabilities			(38,073)	10,170
Net cash provided by operating activities			42,947	95,404
Investing activities
Additions to theatre properties and equipment			(37,863)	(28,219)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired			(11,508)	(28,329)
Proceeds from sale of theatre properties and equipment and other			406	123
Dividends received from subsidiaries				0
Proceeds from intercompany note repayment			0
Investment in joint ventures and other, net			429	(466)
Net cash used for investing activities			(48,536)	(56,891)
Financing activities
Dividends paid to parent			0	(306)
Repayments of long-term debt			0	0
Payment of debt issue costs			0
Repayment of intercompany note			(1,867)
Payments on capital leases			(2,359)	(1,883)
Other			0	(294)
Net cash used for financing activities			(4,226)	(2,483)
Effect of exchange rate changes on cash and cash equivalents			(7,199)	(75)
Increase (decrease) in cash and cash equivalents			(17,014)	35,955
Cash and cash equivalents:
Beginning of period			211,202	133,260
End of period	$ 194,188	$ 169,215	$ 194,188	$ 169,215